<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Trends Endocrinol Metab</journal-id><journal-id journal-id-type="iso-abbrev">Trends Endocrinol Metab</journal-id><journal-id journal-id-type="pmc-domain-id">445</journal-id><journal-id journal-id-type="pmc-domain">elsevierwt</journal-id><journal-title-group><journal-title>Trends in Endocrinology and Metabolism</journal-title></journal-title-group><issn pub-type="ppub">1043-2760</issn><issn pub-type="epub">1879-3061</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Elsevier Sponsored Documents</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11616622</article-id><article-id pub-id-type="pmcid-ver">PMC11616622.1</article-id><article-id pub-id-type="pmcaid">11616622</article-id><article-id pub-id-type="pmcaiid">11616622</article-id><article-id pub-id-type="pmid">38760200</article-id><article-id pub-id-type="doi">10.1016/j.tem.2024.04.015</article-id><article-id pub-id-type="pii">S1043-2760(24)00109-7</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Feature Review</subject></subj-group></article-categories><title-group><article-title>Why cells need iron: a compendium of iron utilisation</article-title></title-group><contrib-group><contrib contrib-type="author" id="au0005"><name name-style="western"><surname>Teh</surname><given-names initials="MR">Megan R.</given-names></name><xref rid="af0005" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au0010"><name name-style="western"><surname>Armitage</surname><given-names initials="AE">Andrew E.</given-names></name><xref rid="af0005" ref-type="aff">1</xref></contrib><contrib contrib-type="author" id="au0015"><name name-style="western"><surname>Drakesmith</surname><given-names initials="H">Hal</given-names></name><email>alexander.drakesmith@imm.ox.ac.uk</email><xref rid="af0005" ref-type="aff">1</xref><xref rid="cr0005" ref-type="corresp">&#8270;</xref></contrib><aff id="af0005"><label>1</label>MRC Translational Immune Discovery Unit, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford, UK</aff></contrib-group><author-notes><corresp id="cr0005"><label>&#8270;</label>Correspondence: <email>alexander.drakesmith@imm.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><month>12</month><year>2024</year></pub-date><volume>35</volume><issue>12</issue><issue-id pub-id-type="pmc-issue-id">476340</issue-id><fpage>1026</fpage><lpage>1049</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>05</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-05 16:25:26.633"><day>05</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; 2024 The Authors</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract abstract-type="author-highlights" id="ab0005"><title>Highlights</title><p><list list-type="simple" id="l0005"><list-item id="li0005"><p id="p0015">Iron has a key role in multiple important cellular processes, including gene regulation, metabolism, bioenergetics, and hormone synthesis.</p></list-item><list-item id="li0010"><p id="p0020">Iron deficiency is globally widespread and associated with several and diverse impacts on health, the underlying mechanisms of which are poorly understood.</p></list-item><list-item id="li0015"><p id="p0025">We describe potential molecular causative links between cellular iron deficiency and a range of symptoms, and indicate important unknowns in the field.</p></list-item></list></p></abstract><abstract id="ab0010"><p>Iron deficiency is globally prevalent, causing an array of developmental, haematological, immunological, neurological, and cardiometabolic impairments, and is associated with symptoms ranging from chronic fatigue to hair loss. Within cells, iron is utilised in a variety of ways by hundreds of different proteins. Here, we review links between molecular activities regulated by iron and the pathophysiological effects of iron deficiency. We identify specific enzyme groups, biochemical pathways, cellular functions, and cell lineages that are particularly iron dependent. We provide examples of how iron deprivation influences multiple key systems and tissues, including immunity, hormone synthesis, and cholesterol metabolism. We propose that greater mechanistic understanding of how cellular iron influences physiological processes may lead to new therapeutic opportunities across a range of diseases.</p></abstract><abstract abstract-type="teaser" id="ab0015"><p>Iron deficiency is globally prevalent, causing an array of developmental, haematological, immunological, neurological, and cardiometabolic impairments, and is associated with symptoms ranging from chronic fatigue to hair loss. Within cells, iron is utilised in a variety of ways by hundreds of different proteins. Here, we review links between molecular activities regulated by iron and the pathophysiological effects of iron deficiency. We identify specific enzyme groups, biochemical pathways, cellular functions, and cell lineages that are particularly iron dependent. We provide examples of how iron deprivation influences multiple key systems and tissues, including immunity, hormone synthesis, and cholesterol metabolism. We propose that greater mechanistic understanding of how cellular iron influences physiological processes may lead to new therapeutic opportunities across a range of diseases.</p></abstract><kwd-group id="ks0005"><title>Keywords</title><kwd>iron</kwd><kwd>enzymes</kwd><kwd>metabolism</kwd><kwd>mitochondria</kwd><kwd>bioenergetics</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s0005"><title>Iron is essential for life</title><p id="p0030">Life relies on metal cofactors, including iron, zinc, manganese, copper, and molybdenum [<xref rid="bb0005" ref-type="bibr">1</xref>,<xref rid="bb0010" ref-type="bibr">2</xref>]. Iron specifically is utilised by almost all species, except <italic toggle="yes">Borrelia burgdorferi</italic> and lactobacilli [<xref rid="bb0015" ref-type="bibr">3.</xref>, <xref rid="bb0020" ref-type="bibr">4.</xref>, <xref rid="bb0025" ref-type="bibr">5.</xref>], with roles ranging from structural to enzymatic [<xref rid="bb0030" ref-type="bibr">6</xref>]. Biological systems have co-opted iron due to its ability to transiently bind gaseous ligands and to efficiently catalyse reduction&#8211;oxidation (redox) reactions necessary for cellular function [<xref rid="bb0035" ref-type="bibr">7</xref>].</p><p id="p0035">Within mammals, &#8764;70% of iron is incorporated into red blood cell (RBC) haemoglobin for oxygen transport to tissues [<xref rid="bb0035" ref-type="bibr">7</xref>,<xref rid="bb0040" ref-type="bibr">8</xref>]. Consequently, a common manifestation of iron deficiency is anaemia, with &gt;1.2 billion cases worldwide [<xref rid="bb0045" ref-type="bibr">9</xref>]. Non-anaemic iron deficiency prevalence is even higher [<xref rid="bb0045" ref-type="bibr">9</xref>]. While iron deficiency anaemia classically presents with hypochromic and microcytic RBCs [<xref rid="bb0050" ref-type="bibr">10</xref>], iron deficiency <italic toggle="yes">per se</italic> likely has broader impacts across body systems since all mammalian cells require iron. Absolute iron deficiency results from insufficient dietary iron intake, impaired iron absorption, or blood loss, while functional iron deficiency occurs during inappropriate prolonged tissue iron sequestration, as during chronic inflammation [<xref rid="bb0050" ref-type="bibr">10</xref>]. Iron depletion can also occur locally within tissue niches, such as the tumour microenvironment [<xref rid="bb0055" ref-type="bibr">11</xref>]. Iron deficiency is increasingly recognised to result in multiple pathophysiological effects, including impaired vaccine responses, hair loss, increased cardiac disease risk, and developmental delay [<xref rid="bb0050" ref-type="bibr">10</xref>,<xref rid="bb0060" ref-type="bibr">12</xref>].</p><p id="p0040">Here, we provide a comprehensive overview of the roles of iron in biochemistry, cell biology, and physiology. Where such information is available, we describe how iron deficiency influences these processes, making, in some cases, a first attempt to link underlying molecular mechanisms to diverse iron-related disease manifestations. We then pose new research questions to further translate our growing basic knowledge of iron biology into medical relevance.</p></sec><sec id="s0010"><title>Cellular iron uptake, storage, and trafficking</title><p id="p0045">The beneficial properties of iron for redox reactions also render iron toxic when in excess, generating reactive oxygen species (ROS) via Fenton reactions [<xref rid="bb0065" ref-type="bibr">13</xref>]. The universality of iron usage across kingdoms of life makes it critical for the growth of many pathogens during infection [<xref rid="bb0070" ref-type="bibr">14</xref>]. As a result, mammalian iron homeostasis is tightly regulated, primarily by the hepcidin&#8211;ferroportin interaction [<xref rid="bb0035" ref-type="bibr">7</xref>], reviewed extensively elsewhere [<xref rid="bb0075" ref-type="bibr">15</xref>,<xref rid="bb0080" ref-type="bibr">16</xref>]. Here, we describe cellular iron transport and then focus on the many roles of iron in cellular biology.</p><p id="p0050">Cellular iron uptake is canonically mediated by the transferrin receptor (TFRC, TfR1) [<xref rid="bb0085" ref-type="bibr">17</xref>]. TFRC binds iron-bound transferrin, inducing clathrin-mediated endocytosis [<xref rid="bb0085" ref-type="bibr">17</xref>]. Endosomal acidification releases iron from transferrin, and subsequent reduction of Fe<sup>3+</sup> to Fe<sup>2+</sup> enables transport into the cytosol, predominantly via DMT1 [NRAMP2/SLC11A2, a <bold>solute carrier (SLC) protein</bold>; see <xref rid="gs0005" ref-type="list">Glossary</xref>] [<xref rid="bb0085" ref-type="bibr">17</xref>,<xref rid="bb0090" ref-type="bibr">18</xref>]. Enterocytic DMT1 also mediates direct uptake of dietary non-haem iron [<xref rid="bb0095" ref-type="bibr">19</xref>]. Non-transferrin-bound iron (NTBI) can enter cells via the zinc transporters ZIP8 (SLC39A8) and ZIP14 (SLC39A14) [<xref rid="bb0100" ref-type="bibr">20</xref>,<xref rid="bb0105" ref-type="bibr">21</xref>], while iron bound to the extracellular matrix polysaccharide, hyaluronan, is proposed to bind CD44, with the resulting complex being taken up by endocytosis [<xref rid="bb0110" ref-type="bibr">22</xref>].</p><p id="p0055">Following cellular entry, iron can be mobilised to mitochondria for haem and iron sulfur (Fe-S) cluster biosynthesis, coordinated as an ion via amino acid side-chains into proteins, or stored by ferritin [<xref rid="bb0115" ref-type="bibr">23</xref>]. Ferritin is a 24-subunit cage-like protein complex comprising heavy (FTH) and light (FTL1/2) chain subunits [<xref rid="bb0035" ref-type="bibr">7</xref>], which can store up to &#8764;4300 iron atoms [<xref rid="bb0120" ref-type="bibr">24</xref>]. Ferritin buffers cellular iron by storing excess iron during abundance and releasing it during scarcity [<xref rid="bb0115" ref-type="bibr">23</xref>]. Iron release is mediated by ferritin breakdown (ferritinophagy) following delivery to autophagosomes by NCOA4 [<xref rid="bb0125" ref-type="bibr">25</xref>]. Trafficking of iron to ferritin and other cellular iron-binding proteins requires metallochaperones, such as PCBP1 and PCBP2 [<xref rid="bb0130" ref-type="bibr">26</xref>]. Fe-S clusters and haem groups are similarly chaperoned by proteins/complexes, such as <bold>glutaredoxin (GLRX)-</bold>3&#8211;BOLA2 and PGMRC2, respectively [<xref rid="bb0130" ref-type="bibr">26</xref>,<xref rid="bb0135" ref-type="bibr">27</xref>].</p><p id="p0060">Cellular iron export relies predominantly on ferroportin (SLC40A1) [<xref rid="bb0140" ref-type="bibr">28.</xref>, <xref rid="bb0145" ref-type="bibr">29.</xref>, <xref rid="bb0150" ref-type="bibr">30.</xref>, <xref rid="bb0155" ref-type="bibr">31.</xref>], although iron egress via secretion of ferritin-bound iron in extracellular vesicles and haem export via FLVCR1a, ABCG2, and ABCB5 have also been reported [<xref rid="bb0075" ref-type="bibr">15</xref>,<xref rid="bb0160" ref-type="bibr">32.</xref>, <xref rid="bb0165" ref-type="bibr">33.</xref>, <xref rid="bb0170" ref-type="bibr">34.</xref>].</p></sec><sec id="s0015"><title>Intracellular iron regulation</title><sec id="s0020"><title>Iron regulatory proteins</title><p id="p0065">Intracellular iron is tightly regulated because both iron deficiency and overload are associated with detrimental effects. Classically, intracellular iron is regulated by the iron regulatory protein (IRP)/iron response element (IRE) system [<xref rid="bb0115" ref-type="bibr">23</xref>]. The IRPs, cytosolic aconitase 1 (ACO1, IRP1) and IREB2 (IRP2), are activated by low cellular iron acting post transcriptionally by stabilising transcripts of proteins involved in iron uptake and preventing translation of transcripts encoding iron egress and storage proteins [<xref rid="bb0115" ref-type="bibr">23</xref>]. During iron repletion, ACO1 binds an [4Fe-4S] cluster, enabling catalysis but obstructing its RNA-binding site [<xref rid="bb0115" ref-type="bibr">23</xref>]. Upon cellular iron deficiency, the Fe-S cluster is lost, permitting ACO1 RNA binding [<xref rid="bb0115" ref-type="bibr">23</xref>]. By contrast, IREB2 is degraded during iron repletion following ubiquitination by the [2Fe-2S] cluster-stabilised ubiquitin-ligase, FBXL5 [<xref rid="bb0175" ref-type="bibr">35</xref>,<xref rid="bb0180" ref-type="bibr">36</xref>]. IRPs operate by binding IREs, which are mRNA hairpin loops in the 3&#8242; untranslated regions (UTR) of mRNAs encoding proteins that promote iron uptake (TFRC and DMT1) and in the 5&#8242; UTR of mRNAs linked to iron egress (ferroportin) and storage (FTL1/2, FTH) [<xref rid="bb0115" ref-type="bibr">23</xref>]. During iron deficiency, IRP binding to <italic toggle="yes">TFRC</italic> and <italic toggle="yes">DMT1</italic> 3&#8242;-IREs stabilises mRNA by blocking RNase entry, promoting iron uptake, while IRP binding to 5&#8242;-IRE-containing mRNAs excludes ribosome binding and translation, suppressing iron egress and storage by ferroportin and ferritin, respectively [<xref rid="bb0115" ref-type="bibr">23</xref>]. During iron scarcity, the IRE-IRP system also downregulates proteins associated with iron usage [<xref rid="bb0185" ref-type="bibr">37</xref>], including the haem synthesis protein, <bold>5-aminolevulinic acid synthase (ALAS)-2</bold> [<xref rid="bb0190" ref-type="bibr">38</xref>], and the tricarboxylic acid (TCA) cycle enzyme, mitochondrial aconitase 2 (ACO2), which requires a [2Fe-2S] cluster for catalysis [<xref rid="bb0195" ref-type="bibr">39</xref>]. Reducing iron use by haem synthesis and the TCA cycle may enable more efficient iron budgeting toward other essential pathways.</p></sec><sec id="s0025"><title>Hypoxia inducible factor</title><p id="p0070">Hypoxia-inducible factor (HIF) proteins are key regulators of the hypoxia response [<xref rid="bb0200" ref-type="bibr">40</xref>]. Under normoxic or iron-replete conditions, HIF&#945; proteins are hydroxylated by PHD enzymes, which are members of a large iron, oxygen, and 2-oxoglutarate [2-OG, &#945;-ketoglutarate (&#945;-KG)]-dependent enzyme family [<bold>2-OG dependent dioxygenases (2-OGDDs)</bold>] [<xref rid="bb0200" ref-type="bibr">40</xref>]. Hydroxylation promotes HIF&#945; ubiquitination by VHL proteins, marking HIF&#945; proteins for degradation [<xref rid="bb0200" ref-type="bibr">40</xref>]. Conversely, when oxygen or iron is limiting, PHD protein inactivity allows HIF&#945; stabilisation and transcriptional activity [<xref rid="bb0200" ref-type="bibr">40</xref>]. HIF&#945; proteins have broad transcriptional activity, but notably regulate metabolism [<xref rid="bb0205" ref-type="bibr">41</xref>]. HIF1&#945; promotes a metabolic shift away from oxygen consumption by upregulating glycolysis and suppressing oxidative phosphorylation (OXPHOS) and fatty acid &#946;-oxidation (both iron-requiring processes, see following section) [<xref rid="bb0205" ref-type="bibr">41</xref>]. Iron chelators and cobalt ions (which displace iron, thereby inactivating PHDs and stabilising HIF1&#945;) have historically been used to study hypoxia responses [<xref rid="bb0210" ref-type="bibr">42</xref>,<xref rid="bb0215" ref-type="bibr">43</xref>].</p></sec><sec id="s0030"><title>Haem-regulated inhibitor</title><p id="p0075">Cellular iron homeostasis is also regulated by haem in erythroid precursors via haem-regulated inhibitor (HRI, EIF2AK1) [<xref rid="bb0220" ref-type="bibr">44</xref>]. During haem repletion, haem binding inhibits the kinase activity of HRI [<xref rid="bb0220" ref-type="bibr">44</xref>]. Conversely, during haem deficiency, HRI becomes active, phosphorylating itself and the translational initiation factor, eIF-2&#945; [<xref rid="bb0220" ref-type="bibr">44</xref>]. eIF-2&#945; phosphorylation blocks globin translation, preventing detrimental accumulation of misfolded globins in the absence of haem [<xref rid="bb0220" ref-type="bibr">44</xref>]. Concurrently, eIF-2&#945; phosphorylation promotes the integrated stress response to support cell survival during haem insufficiency [<xref rid="bb0220" ref-type="bibr">44</xref>]. Recent work identified non-erythroid roles of HRI in the responses to mitochondrial stress and cytosolic protein misfolding [<xref rid="bb0225" ref-type="bibr">45.</xref>, <xref rid="bb0230" ref-type="bibr">46.</xref>, <xref rid="bb0235" ref-type="bibr">47.</xref>]. Whether HRI also has a role in haem sensing in non-erythroid cells remains an open question.</p></sec><sec id="s0035"><title>Tristetraprolin and mTOR</title><p id="p0080">Tristetraprolin (TTP) was recently described to mobilise iron to essential pathways during extended iron depletion by inhibiting nonessential but particularly iron-demanding processes [<xref rid="bb0240" ref-type="bibr">48.</xref>, <xref rid="bb0245" ref-type="bibr">49.</xref>, <xref rid="bb0250" ref-type="bibr">50.</xref>]. During iron limitation, TTP is upregulated and binds to AU-rich elements of mRNA 3&#8242;-UTRs, promoting decay of mRNAs encoding <bold>lipoic acid synthase (LIAS)</bold>, ACO2, <bold>NADH:ubiquinone oxidoreductase core subunit S1 (NDUFS1),</bold> and <bold>ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (UQCRFS1)</bold>, all of which support mitochondrial OXPHOS [<xref rid="bb0240" ref-type="bibr">48</xref>]. Notably, this suggests OXPHOS to be &#8216;nonessential&#8217; due to the capacity of cells to switch to glycolysis for energy generation [<xref rid="bb0240" ref-type="bibr">48.</xref>, <xref rid="bb0245" ref-type="bibr">49.</xref>, <xref rid="bb0250" ref-type="bibr">50.</xref>]. mTOR, a crucial integrator of diverse metabolic cues, including amino acid depletion, is proposed to act upstream of TTP [<xref rid="bb0245" ref-type="bibr">49</xref>]. mTOR inhibition during iron depletion was recently reported to act via iron sensing by the 2-OGDD protein, <bold>histone lysine demethylase (KDM)-</bold>3B [<xref rid="bb0255" ref-type="bibr">51</xref>]. KDM3B uses iron to catalyse the removal of the repressive histone mark, histone 3 lysine 9 dimethylation (H3K9me2) [<xref rid="bb0255" ref-type="bibr">51</xref>]. Under iron deficiency, KDM3B becomes defective, allowing H3K9me2 accumulation and preventing transcription of the gene encoding the leucine transporter, LAT3 [<xref rid="bb0255" ref-type="bibr">51</xref>]. LAT3 downregulation prevents leucine uptake, inhibiting mTOR via the NPRL2-leucine sensing pathway [<xref rid="bb0255" ref-type="bibr">51</xref>]. mTOR suppression via this pathway may induce TTP.</p><p id="p0085">Therefore, cellular iron is tightly regulated at multiple nodes, involving different forms of iron: Fe-S clusters (IRE-IRP), iron ions (PHD-HIF&#945; and KDM3B-mTOR-TTP) and haem (HRI). Using diverse regulators may facilitate more nuanced responses to specific environmental stimuli. For instance the IRE-IRP system enables rapid responses to acute changes in cellular iron levels by increasing uptake and releasing iron stores [<xref rid="bb0115" ref-type="bibr">23</xref>]. The TTP system is instead proposed to enable cells to survive extended periods of iron scarcity [<xref rid="bb0240" ref-type="bibr">48.</xref>, <xref rid="bb0245" ref-type="bibr">49.</xref>, <xref rid="bb0250" ref-type="bibr">50.</xref>]. How the four axes of cellular iron regulation described (IRE-IRP, PHD-HIF, KDM3B-mTOR-TTP, and haem-HRI) act in concert, and in different cell types across different anatomical sites and tissues where local concentrations of iron may fluctuate substantially, is unknown. Furthermore, iron fluctuations could be detected and responded to by alternative, as yet undiscovered, pathways.</p></sec></sec><sec id="s0040"><title>Iron in cellular biochemistry</title><p id="p0090">Within human cells, iron is predicted to interact with &#8764;400 different proteins [<xref rid="bb0030" ref-type="bibr">6</xref>]. Iron-interacting proteins broadly utilise iron for its capacity to easily exchange electrons and to form bonds with many other elements in different orientations [<xref rid="bb0035" ref-type="bibr">7</xref>]. Iron may bind proteins as iron ions or complexed into Fe-S clusters or haem groups [<xref rid="bb0030" ref-type="bibr">6</xref>]. These proteins operate in and regulate diverse pathways, which we describe in the following sections, beginning with aspects of gene regulation and DNA metabolism.</p></sec><sec id="s0045"><title>Iron in DNA replication and repair</title><p id="p0095">DNA replication begins with DNA helix unwinding by helicases, including iron-dependent DNA2 [<xref rid="bb0260" ref-type="bibr">52</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). The Fe-S cluster of DNA2 configures DNA2 for efficient DNA binding and helicase activity [<xref rid="bb0260" ref-type="bibr">52</xref>]. After DNA unwinding, a short RNA primer is deposited for DNA replication initiation [<xref rid="bb0265" ref-type="bibr">53</xref>]. Primase, which comprises two subunits, including iron-dependent PRIM2, places this primer [<xref rid="bb0265" ref-type="bibr">53</xref>]. DNA polymerases Pol&#945;, Pol&#946;, and Pol&#949; then synthesise the complementary DNA strand using their [4Fe-4S] cluster-binding catalytic subunits (POLA1, POLD1, and POLE1, respectively) [<xref rid="bb0270" ref-type="bibr">54</xref>] and purine and pyrimidine dNTPs. Notably, <bold>phosphoribosyl pyrophosphate aminotransferase (PPAT)</bold>, the initiating enzyme in purine nucleotide synthesis, contains an Fe-S cluster [<xref rid="bb0275" ref-type="bibr">55</xref>]. Meanwhile, RRM2, a component of ribonucleotide reductase (RNR), which converts NTPs to dNTPs, requires an iron core for catalysis [<xref rid="bb0280" ref-type="bibr">56</xref>,<xref rid="bb0285" ref-type="bibr">57</xref>]. Accordingly, iron chelation potently suppresses cancer cell line expansion <italic toggle="yes">in vitro</italic>, in part by impairing RNR [<xref rid="bb0290" ref-type="bibr">58</xref>]. Similarly, low iron availability suppresses primary T cell clonal expansion and cell cycle progression [<xref rid="bb0295" ref-type="bibr">59</xref>]. However, whether iron chelation or deficiency inhibits other components of the DNA replication machinery beyond RNR is unexplored. Virally encoded enzymes important for viral replication, such as Herpes simplex virus RNR and severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) helicase and RNA-dependent RNA polymerase, are similarly iron dependent [<xref rid="bb0300" ref-type="bibr">60.</xref>, <xref rid="bb0305" ref-type="bibr">61.</xref>, <xref rid="bb0310" ref-type="bibr">62.</xref>], suggesting that iron starvation may inhibit the replication of certain viruses [<xref rid="bb0315" ref-type="bibr">63</xref>].<fig id="f0005" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Iron in DNA synthesis, repair, and gene expression.</p><p>DNA synthesis begins with the unwinding of the DNA helix by helicases, including iron-dependent DNA2. Primase utilises its iron catalytic unit, PRIM2, to deposit a primer, and iron-dependent polymerases elongate the DNA strand. dNTPs necessary for DNA synthesis are produced by iron-dependent ribonucleotide reductase via conversion of rNTPs to dNTPs. Purine synthesis requires the activity of the iron sulfur (Fe-S) cluster-binding initiating enzyme, phosphoribosyl pyrophosphate aminotransferase (PPAT). DNA repair similarly utilises not only iron-dependent helicases, but also iron-dependent MUTYH in base excision repair and alkylation B homolog 2/3 (ALKBH2/3) for repairing alkylation damage. Demethylation of histones, DNA, mRNAs, tRNAs, and the ribosome is mediated by iron-dependent 2-oxoglutarate dependent dioxygenases (2-OGDDs), with crucial roles in maintaining chromatin structure and translational efficiency. The transcription factors BACH1, CLOCK and NPAS2 and the transcriptional repressors REV-ERB&#945;/&#946; are regulated by haem. Iron-dependent deoxyhypusine monooxygenase (DOHH) deposits hypusine on eIF5A to support translational efficiency, while ABCE1 allows for ribosomal recycling. Iron-dependent proteins are denoted in dark red.</p></caption><alt-text id="al0005">Figure 1</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0005" position="float" orientation="portrait" xlink:href="gr1.jpg"/></fig></p><p id="p0100">Several DNA repair enzymes are iron dependent [<xref rid="bb0270" ref-type="bibr">54</xref>]. Similar to DNA2, the iron-dependent helicases BRIP1 (FANCJ), ERCC2 (XPD), RTEL1, and DDX11 (CHLR1) utilise Fe-S clusters in DNA unwinding, enabling removal of detrimental DNA secondary structures, such as G-quadruplexes, and entry to damaged DNA sites [<xref rid="bb0260" ref-type="bibr">52</xref>,<xref rid="bb0270" ref-type="bibr">54</xref>,<xref rid="bb0320" ref-type="bibr">64.</xref>, <xref rid="bb0325" ref-type="bibr">65.</xref>, <xref rid="bb0330" ref-type="bibr">66.</xref>, <xref rid="bb0335" ref-type="bibr">67.</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). RTEL1 is also critical for telomere maintenance, with mutations resulting in telomere shortening [<xref rid="bb0335" ref-type="bibr">67</xref>]. DNA glycosylases, including iron-dependent MUTYH, mediate initial base removal in base excision repair alongside APE1 [<xref rid="bb0270" ref-type="bibr">54</xref>,<xref rid="bb0340" ref-type="bibr">68</xref>]. Translesional DNA synthesis is then completed by Pol&#950;, which, similar to the DNA replication polymerases, contains an iron-dependent subunit, REV3L [<xref rid="bb0270" ref-type="bibr">54</xref>,<xref rid="bb0345" ref-type="bibr">69</xref>]. DNA bases featuring alkylation damage can be corrected directly by the iron-dependent 2-OGDD family <bold>alkylation B homolog (ALKBH) enzymes</bold>, ALKBH2 and ALKBH3 [<xref rid="bb0350" ref-type="bibr">70</xref>]. These both use iron to catalyse oxidation of aberrant alkyl groups, which spontaneously dissociate as formaldehyde, returning the base to its undamaged state [<xref rid="bb0350" ref-type="bibr">70</xref>].</p><p id="p0105">DNA replication is critical for cellular division, and maintenance of genomic stability is necessary to avoid malignancy. While iron deprivation is known to impair cellular replication, its impact on genome fidelity and mutation remains an open question. This may have particular relevance for tumours, in which regulatory control of proliferation is lost, but where microenvironments may be low in iron due to both local cellular iron acquisition [<xref rid="bb0055" ref-type="bibr">11</xref>] and underlying systemic iron deficiency, which is associated with some cancers [<xref rid="bb0355" ref-type="bibr">71</xref>]. Under these conditions, low iron availability might influence mutagenesis.</p></sec><sec id="s0050"><title>Iron in gene expression</title><p id="p0110">Cell type and function is fundamentally dictated by gene expression, which is regulated at various levels. Iron-dependent enzymes operate at stages including epigenetic regulation, transcription, RNA processing, and translation.</p><sec id="s0055"><title>Iron in epigenetic regulation</title><p id="p0115">Access of the transcriptional machinery to DNA is determined by the chromatin landscape [<xref rid="bb0360" ref-type="bibr">72</xref>], which is modulated by chemical modifications on DNA itself and on histone DNA-packaging proteins [<xref rid="bb0360" ref-type="bibr">72</xref>]. Methylation represents a critical epigenetic marker on DNA and histone substrates [<xref rid="bb0365" ref-type="bibr">73</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). DNA and histone methylation is regulated by methyltransferases, which deposit methyl groups, and demethylases, which remove them [<xref rid="bb0365" ref-type="bibr">73</xref>]. Many DNA and histone demethylases are iron-dependent 2-OGDD enzymes, which hydroxylate methyl groups, producing unstable methyl&#8211;hydroxy intermediates that spontaneously dissociate [<xref rid="bb0365" ref-type="bibr">73</xref>]. DNA methylation at cytosine bases, arbitrated by the iron-dependent <bold>Ten-eleven translocases (TETs),</bold> represses gene expression by sterically hindering transcription factor binding and, via recruitment of transcriptional repressors [<xref rid="bb0365" ref-type="bibr">73</xref>,<xref rid="bb0370" ref-type="bibr">74</xref>] and iron chelation, impairs TET2 demethylation activity in <italic toggle="yes">in vitro</italic> adipocytes [<xref rid="bb0375" ref-type="bibr">75</xref>].</p><p id="p0120">Meanwhile, effects of histone methylation depend on where modification occurs. H3K4me3 is an activating histone mark typically located around transcription start sites [<xref rid="bb0360" ref-type="bibr">72</xref>]. H3K9me3 typically denotes transcriptionally silenced regions of the genome, while H3K27me3 represses transcription [<xref rid="bb0360" ref-type="bibr">72</xref>]. Iron chelation impairs the activity of isolated KDM4A [<xref rid="bb0380" ref-type="bibr">76</xref>], and abrogates KDM3A/B demethylation in cells <italic toggle="yes">in vitro</italic> [<xref rid="bb0255" ref-type="bibr">51</xref>,<xref rid="bb0375" ref-type="bibr">75</xref>,<xref rid="bb0385" ref-type="bibr">77</xref>]. KDM3B inhibition results in accumulation of repressive H3K9me2 and decreases transcription of genes encoding leucine importers [<xref rid="bb0255" ref-type="bibr">51</xref>] and cyclins critical for cell cycle progression [<xref rid="bb0385" ref-type="bibr">77</xref>]. Low iron also promotes accumulation of repressive H3K27me3, which is normally removed by KDM6A/B during T helper (Th)-17 CD4+ T cell activation [<xref rid="bb0390" ref-type="bibr">78</xref>]. The sensitivity of DNA and histone demethylation to iron availability suggests a mechanism through which iron controls cell fate and function. Availability of the other 2-OGDD enzyme co-factors, &#945;-KG and oxygen, which require iron in the TCA cycle and haemoglobin, respectively, could also link iron deficiency to histone demethylase activity and epigenetic regulation.</p></sec><sec id="s0060"><title>Iron in transcription</title><p id="p0125">Multiple transcription factors and co-regulators, many of which are involved in circadian rhythm maintenance, are haem-binding proteins, although the effects of haem binding on activity appear to be inconsistent. Haem binding to the transcription factors BACH1 or CLOCK inhibits their DNA-binding capacity <italic toggle="yes">in vitro</italic> [<xref rid="bb0395" ref-type="bibr">79</xref>,<xref rid="bb0400" ref-type="bibr">80</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>), while haem promotes the activity of the transcriptional repressors, REV-ERB&#945; and REV-ERB&#946; [<xref rid="bb0405" ref-type="bibr">81</xref>]. Haem binding in NPAS2 enables carbon monoxide (CO) sensing, where CO binding in the presence of haem prevents NPAS2&#8211;DNA interactions [<xref rid="bb0410" ref-type="bibr">82</xref>]. The conspicuous enrichment of circadian regulatory proteins (CLOCK, NPAS2, REV-ERB&#945;, and REV-ERB&#946;) among the limited number of haem-binding transcription-associated proteins suggests that haem itself or haem-binding ligands, such as O<sub>2</sub>, CO, or nitric oxide (NO), are critical regulators of the circadian system. Plasma iron concentrations display circadian variation [<xref rid="bb0415" ref-type="bibr">83</xref>], implying that cellular iron also likely varies with periodicity. Furthermore, mouse models suggest that cellular iron availability influences circadian regulation [<xref rid="bb0420" ref-type="bibr">84</xref>]. Whether circadian rhythms are influenced in humans under physiological iron deficiency is less clear. However, brain iron deficiency has been linked to the circadian disorder, restless leg syndrome, which is a compulsion to move one&#8217;s legs when at rest, typically exacerbated at night [<xref rid="bb0425" ref-type="bibr">85</xref>]. Such links could plausibly relate to the effects of iron on transcriptional control of circadian regulation and/or on neurotransmitter activity (described in the &#8216;Iron in the nervous system&#8217; section).</p></sec><sec id="s0065"><title>Iron in mRNA processing and translation</title><p id="p0130">Transcribed mRNAs are trafficked into the cytosol for processing and translation. Translational efficiency and fidelity are controlled at several steps by iron-dependent enzymes. Post transcription, pre-mRNAs are spliced and accumulate exon junction complexes (EJCs) at exon&#8211;exon boundaries [<xref rid="bb0430" ref-type="bibr">86</xref>]. As the resulting mRNAs are translated, EJCs are displaced by the ribosome and, once translation terminates, the Fe-S cluster protein, ABCE1, is recruited to release the ribosome from the mRNA [<xref rid="bb0430" ref-type="bibr">86</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). In mRNAs with premature stop codons, EJCs are inefficiently removed, and nonsense-mediated decay (NMD) is initiated, preventing accumulation of deleterious truncated proteins [<xref rid="bb0430" ref-type="bibr">86</xref>]. In cells lacking ABCE1, or with impaired iron uptake, ribosomes are inefficiently recycled, resulting in aberrant ribosomal readthrough, EJC displacement, and accumulation of nonsense transcripts [<xref rid="bb0430" ref-type="bibr">86</xref>], indicating that iron is critical for transcriptome surveillance.</p><p id="p0135">mRNA and tRNA demethylation are mediated by iron-dependent 2-OGDD demethylases (mRNA demethylases include FTO and ALKBH5; tRNA demethylases include TYW5, ALKBH7, and ALKBH8) and have important roles in mRNA folding, maturation, nuclear export, translation, and decay [<xref rid="bb0365" ref-type="bibr">73</xref>,<xref rid="bb0435" ref-type="bibr">87</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). For instance, ALKBH7 demethylates mitochondrial polycistronic RNAs within the pre-Ile and Leu tRNA regions, promoting correct tRNA processing and, consequently, normal mitochondrial translation and function [<xref rid="bb0440" ref-type="bibr">88</xref>]. Finally, ribosomal hydroxylation by the 2-OGDD protein OGFOD1 is important for translation efficiency since OGFOD1 knockout results in translational stress [<xref rid="bb0445" ref-type="bibr">89</xref>]. The iron sensitivity of 2-OGDD enzymes involved in histone demethylation suggests that 2-OGDD enzymes modulating RNA methylation may be similarly iron sensitive.</p><p id="p0140">Translational efficiency also depends on the addition of a hypusine moiety to the translation initiation factor, eIF5A [<xref rid="bb0450" ref-type="bibr">90</xref>]. The iron-dependent enzyme <bold>deoxyhypusine monooxygenase (DOHH)</bold> mediates hypusination, whereas iron chelation impairs it [<xref rid="bb0455" ref-type="bibr">91</xref>] (<xref rid="f0005" ref-type="fig">Figure 1</xref>). Defects in this process due to mutations in the other essential hypusination protein, DHPS, result in neuromuscular defects [<xref rid="bb0450" ref-type="bibr">90</xref>]. Whether eIF5a dysfunction during iron deficiency also contributes to neurological symptoms remains unexplored.</p><p id="p0145">In summary, iron is involved in multiple steps across gene regulation, from DNA synthesis, replication, and repair, and epigenetic control, to certain transcription factors related to circadian maintenance, mRNA processing and translation. Of these processes, current evidence suggests that DNA synthesis and histone demethylation activities are most iron sensitive, although these effects have yet to be demonstrated conclusively <italic toggle="yes">in vivo</italic>. Further work is required to explore other potential effects of iron starvation, occurrence <italic toggle="yes">in vivo</italic> under physiological iron deficiency, and effects on health, particularly in the context of cancer, where gene regulation is disrupted.</p></sec></sec><sec id="s0070"><title>Iron in mitochondria</title><p id="p0150">Iron-interacting proteins are particularly enriched in mitochondria, where 7% of mitochondrial proteins are predicted to bind iron relative to 2% overall for all proteins [<xref rid="bb0030" ref-type="bibr">6</xref>]. To cross the outer mitochondrial membrane (OMM), iron may pass through large porins called VDACs, which enable uptake of metabolites, including pyruvate and ATP [<xref rid="bb0460" ref-type="bibr">92</xref>]. Alternatively, iron may enter via direct fusion of iron-containing endosomes with the OMM [<xref rid="bb0465" ref-type="bibr">93</xref>] or via an OMM-localised isoform of DMT1 [<xref rid="bb0470" ref-type="bibr">94</xref>,<xref rid="bb0475" ref-type="bibr">95</xref>]. Once iron has entered the intermembrane space, iron is transported into the matrix via mitoferrin 1 and 2 (MFN1/2) [<xref rid="bb0480" ref-type="bibr">96</xref>,<xref rid="bb0485" ref-type="bibr">97</xref>].</p><p id="p0155">Mitochondrially localised iron can be stored in mitochondrial ferritin [<xref rid="bb0490" ref-type="bibr">98</xref>,<xref rid="bb0495" ref-type="bibr">99</xref>], utilised for haem and Fe-S cluster biosynthesis, or used by mitochondrial proteins [<xref rid="bb0500" ref-type="bibr">100</xref>] (<xref rid="f0010" ref-type="fig">Figure 2</xref>). Inefficient haem or Fe-S cluster synthesis due to mutations in these pathways causes mitochondrial iron overload as cells attempt to rectify biosynthetic blocks by trafficking further iron into the mitochondria [<xref rid="bb0500" ref-type="bibr">100</xref>,<xref rid="bb0505" ref-type="bibr">101</xref>]. Notably, this mitochondrial iron loading comes at the expense of cytosolic iron homeostasis, resulting in cytosolic iron deficiency and induction of the low iron IRP&#8211;IRE response, suggesting that, as destinations for iron, mitochondria are hierarchically above other cellular compartments [<xref rid="bb0505" ref-type="bibr">101</xref>].<fig id="f0010" position="float" orientation="portrait"><label>Figure 2</label><caption><p>Iron in mitochondrial function.</p><p>Iron crosses the outer mitochondrial membrane (OMM) into the intermembrane space by direct fusion of endocytic vesicles, via VDAC1 channels or using the DMT1 transporter. Iron then enters the matrix via mitoferrins (MFN). Iron in mitochondria is used for catalysis by aconitase 2 (ACO2) and succinate dehydrogenase (SDH) in the tricarboxylic acid (TCA) cycle, and by lipoic acid synthase (LIAS) to deposit lipoic acid on the enzymes pyruvate dehydrogenase (PDH) and &#945;-KG dehydrogenase (&#945;-KGDH). Iron cofactors are required for electron transfer by all four complexes of the electron transport chain (ETC), and for haem and iron sulfur (Fe-S) cluster synthesis. Succinyl-CoA from the TCA cycle can be condensed with glycine to initiate haem synthesis, which is an eight-step process that concludes with the deposition of iron into the porphyrin ring structure by the [2Fe-2S] cluster-binding protein ferrochelatase (FECH). Fe-S cluster synthesis begins with the formation of a [2Fe-2S] cluster on a scaffold of proteins, which includes ISCU and NFS1. The [2Fe-2S] cluster is transferred to glutaredoxin 5 (GLRX5) with the help of HSPA9 [<xref rid="bb0540" ref-type="bibr">108</xref>]. GLRX5 can transfer the [2Fe-2S] cluster to target proteins or two can be linked together to form a [4Fe-4S] cluster on the Fe-S cluster assembly 1 and 2 (ISCA1/)2 complex. [4Fe-4S] clusters are delivered to target proteins by chaperones, such as BOLA1, BOLA3 and NFU1. Iron-dependent proteins are denoted in dark red. Green text shows production of NADH/FADH<sub>2</sub>, while orange text shows consumption of NADH/FADH<sub>2</sub>. Red dots denote iron atoms.</p></caption><alt-text id="al0010">Figure 2</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0010" position="float" orientation="portrait" xlink:href="gr2.jpg"/></fig></p><p id="p0160">Mitochondria are particularly sensitive to oxidative stress due to the presence of the electron transport chain (ETC) machinery and other iron-dependent redox processes. Iron-related lipid oxidation is particularly implicated in ferroptosis, a nonapoptotic cell death pathway [<xref rid="bb0075" ref-type="bibr">15</xref>,<xref rid="bb0510" ref-type="bibr">102</xref>] (<xref rid="b0005" ref-type="boxed-text">Box 1</xref>). Glutathione (GSH) is a cytosolically synthesised antioxidant imported into the mitochondria by the Fe-S cluster-binding protein, SLC25A39, to aid mitochondrial antioxidant responses [<xref rid="bb0515" ref-type="bibr">103</xref>,<xref rid="bb0520" ref-type="bibr">104</xref>]. SLC25A39 import is regulated by iron: during iron scarcity and in the absence of [2Fe-2S] cluster binding, SLC25A39 is degraded by AFG3L2 [<xref rid="bb0515" ref-type="bibr">103</xref>,<xref rid="bb0520" ref-type="bibr">104</xref>]. During iron repletion, SLC25A39 binds a [2Fe-2S] cluster, promoting its stabilisation and GSH mitochondrial import [<xref rid="bb0515" ref-type="bibr">103</xref>,<xref rid="bb0520" ref-type="bibr">104</xref>], demonstrating tight links between iron and the antioxidant response.<boxed-text id="b0005" position="float" orientation="portrait"><label>Box 1</label><caption><title>Iron in cellular toxicity and ferroptosis</title></caption><p id="p0005">The capacity of iron to easily exchange electrons has been capitalised on by many cellular proteins and enzymes. However, these same redox properties that make iron useful also contribute to cellular toxicity by driving Fenton reactions and the production of free radicals, which can damage cellular components [<xref rid="bb0065" ref-type="bibr">13</xref>]. Iron overload, for instance in hereditary hemochromatosis, can result in a multi-tissue disease with toxicity in organs, including the liver (liver cirrhosis and hepatocellular carcinoma), heart, and pancreas (diabetes) [<xref rid="bb1115" ref-type="bibr">223</xref>].</p><p id="p0010">Beyond simply causing cellular damage via Fenton reactions, iron has also more recently been implicated in an alternative, regulated, nonapoptotic cell death pathway known as ferroptosis [<xref rid="bb0510" ref-type="bibr">102</xref>]. Ferroptosis is characterised by the peroxidation of PUFA-containing phospholipids [<xref rid="bb0510" ref-type="bibr">102</xref>]. These phospholipids are specifically implicated because the double bonds contained within the PUFA chains make these phospholipids particularly susceptible to oxidation damage [<xref rid="bb0510" ref-type="bibr">102</xref>]. Mutations in genes preventing PUFA usage in phospholipids are protective against ferroptosis [<xref rid="bb1120" ref-type="bibr">224.</xref>, <xref rid="bb1125" ref-type="bibr">225.</xref>, <xref rid="bb1130" ref-type="bibr">226.</xref>, <xref rid="bb1135" ref-type="bibr">227.</xref>]. While the term &#8216;ferroptosis&#8217; implies the requirement of iron for this process, it is unclear how iron specifically mediates lipid peroxidation [<xref rid="bb0075" ref-type="bibr">15</xref>]. Previous work attributed lipid peroxidation activity to iron itself, iron-containing lipoxygenase enzymes, and haem-dependent CYB5R1 [<xref rid="bb0075" ref-type="bibr">15</xref>]. Under homeostatic conditions, lipid peroxidation is controlled by lipid peroxide repair mechanisms [<xref rid="bb0510" ref-type="bibr">102</xref>]. GPX4 appears to be the main enzyme involved in lipid oxidation detoxification and utilises glutathione to convert lipid peroxides to lipid alcohols [<xref rid="bb0510" ref-type="bibr">102</xref>]. Vitamin E and coenzyme Q10 have also been shown to detoxify lipid peroxides [<xref rid="bb0510" ref-type="bibr">102</xref>]. Accumulation of sufficient lipid peroxides results in membrane rupture and death [<xref rid="bb1140" ref-type="bibr">228</xref>].</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0025"><p>Alt-text: Box 1</p></notes></boxed-text></p><sec id="s0075"><title>Iron in haem and Fe-S cluster biosynthesis</title><p id="p0165">Haem synthesis begins with condensation of glycine to succinyl-CoA by the rate-limiting enzymes, ALAS1/2 (ALAS1 is found in all cells, while ALAS2 is erythroid lineage specific) in the mitochondrial matrix [<xref rid="bb0500" ref-type="bibr">100</xref>,<xref rid="bb0525" ref-type="bibr">105</xref>] (<xref rid="f0010" ref-type="fig">Figure 2</xref>). The product, 5-aminolevulinic acid (ALA), passes through seven cytosolic (steps 2&#8211;5) and mitochondrial (steps 6&#8211;8) reactions. Insertion of iron into porphyrin by the Fe-S cluster-containing protein, ferrochelatase (FECH) completes haem production [<xref rid="bb0500" ref-type="bibr">100</xref>,<xref rid="bb0530" ref-type="bibr">106</xref>]. Haem can be used locally [e.g., in complex I (CI) of the ETC] or transported to the cytosol by FLVCR1b for other uses in the cell [<xref rid="bb0500" ref-type="bibr">100</xref>,<xref rid="bb0535" ref-type="bibr">107</xref>].</p><p id="p0170">Fe-S cluster synthesis includes both mitochondrial and cytosolic assembly pathways [<xref rid="bb0540" ref-type="bibr">108</xref>]. Mitochondrial synthesis begins with formation of a scaffold including two each of the proteins ISCU2, NFS1, frataxin, FDX2, ISD11, and ACP1 [<xref rid="bb0540" ref-type="bibr">108</xref>] (<xref rid="f0010" ref-type="fig">Figure 2</xref>). This complex extracts sulfur from the amino acid cysteine and combines it with iron, forming a [2Fe-2S] cluster [<xref rid="bb0540" ref-type="bibr">108</xref>]. ISCU2 transfers [2Fe-2S] to a GLRX5 dimer, assisted by HSPA9 (HSP70) and HSP40 (HSC20) [<xref rid="bb0540" ref-type="bibr">108</xref>]. [2Fe-2S] clusters can either be delivered to proteins by GLRX5 or fused to form [4Fe-4S] clusters by a complex comprising <bold>Fe-S cluster assembly 1 and 2 (ISCA1/)2</bold> and IBA57 [<xref rid="bb0540" ref-type="bibr">108</xref>]. [4Fe-4S] clusters are then inserted into their target proteins by chaperones, including NFU1, IND1, BOLA1, and BOLA3 [<xref rid="bb0540" ref-type="bibr">108</xref>]. Mitochondrial Fe-S cluster targets include ACO2, LIAS, and CI and complex II (CII) of the ETC [<xref rid="bb0540" ref-type="bibr">108</xref>].</p><p id="p0175">Although intact mitochondrial Fe-S cluster synthesis is essential for nonmitochondrial Fe-S cluster-binding proteins, mitochondrially derived Fe-S clusters are not believed to cross the mitochondrial membrane [<xref rid="bb0540" ref-type="bibr">108</xref>]. Instead, an uncharacterised sulfur-containing factor (X-S) is thought to be produced by mitochondrial Fe-S cluster synthesis and passaged to the cytosol by ABCB7 for completion by the cytosolic Fe-S cluster synthesis pathway [<xref rid="bb0540" ref-type="bibr">108</xref>].</p><p id="p0180">The essentiality of Fe-S clusters for cellular function is demonstrated by individuals with Fe-S cluster biogenesis defects caused by mutations in genes encoding frataxin, GLRX5, and ISCU [<xref rid="bb0545" ref-type="bibr">109</xref>]. Mutations in frataxin result in Friedrich&#8217;s ataxia, a neurodegenerative disease featuring limb ataxia, muscle weakness, and cardiomyopathy [<xref rid="bb0545" ref-type="bibr">109</xref>]. Meanwhile, GLRX5 and ISCU deficiencies cause microcytic anaemia and myopathy, respectively [<xref rid="bb0545" ref-type="bibr">109</xref>]. Interestingly, each of these mutations presents with different predominant clinical effects despite similar underlying biochemical features, including dysfunction in enzymes, such as ACO2, and cellular iron loading [<xref rid="bb0545" ref-type="bibr">109</xref>]. Iron deficiency could conceivably modulate phenotypic severities of mutations in Fe-S cluster biosynthesis.</p></sec><sec id="s0080"><title>Iron in mitochondrial metabolism</title><p id="p0185">Mitochondrial metabolism is highly iron dependent. ACO2 and succinate dehydrogenase (SDH) use Fe-S clusters to catalyse essential steps in the TCA cycle, which generates metabolic intermediates and the redox cofactors, NADH and FADH<sub>2</sub> [<xref rid="bb0500" ref-type="bibr">100</xref>] (<xref rid="f0010" ref-type="fig">Figure 2</xref>). Electrons from NADH and FADH<sub>2</sub> are passed to four ETC complexes that heavily rely on haem and Fe-S clusters for efficient electron transfer [<xref rid="bb0500" ref-type="bibr">100</xref>]. The energy released from the ETC generates a proton gradient across the inner mitochondrial membrane (IMM) that promotes ATP production [<xref rid="bb0500" ref-type="bibr">100</xref>]. Beyond energy generation, a [4Fe-4S] cluster in LIAS mediates the essential lipoylation of metabolic enzymes, such as pyruvate dehydrogenase (PDH) and &#945;-KG dehydrogenase (&#945;-KGDH) [<xref rid="bb0540" ref-type="bibr">108</xref>]. <bold>Electron transfer flavoprotein dehydrogenase (ETFDH)</bold> and FECH use Fe-S clusters for fatty acid &#946;-oxidation and the final step of haem synthesis, respectively [<xref rid="bb0540" ref-type="bibr">108</xref>], and METTL17 utilises a [4Fe-4S] cluster in mitochondrial ribosome assembly and translation [<xref rid="bb0550" ref-type="bibr">110</xref>].</p><p id="p0190">The high dependence of mitochondria on iron for metabolic processes and haem and Fe-S cluster synthesis suggests that iron deficiency profoundly affects mitochondrial processes and extra-mitochondrial pathways that rely on haem, Fe-S cluster cofactors, or mitochondrially derived metabolites produced by iron-dependent processes (e.g., &#945;-KG for 2-ODGG enzymes).</p><p id="p0195">Accordingly, swollen, rounded mitochondria with aberrant cristae and fewer mitochondrial cytochromes are observed under iron-deficient conditions [<xref rid="bb0555" ref-type="bibr">111.</xref>, <xref rid="bb0560" ref-type="bibr">112.</xref>, <xref rid="bb0565" ref-type="bibr">113.</xref>]. Liver mitochondria from iron-deficient rats have decreased mitochondrial respiration efficiency [<xref rid="bb0570" ref-type="bibr">114</xref>], lower mitochondrial membrane potential and ATP production [<xref rid="bb0565" ref-type="bibr">113</xref>], and suppressed capacity for gluconeogenesis via <bold>phosphoenolpyruvate carboxykinase (PCK)</bold> [<xref rid="bb0575" ref-type="bibr">115</xref>]. Similarly, T cell iron restriction abrogates mitochondrial ATP production and reduces mitochondrial membrane potential [<xref rid="bb0295" ref-type="bibr">59</xref>,<xref rid="bb0580" ref-type="bibr">116</xref>,<xref rid="bb0585" ref-type="bibr">117</xref>]. Iron chelation also impairs TCA cycle progression, with citrate and succinate accumulation upstream of iron-dependent ACO2 and SDH and depletion of the downstream metabolites, fumarate and malate [<xref rid="bb0255" ref-type="bibr">51</xref>]. As noted in the preceding text, iron deficiency can induce shifts toward glycolysis; none of the enzymes in the core glycolysis pathway are iron dependent. ISCU2 mutant cells lacking efficient Fe-S cluster synthesis similarly accumulate citrate due to reduced ACO2 activity, accompanied by impaired SDH and LIAS activity, and elevated fatty acid synthesis and lipid droplet formation [<xref rid="bb0590" ref-type="bibr">118</xref>].</p><p id="p0200">Together, it appears likely that altered mitochondrial function and metabolism resulting from iron deficiency influences cells and tissues in humans, and contributes to disease processes; however, this is not well characterised.</p></sec></sec><sec id="s0085"><title>Iron in lipid metabolism</title><p id="p0205">Metabolism of lipids, including fatty acids, phospholipids, cholesterol and its derivatives (steroid hormones, bile acids, and vitamin D), and eicosanoids [<xref rid="bb0595" ref-type="bibr">119</xref>], involves many iron-dependent oxidoreductase enzymes, which utilise iron to enable complex metabolic reactions.</p><sec id="s0090"><title>Iron in cholesterol metabolism</title><p id="p0210">Cholesterol is generated endogenously or can be acquired from exogenous sources via uptake of low-density lipoproteins (LDLs) containing cholesteryl ester [<xref rid="bb0600" ref-type="bibr">120</xref>]. Endogenous cholesterol synthesis is a complex multistep process catalysed by many enzymes, including the haem-dependent enzyme, CYP51A1, which metabolises the early cholesterol precursor, lanosterol [<xref rid="bb0605" ref-type="bibr">121</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). Downstream cholesterol metabolism, which is critical for the synthesis of steroid hormones, bile acids, and vitamin D, depends on haem-dependent cytochrome P450 enzymes [<bold>cytochrome P450 (CYP) proteins</bold>] [<xref rid="bb0610" ref-type="bibr">122</xref>].<fig id="f0015" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Iron in lipid metabolism.</p><p>Iron is utilised for the synthesis and metabolism of a diversity of lipid species. Polyunsaturated fatty acids (PUFAs), such as arachidonic acid, are synthesised from acetyl-CoA using the iron-dependent enzymes fatty acid desaturase (FADS)-1/2/3 and stearoyl-CoA desaturase (SCD), to mediate the desaturation reactions. Arachidonic acid is used for eicosanoid metabolism. Cyclooxygenase 1/2 (COX1/2) uses iron to convert arachidonic acid to PGH<sub>2</sub> which is subsequently metabolised to prostaglandins and thromboxane by cytochrome P450 (CYP) proteins. The lipoxygenase (LOX) enzymes [(5-LOX, 8-LOX, 12-LOX, and 15-LOX) use iron to produce leukotrienes and hydroxyeicosatetraenoic acids (HETEs). The CYP proteins use haem cofactors to mediate synthesis of HETES, epoxyeicosatrienoic acids (EETs), dihydroxyeicosatetraenoic acid (diHETEs), and lipoxins. Acetyl-CoA is also converted to cholesterol via a pathway requiring haem-dependent CYP51A1. CYP proteins convert cholesterol to steroid hormones in tissues, such as the adrenal glands, testes, and ovaries, and to bile acids in the liver. The cholesterol precursor 7-hydrocholesterol is also converted to vitamin D via sunlight and is processed to the active form, 1,25(OH<sub>2</sub>)D by haem-dependent CYP2R1 and CYP27B1. Iron deficiency induces production of the growth factor FGF23, which inhibits the activity of CYP27B1 directly and via suppression of the CYP27B1 agonist, parathyroid hormone. Iron-dependent proteins are denoted in dark red.</p></caption><alt-text id="al0015">Figure 3</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0015" position="float" orientation="portrait" xlink:href="gr3.jpg"/></fig></p><p id="p0215">CYP proteins use haem prosthetic groups in metabolising diverse targets, including endogenous fatty acids, bile acids, and steroids, and for detoxifying xenobiotics, such as pharmaceuticals [<xref rid="bb0610" ref-type="bibr">122</xref>]. CYP proteins are classed as mitochondrial-localised type 1 and endoplasmic reticulum (ER)-localised type 2 CYP proteins [<xref rid="bb0615" ref-type="bibr">123</xref>]. Type 1 CYP proteins rely on electrons passed from NADPH via ferrochelatase to the Fe-S cluster protein ferredoxin [<xref rid="bb0615" ref-type="bibr">123</xref>], which then passes electrons to the CYP proteins [<xref rid="bb0615" ref-type="bibr">123</xref>]. The ferredoxin dependence of type 1 CYP proteins renders mitochondrial CYP reactions dually iron dependent, relying on both haem and Fe-S cluster cofactors. Type 2 CYP proteins contrastingly receive electrons from NADPH via the protein POR [<xref rid="bb0615" ref-type="bibr">123</xref>].</p><p id="p0220">The sex-linked anaemic (SLA) mutation in mice prevents intestinal iron absorption by impairing the ferroxidase hephaestin, causing iron deficiency anaemia [<xref rid="bb0620" ref-type="bibr">124</xref>]. SLA mice have reduced hepatic cholesterol synthesis [<xref rid="bb0620" ref-type="bibr">124</xref>]. Iron chelators suppress cholesterol levels in neuroblastoma cell lines [<xref rid="bb0625" ref-type="bibr">125</xref>], while, conversely, elevated iron availability promotes cholesterol synthesis in endothelial cells [<xref rid="bb0630" ref-type="bibr">126</xref>]. Together, this suggests that iron availability modulates cholesterol metabolism. Whether this relates to direct impairment of cholesterol synthesis via iron-dependent CYP51A1 or to negative feedback on cholesterol biosynthesis by downstream iron-dependent pathways is unclear. Although mechanistic links between iron regulation and cholesterol levels are evident in mice [<xref rid="bb0635" ref-type="bibr">127</xref>], further work should explore how altered iron influences cholesterol metabolism in humans.</p></sec><sec id="s0095"><title>Iron in steroid hormone synthesis</title><p id="p0225">Steroid hormones are synthesised from cholesterol and have many roles in systemic biology. Five classes of steroid hormone exist: androgens (e.g., testosterone), oestrogens (e.g., oestradiol), progestogens (e.g., progesterone), glucocorticoids (e.g., cortisol), and mineralocorticoids (e.g., aldosterone) [<xref rid="bb0640" ref-type="bibr">128</xref>]. Androgens, oestrogens, and progestogens are involved in reproductive biology, with roles such as sex differentiation and pregnancy maintenance [<xref rid="bb0615" ref-type="bibr">123</xref>,<xref rid="bb0640" ref-type="bibr">128</xref>]. Glucocorticoids and mineralocorticoids regulate cell metabolism and salt and water balance, respectively [<xref rid="bb0640" ref-type="bibr">128</xref>].</p><p id="p0230">Steroid hormone synthesis begins with cholesterol transport into the mitochondria for conversion to pregnenolone by haem-dependent CYP11A1 [<xref rid="bb0615" ref-type="bibr">123</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). The various steroid hormones are then synthesised by haem-dependent CYP proteins, which mediate irreversible hydroxylation reactions and hydroxysteroid dehydrogenases (HSD), which catalyse reversible reactions [<xref rid="bb0615" ref-type="bibr">123</xref>]. Although cortisol secretion may be reduced in iron deficiency in humans [<xref rid="bb0645" ref-type="bibr">129</xref>], establishing whether physiological iron deficiency impacts steroid synthesis, with potential implications for development and reproductive fitness, requires more work.</p></sec><sec id="s0100"><title>Iron in vitamin D metabolism</title><p id="p0235">Vitamin D promotes calcium and phosphorous absorption for skeletal development [<xref rid="bb0650" ref-type="bibr">130</xref>]. It comes in two forms, with different sidechains but similar behaviour [<xref rid="bb0655" ref-type="bibr">131</xref>]. Vitamin D<sub>2</sub> derives from plant and fungal dietary sources, while vitamin D<sub>3</sub> is synthesised in the skin from the cholesterol precursor, 7-dehydrocholesterol (7-HDC), which is non-enzymatically converted to pre-vitamin D<sub>3</sub> by ultraviolet (UV)-B radiation [<xref rid="bb0655" ref-type="bibr">131</xref>]. Pre-vitamin D<sub>3</sub> subsequently isomerises to vitamin D<sub>3</sub> [<xref rid="bb0655" ref-type="bibr">131</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). For biological activity, vitamin D must be converted to 25-hydroxyvitamin D (25-OHD) and then to 1,25(OH)<sub>2</sub>D [<xref rid="bb0655" ref-type="bibr">131</xref>] in reactions mediated by the haem-dependent enzymes CYP2R1 (in the liver) and CYP27B1 (in the kidney, but also in keratinocytes and immune cells), respectively [<xref rid="bb0655" ref-type="bibr">131</xref>]. Similar to Vitamin D deficiency, mutation of either enzyme results in rickets, where defective bone mineralisation causes skeletal deformities, indicating the crucial role of these iron-dependent enzymes in vitamin D metabolism [<xref rid="bb0650" ref-type="bibr">130</xref>,<xref rid="bb0655" ref-type="bibr">131</xref>].</p><p id="p0240">CYP27B1 activity is inhibited by FGF23 [<xref rid="bb0655" ref-type="bibr">131</xref>]. Notably, FGF23 is upregulated during iron deficiency, resulting in CYP27B1 downregulation and suppressed 1,25(OH)<sub>2</sub>D production [<xref rid="bb0660" ref-type="bibr">132</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). FGF23 also indirectly suppresses 1,25(OH)<sub>2</sub>D production via suppression of parathyroid hormone, which stimulates CYP27B1 [<xref rid="bb0660" ref-type="bibr">132</xref>]; however, whether iron scarcity directly impairs CYP27B1 activity is unclear. Notably, reduced iron intake has been associated with reduced bone mineral density [<xref rid="bb0665" ref-type="bibr">133</xref>] and increased risk for osteoporosis [<xref rid="bb0670" ref-type="bibr">134</xref>] in women. Iron deficiency in rats also significantly reduces bone mineral content and density [<xref rid="bb0675" ref-type="bibr">135</xref>,<xref rid="bb0680" ref-type="bibr">136</xref>]. These data suggest that iron deficiency may impair bone formation potentially via suppression of vitamin D synthesis, but this requires further investigation.</p></sec><sec id="s0105"><title>Iron in bile acid metabolism</title><p id="p0245">Bile acids are synthesised exclusively in the liver from cholesterol and are excreted in bile with cholesterol and phospholipids into the small intestine following food ingestion [<xref rid="bb0685" ref-type="bibr">137</xref>]. Bile acids act as detergents facilitating solubilisation, digestion and absorption of lipophilic molecules, including dietary fats, steroids, certain drugs, and vitamins (A, D, E, and K) [<xref rid="bb0685" ref-type="bibr">137</xref>]. In humans, most bile acids are synthesised via the classical pathway (&gt;90%), which is initiated by ER-localised haem-dependent CYP7A1, but also requires CYP8B1 and CYP27A1 [<xref rid="bb0685" ref-type="bibr">137</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). An alternative pathway utilising CYP27A1 and CYP7B1 also generates bile acids (&lt;10%) [<xref rid="bb0685" ref-type="bibr">137</xref>]. Reduced bile acid synthesis during iron overload may partly result from CYP7A1 downregulation [<xref rid="bb0690" ref-type="bibr">138</xref>], but whether direct effects of iron on bile acid metabolism or general liver dysfunction are responsible is unclear. Interestingly, a study in prairie dogs found that iron-deficient animals had lower CYP7A1 levels and increased likelihood of cholesterol gallstones [<xref rid="bb0695" ref-type="bibr">139</xref>]. Cholesterol gallstones form when cholesterol becomes insoluble in bile; some bile acids promote cholesterol solubility and protect against gallstones, consistent with impaired bile acid synthesis promoting gallstones [<xref rid="bb0700" ref-type="bibr">140</xref>]. Notably, an increased frequency of gallstones in patients with iron deficiency has also been reported [<xref rid="bb0705" ref-type="bibr">141</xref>]; however, these potential mechanistic links require confirmation.</p></sec><sec id="s0110"><title>Iron in fatty acid and eicosanoid metabolism</title><p id="p0250">Most enzymes involved in fatty acid synthesis do not utilise iron. However, the fatty acid desaturase enzymes, <bold>fatty acid desaturase (FADS)-</bold>1/2/3 and <bold>stearoyl-CoA desaturase (SCD)</bold>, which generate <bold>polyunsaturated fatty acids (PUFAs</bold>; i.e., double bond-containing), rely on di-iron cores [<xref rid="bb0595" ref-type="bibr">119</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). PUFAs are used in several downstream metabolic processes, including sphingolipid and eicosanoid synthesis [<xref rid="bb0595" ref-type="bibr">119</xref>,<xref rid="bb0710" ref-type="bibr">142</xref>]. PUFAs and their derivatives influence membrane fluidity and cellular signalling, as both lipid mediators and agonists for nuclear receptor transcription factors, including PPAR and LXR [<xref rid="bb0710" ref-type="bibr">142</xref>]. Notably, rats fed an iron-deficient diet displayed decreased plasma levels of the PUFA arachidonic acid [<xref rid="bb0715" ref-type="bibr">143</xref>] and reduced hepatic PUFAs in phosphatidylcholine and phosphatidylethanolamine phospholipids, suggesting reduced desaturase activity [<xref rid="bb0720" ref-type="bibr">144</xref>,<xref rid="bb0725" ref-type="bibr">145</xref>]. Whether iron deficiency similarly suppresses fatty acid desaturation in humans with impacts on downstream processes, such as membrane remodelling and signalling, remains unexplored.</p><p id="p0255">Arachidonic acid metabolism is critical for synthesis of eicosanoid lipid mediators, such as prostaglandins, thromboxane, and leukotrienes [<xref rid="bb0730" ref-type="bibr">146</xref>]. Eicosanoids have important roles in cardiovascular function, inflammation, and cancer and are metabolised from arachidonic acid by three classes of iron-dependent enzyme [<xref rid="bb0730" ref-type="bibr">146</xref>] (<xref rid="f0015" ref-type="fig">Figure 3</xref>). The iron-dependent lipoxygenase (LOX) enzymes catalyse leukotriene and hydroxyeicosatetraenoic acid (HETE) synthesis [<xref rid="bb0730" ref-type="bibr">146</xref>]. Meanwhile, the cyclooxygenases (COX1/2), which are targets of nonsteroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and aspirin, are haem dependent, catalysing the initial step in prostaglandin and thromboxane synthesis [<xref rid="bb0730" ref-type="bibr">146</xref>,<xref rid="bb0735" ref-type="bibr">147</xref>]. COX enzymes convert arachidonic acid to PGH<sub>2</sub> and PHG<sub>2</sub>, which are metabolised to a variety of prostaglandins, including by the iron-dependent CYP proteins PGIS (CYP8A1) and TBXAS (CYP5A1), yielding prostacyclin (PGI<sub>2</sub>) and thromboxane A<sub>2</sub> (TXA<sub>2</sub>), respectively [<xref rid="bb0730" ref-type="bibr">146</xref>]. CYP proteins are also involved in the production of HETEs, epoxyeicosatrienoic acids (EETs), dihydroxyeicosatetraenoic acid (diHETEs), and lipoxins [<xref rid="bb0730" ref-type="bibr">146</xref>].</p><p id="p0260">Given the important role of eicosanoids in settings such as inflammation and cardiovascular function, alterations in eicosanoid metabolism could have important implications for human health. Iron-overloaded <italic toggle="yes">in vitro</italic>-cultured myocytes produce higher levels of the prostaglandins PGE<sub>2</sub>, PGF<sub>2&#945;</sub>, and PGI<sub>2</sub> [<xref rid="bb0740" ref-type="bibr">148</xref>]<sub>,</sub> suggesting that eicosanoid synthesis is iron sensitive.</p></sec></sec><sec id="s0115"><title>Iron in cellular detoxification and catabolism</title><p id="p0265">Iron-dependent proteins have key roles in drug metabolism, detoxification, and catabolism of cellular components. Many haem-dependent CYP proteins effect drug detoxification [<xref rid="bb0610" ref-type="bibr">122</xref>], and THAP4 and catalase use haem to detoxify the reactive nitrogen and oxygen species, peroxynitrite and H<sub>2</sub>O<sub>2</sub>, respectively [<xref rid="bb0745" ref-type="bibr">149</xref>,<xref rid="bb0750" ref-type="bibr">150</xref>]. By contrast, <bold>phytanoyl-CoA dioxygenase (PHYH)</bold> is a 2-OGDD enzyme that degrades dietary phytanic acid [<xref rid="bb0755" ref-type="bibr">151</xref>]. Degradation of specific amino acids similarly requires iron. Tyrosine degradation requires iron-dependent <bold>4-hydroxyphenylpyruvate dioxygenase (HPD)</bold> and <bold>homogentisate 1,2-dioxygenase (HGD)</bold> [<xref rid="bb0760" ref-type="bibr">152</xref>]. Meanwhile, three iron-dependent enzymes, <bold>tryptophan 1,2-dioxygenase (TDO)</bold>, <bold>indoleamine 2,3-dioxygenase 1/2 (IDO1/2)</bold>, initiate tryptophan degradation, converting tryptophan to <italic toggle="yes">N</italic>-formyl-kynurenine [<xref rid="bb0765" ref-type="bibr">153</xref>]. Iron-dependent <bold>3-hydroxyanthranilate 3,4-dioxygenase (HAAO)</bold> acts downstream in tryptophan degradation [<xref rid="bb0765" ref-type="bibr">153</xref>]. Decreased serum tryptophan has been described during iron deficiency [<xref rid="bb0770" ref-type="bibr">154</xref>], but whether this relates directly to tryptophan metabolism and/or degradation is unclear.</p><p id="p0270">Three critical degradative enzymes, SUOX, <bold>xanthine dehydrogenase (XDH),</bold> and AOX1, require not only iron, but also molybdenum, another essential micronutrient [<xref rid="bb0775" ref-type="bibr">155</xref>]. Molybdenum is always complexed within the molybdenum cofactor (MOCO), a complex nitrogen heterocyclic structure that requires iron for its biosynthesis [<xref rid="bb0775" ref-type="bibr">155</xref>]. Specifically, MOCS1A uses two [4Fe-4S] clusters to initiate MOCO synthesis [<xref rid="bb0775" ref-type="bibr">155</xref>]. SUOX uses MOCO and haem to convert toxic sulfite released from cysteine degradation to sulfate [<xref rid="bb0780" ref-type="bibr">156</xref>]. While SUOX deficiency typically results in toxic accumulation of sulfite causing death in infancy, a novel SUOX mutation in the haem-binding domain (SUOX<sup>H143N</sup>) associated with milder disease was recently identified [<xref rid="bb0785" ref-type="bibr">157</xref>]. Despite loss of the haem cofactor, SUOX<sup>H143N</sup>, still retains capacity to detoxify sulfite [<xref rid="bb0785" ref-type="bibr">157</xref>], suggesting that iron deficiency would only have mild effects on SUOX function. XDH uses MOCO and two [2Fe-2S] clusters to convert hypoxanthine produced from purine degradation to uric acid [<xref rid="bb0780" ref-type="bibr">156</xref>]. Interestingly, dietary iron deficiency suppresses intestinal, but not liver XDH activity in rats [<xref rid="bb0790" ref-type="bibr">158</xref>]. Similar to XDH, AOX1 requires MOCO and two [2Fe-2S] clusters, but mediates the conversion of aldehydes to carboxylic acids on a range of substrates, making it important for drug metabolism [<xref rid="bb0780" ref-type="bibr">156</xref>].</p><p id="p0275">The extensive use of iron for detoxification and catabolic reactions suggests that iron starvation results in accumulation of toxic compounds. Iron-deficient rats may display defective hepatic detoxification [<xref rid="bb0795" ref-type="bibr">159</xref>], but the extent and specificity of the impact of iron deficiency on catabolism remain uncertain.</p></sec><sec id="s0120"><title>Iron in tissue and cell-specific processes</title><sec id="s0125"><title>Iron in the immune system</title><p id="p0280">Iron is increasingly recognised to have important roles in immune function. Most prominently, children bearing mutations in the gene encoding the iron uptake receptor, TFRC, have impaired adaptive and innate immune responses, presenting as combined immunodeficiency; these mutations cause impaired cellular iron uptake [<xref rid="bb0800" ref-type="bibr">160.</xref>, <xref rid="bb0805" ref-type="bibr">161.</xref>, <xref rid="bb0810" ref-type="bibr">162.</xref>]. Low serum iron is associated with nonresponse to influenza virus vaccination in older individuals [<xref rid="bb0815" ref-type="bibr">163</xref>], while iron supplementation in Kenyan infants who were likely iron deficient increased vaccine responses [<xref rid="bb0060" ref-type="bibr">12</xref>], pointing to interactions between iron deficiency and vaccine efficacy [<xref rid="bb0820" ref-type="bibr">164</xref>].</p><p id="p0285">Innate immune cells, including macrophages, neutrophils, and natural killer (NK) cells rapidly respond to infections or perturbations [<xref rid="bb0825" ref-type="bibr">165</xref>]. Macrophages and neutrophils facilitate bacterial clearance by phagocytosis and utilise multiple iron-requiring enzymes, including <bold>Myeloperoxidase (MPO)</bold>, NOX2, and COX2, for pathogen killing via production of toxic ROS and reactive nitrogen species [<xref rid="bb0830" ref-type="bibr">166.</xref>, <xref rid="bb0835" ref-type="bibr">167.</xref>, <xref rid="bb0840" ref-type="bibr">168.</xref>, <xref rid="bb0845" ref-type="bibr">169.</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). Iron-depleted neutrophils show defects in phagocytosis, bacterial killing, and cytokine production [<xref rid="bb0850" ref-type="bibr">170</xref>], but the specific cellular pathways that are impaired are unclear. Moreover, neutrophil development is also impaired by iron restriction [<xref rid="bb0850" ref-type="bibr">170</xref>,<xref rid="bb0855" ref-type="bibr">171</xref>]. Meanwhile, differential expression of key iron regulatory proteins associates with macrophage polarisation toward inflammatory or reparative subsets [<xref rid="bb0860" ref-type="bibr">172</xref>]. Proinflammatory M1 macrophages are more iron sequestering (reduced ferroportin, increased ferritin), while tissue homeostatic M2 macrophages are primed for iron export (increased ferroportin, reduced ferritin) [<xref rid="bb0860" ref-type="bibr">172</xref>]. Correspondingly, iron loading drives inflammatory macrophages, while iron chelation attenuates inflammatory signatures [<xref rid="bb0865" ref-type="bibr">173</xref>,<xref rid="bb0870" ref-type="bibr">174</xref>]. NK cells, which are early-responding cytotoxic cells important for killing virus-infected cells and tumour cells [<xref rid="bb0875" ref-type="bibr">175</xref>], are also impaired by iron starvation [<xref rid="bb0880" ref-type="bibr">176</xref>].<fig id="f0020" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Tissue and system specific roles of iron.</p><p>Iron is utilised by all mammalian cells. However, iron-interacting proteins have many cell-, organ-, and tissue-specific roles. Bold red text denotes known iron-dependent proteins. Bold blue text denotes described iron-dependent processes with incomplete mechanistic understanding. Abbreviations: COX2, cyclooxygenase; CYP, cytochrome P450; MPO, myeloperoxidase; OXPHOS: oxidative phosphorylation; PAH, phenylalanine hydroxylase; PLOD, procollagen lysine 2-oxoglutarate 5-dioxygenase; T3, triiodothyronine; T4, thyroxine; TH, tyrosine hydroxylase; TPH, tryptophan hydroxylase; TPO, thyroid peroxidase.</p></caption><alt-text id="al0020">Figure 4</alt-text><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="lk0020" position="float" orientation="portrait" xlink:href="gr4.jpg"/></fig></p><p id="p0290">The adaptive immune arm comprising B and T cells provides higher specificity responses to immune stimuli together with immune memory [<xref rid="bb0885" ref-type="bibr">177</xref>]. T cell receptor (TCR) binding to specific cognate antigen:MHC complexes induces activation via signalling pathways involving calcium influx [<xref rid="bb0890" ref-type="bibr">178</xref>]. Calcium activates calmodulin, which signals via iron-dependent calcineurin to stimulate the transcription factor NFAT [<xref rid="bb0890" ref-type="bibr">178</xref>,<xref rid="bb0895" ref-type="bibr">179</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). Whether iron scarcity impairs calcineurin signalling is unclear. However, iron depletion does impair T and B cell responses to vaccination [<xref rid="bb0295" ref-type="bibr">59</xref>,<xref rid="bb0385" ref-type="bibr">77</xref>], influenza infection [<xref rid="bb0295" ref-type="bibr">59</xref>], and autoimmune stimuli [<xref rid="bb0585" ref-type="bibr">117</xref>,<xref rid="bb0900" ref-type="bibr">180.</xref>, <xref rid="bb0905" ref-type="bibr">181.</xref>, <xref rid="bb0910" ref-type="bibr">182.</xref>]. Iron-starved T cells fail to proliferate, show defects in mitochondrial function [<xref rid="bb0295" ref-type="bibr">59</xref>], and have increased levels of the repressive histone mark H3K27me3 [<xref rid="bb0390" ref-type="bibr">78</xref>]. Iron-starved B cells similarly show proliferative defects and suppressed removal of H3K9me2/3 [<xref rid="bb0385" ref-type="bibr">77</xref>]. Overall, while it is clear that iron scarcity impacts immunity at both the cellular and systems levels, whether this is driven by one or more specific requirements of cellular function for iron (e.g., DNA synthesis, mitochondrial function, or epigenetic regulation) remains to be determined. At a higher level, how iron deficiency quantitatively and qualitatively influences immune system development (e.g., haematopoietic output, and immune cell populations at barrier sites) requires more research.</p></sec><sec id="s0130"><title>Iron in the nervous system</title><p id="p0295">Iron deficiency is commonly associated with fatigue, impaired cognitive development, and dizziness [<xref rid="bb0050" ref-type="bibr">10</xref>]. While anaemia and reduced oxygen availability may contribute to this, iron may also directly influence neurological function [<xref rid="bb0915" ref-type="bibr">183</xref>]. Serotonin production from tryptophan requires the iron-dependent enzyme <bold>tryptophan hydroxylase 1/2 (TPH1/2)</bold> [<xref rid="bb0920" ref-type="bibr">184</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). Meanwhile, dopamine and noradrenaline synthesis from phenylalanine (via tyrosine) requires iron-dependent <bold>tyrosine hydroxylase (TH)</bold> and <bold>phenylalanine hydroxylase (PAH)</bold> [<xref rid="bb0920" ref-type="bibr">184</xref>]. Serotonin, dopamine, and noradrenaline are neurotransmitters that regulate neurological processes, including emotional state [<xref rid="bb0920" ref-type="bibr">184</xref>]. Notably, restless leg syndrome, believed to be caused by dysregulated dopamine signalling, is associated with brain iron deficiency [<xref rid="bb0050" ref-type="bibr">10</xref>,<xref rid="bb0925" ref-type="bibr">185</xref>].</p><p id="p0300">Early-life iron deficiency in rats was shown to alter DNA and histone methylation at the gene encoding <bold>brain-derived neurotrophic factor (BDNF)</bold>, important for neural function in the hippocampus [<xref rid="bb0930" ref-type="bibr">186</xref>]. Iron is also implicated in myelin-producing oligodendrocytes, which have high requirements for OXPHOS [<xref rid="bb0935" ref-type="bibr">187</xref>]. Such factors may underly well-established associations between iron deficiency and impaired cognitive development in infants [<xref rid="bb0940" ref-type="bibr">188</xref>].</p></sec><sec id="s0135"><title>Iron in thyroid function</title><p id="p0305"><bold>Thyroid peroxidase (TPO)</bold> is an iron-dependent enzyme important for production of the thyroid hormones triiodothyronine (T3) and thyroxine (T4) [<xref rid="bb0945" ref-type="bibr">189</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). Thyroid hormones control systemic metabolism, with important roles in thermoregulation [<xref rid="bb0950" ref-type="bibr">190</xref>]. Upon cold exposure, they stimulate heat preserving and generating pathways, such as vasoconstriction, shivering, and activation of heat-generating brown adipose tissue [<xref rid="bb0950" ref-type="bibr">190</xref>]. Rats on iron-deficient diets have reduced TPO activity and thyroid hormone production [<xref rid="bb0955" ref-type="bibr">191</xref>] and fail to upregulate thyroid hormones upon cold exposure [<xref rid="bb0960" ref-type="bibr">192</xref>]. Lower T3 and T4 hormone levels and significantly lower body temperatures upon cold exposure are also reported in women who are iron deficient, suggesting impaired thermoregulation [<xref rid="bb0965" ref-type="bibr">193</xref>,<xref rid="bb0970" ref-type="bibr">194</xref>].</p></sec><sec id="s0140"><title>Iron in collagen synthesis</title><p id="p0310">Collagens comprise &#8764;30% of the protein mass of the body, maintaining integrity of tissues, such as skin and tendons [<xref rid="bb0975" ref-type="bibr">195</xref>]. They require numerous post-translational modifications [<xref rid="bb0975" ref-type="bibr">195</xref>]. For instance, iron-dependent 2-OGDD enzymes [<bold>procollagen lysine 2-oxoglutarate 5-dioxygenase (PLOD)</bold>1/2/3, P3H, and P4H] mediate proline and lysine hydroxylation [<xref rid="bb0975" ref-type="bibr">195</xref>,<xref rid="bb0980" ref-type="bibr">196</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). Collagens are also cleaved and experience cross-linking between different collagen strands [<xref rid="bb0975" ref-type="bibr">195</xref>]. Type 1 collagen is a major component of bone [<xref rid="bb0665" ref-type="bibr">133</xref>,<xref rid="bb0675" ref-type="bibr">135</xref>,<xref rid="bb0680" ref-type="bibr">136</xref>]; thus, changes in bone density with altered iron (discussed in the preceding text) may also involve defects in collagen synthesis. Koilonychia (indented nails) and dry skin are also associated with iron deficiency [<xref rid="bb0050" ref-type="bibr">10</xref>], but whether these relate to impaired collagen synthesis is unclear.</p></sec><sec id="s0145"><title>Iron in vitamin A metabolism and vision</title><p id="p0315">Vitamin A (retinol) cannot be synthesised endogenously by mammals and is instead acquired from the diet as retinyl esters or &#946;-carotene [<xref rid="bb0985" ref-type="bibr">197</xref>]. Iron-dependent BCO1 mediates the initial cleavage of dietary &#946;-carotene to retinal, before conversion to retinol, retinyl esters, and retinoic acid (<xref rid="f0020" ref-type="fig">Figure 4</xref>) [<xref rid="bb0985" ref-type="bibr">197</xref>]. Retinal is important for vision, while retinoic acid stimulates transcription by retinoic acid receptor transcription factors, which control diverse processes, including immunity, cell differentiation, and development [<xref rid="bb0985" ref-type="bibr">197</xref>]. Retinoic acid clearance depends on haem-dependent CYP26 proteins [<xref rid="bb0990" ref-type="bibr">198</xref>], implicating iron in both vitamin A synthesis and degradation. Iron deficiency in rats associates with reduced plasma retinol and increased liver retinol, consistent with iron influencing vitamin A mobilisation [<xref rid="bb0995" ref-type="bibr">199</xref>,<xref rid="bb1000" ref-type="bibr">200</xref>]. Note that plasma vitamin A, similar to iron, is negatively regulated upon inflammation due to increased liver retention [<xref rid="bb1005" ref-type="bibr">201</xref>], driving correlations between iron and vitamin A, especially during inflammation.</p><p id="p0320">Upon light exposure, photon absorption in the retina converts 11-<italic toggle="yes">cis</italic>-retinal to all-<italic toggle="yes">trans</italic>-retinal, inducing a phototransduction cascade and, consequently, vision [<xref rid="bb1010" ref-type="bibr">202</xref>]. For continuous vision, all-<italic toggle="yes">trans</italic>-retinal must be converted back to 11-<italic toggle="yes">cis</italic>-retinal in the retinal pigment epithelium (i.e., the visual cycle) [<xref rid="bb1010" ref-type="bibr">202</xref>], requiring the iron-dependent enzyme RPE65 [<xref rid="bb1010" ref-type="bibr">202</xref>]. Mutations in the histidines that allow iron binding, or iron chelation, abrogate RPE65 function [<xref rid="bb1010" ref-type="bibr">202</xref>,<xref rid="bb1015" ref-type="bibr">203</xref>]. Interestingly, the iron chelator deferoxamine has been associated with ocular toxicity [<xref rid="bb1020" ref-type="bibr">204</xref>].</p></sec><sec id="s0150"><title>Iron in muscle and cardiovascular function</title><p id="p0325">Iron deficiency is highly prevalent in patients with heart failure, and serum iron deficiency associates with increased risk of cardiovascular disease and worse outcomes upon heart failure [<xref rid="bb0605" ref-type="bibr">121</xref>] (<xref rid="f0020" ref-type="fig">Figure 4</xref>). In mouse models, cardiomyocyte iron deficiency has been linked with cardiomyopathy and impaired contractile function [<xref rid="bb1025" ref-type="bibr">205</xref>,<xref rid="bb1030" ref-type="bibr">206</xref>], while maternal iron deficiency has been implicated in severe embryonic cardiovascular defects [<xref rid="bb1035" ref-type="bibr">207</xref>]. The mechanisms driving these clear iron&#8211;cardiovascular interactions are uncertain. Similar to haemoglobin, myoglobin uses iron to store oxygen in cardiac and skeletal muscle [<xref rid="bb0605" ref-type="bibr">121</xref>] and iron-deficient rats show reduced myoglobin in skeletal muscle, but not cardiac muscle [<xref rid="bb1040" ref-type="bibr">208</xref>]. Muscle also has high metabolic demands and, accordingly, iron deficiency in cardiomyocytes promotes dysfunctional mitochondrial processes, including impaired ETC activity, increased oxidative stress, and a switch to glycolysis [<xref rid="bb1025" ref-type="bibr">205</xref>,<xref rid="bb1030" ref-type="bibr">206</xref>,<xref rid="bb1045" ref-type="bibr">209</xref>,<xref rid="bb1050" ref-type="bibr">210</xref>]. Iron deficiency in rats similarly results in muscle cytochrome C depletion and reduced activity of CI and CII (SDH) [<xref rid="bb1055" ref-type="bibr">211</xref>].</p></sec></sec><sec id="s0155"><title>Concluding remarks and future perspectives</title><p id="p0330">We have described many roles of iron in mammalian cellular biochemistry and summarised what is known regarding the impacts of iron perturbations on these processes. Clearly, our review cannot be exhaustive; other iron-dependent proteins exist in humans [<xref rid="bb0030" ref-type="bibr">6</xref>] and especially in other organisms, and others may remain to be discovered. However, despite the extensive involvement of iron in cellular biochemistry, the mechanisms by which iron deficiency interacts with these processes are, in many cases, either uncharacterised or definitive data remain somewhat limited. Nevertheless, understanding where and how iron is utilised at the cellular level lays the groundwork for rationally hypothesising and testing how iron deficiency may cause dysfunction potentially affecting clinical pathology. Moreover, such understanding may suggest whether known pathological conditions have iron dysregulation implicated in their pathogenesis (see <xref rid="b0010" ref-type="boxed-text">Outstanding questions</xref>).</p><p id="p0335">Iron scarcity has several underlying causes in humans, ranging from dietary iron deficiency [<xref rid="bb0050" ref-type="bibr">10</xref>] and inflammation-induced hypoferremia [<xref rid="bb1060" ref-type="bibr">212</xref>] to iron restriction within local tissue niches due to the presence of iron-demanding tumours [<xref rid="bb0055" ref-type="bibr">11</xref>] or pathogens [<xref rid="bb1065" ref-type="bibr">213</xref>]. While all mammalian cells require iron, different cell and tissue types will likely have different iron requirements and, consequently, differential sensitivity to iron deficiency. Demonstrating this principle, erythroid lineages, which rely heavily on iron for haemoglobin, are more sensitive to <italic toggle="yes">in vitro iron deprivation</italic>compared with megakaryocytic and granulocytic lineages [<xref rid="bb1070" ref-type="bibr">214</xref>]. Similarly, neutropoiesis shows higher sensitivity to <italic toggle="yes">in vivo</italic> iron limitation relative to monopoiesis, potentially due to the high predicted iron requirements of neutrophils [<xref rid="bb0850" ref-type="bibr">170</xref>]. Furthermore, cells that experience high turnover will likely have higher iron demands due to cell division and dilution of iron between daughter cells. For example, activated and rapidly proliferating T cells are considerably more sensitive to iron scarcity compared with their na&#239;ve and quiescent counterparts [<xref rid="bb0800" ref-type="bibr">160</xref>]. Cells that rely heavily on iron-dependent processes, such as mitochondrial energy generation in cardiomyocytes, would also be predicted to be more affected by iron starvation.</p><p id="p0340">The interaction of iron scarcity with inflammatory signals and immune cell activation and migration could influence multiple factors in cellular and tissue biology. One relevant scenario is viral infection that induces strong inflammatory responses and hypoferremia: during SARS-CoV-2 infection, plasma iron concentrations can plummet to extremely low levels because tissue damage is ongoing [<xref rid="bb1075" ref-type="bibr">215</xref>,<xref rid="bb1080" ref-type="bibr">216</xref>]. Dysregulation of iron homeostasis early in infection may impair tissue oxygenation due to decreasing haemoglobin and influence cellular metabolism via iron redistribution [<xref rid="bb1085" ref-type="bibr">217</xref>]. Indeed, altered iron homeostasis, impaired erythropoiesis, iron-deficient lymphocytes, but iron-loaded monocyte populations during the first month after SARS-CoV-2 infection are associated with symptoms of Long Covid [<xref rid="bb1090" ref-type="bibr">218</xref>]. This may be an example of disturbances of iron availability at cellular level influencing metabolism and function and leading to chronic systemic pathology [<xref rid="bb1090" ref-type="bibr">218</xref>,<xref rid="bb1095" ref-type="bibr">219</xref>].</p><p id="p0345">A consideration for understanding cellular effects of iron deficiency is that iron-dependent proteins will likely have different sensitivities to iron deprivation, with distinct cellular processes likely differentially impacted by reduced iron. For instance, the proteins from which iron is sequentially lost during iron scarcity will be governed by factors including iron binding affinity and protein turnover. Notably, different 2-OGDD proteins are suggested to have different iron-binding affinities [<xref rid="bb1100" ref-type="bibr">220</xref>]. Specifically, PHD2 (involved in HIF signalling) displays very high binding affinity, whereas P4H (collagen hydroxylation) binds iron more weakly [<xref rid="bb1100" ref-type="bibr">220</xref>]. Thus, P4H may lose iron prematurely, while more extreme iron scarcity may be required to induce HIF signalling. Differential binding affinities are also likely to vary within Fe-S cluster and haem-binding protein families. Proteins experiencing slower turnover may retain their iron cofactors when iron limitation is imposed, making them more resistant to iron deprivation relative to proteins with a high rate of turnover, which will more readily recycle iron back into the cellular iron pool.</p><p id="p0350">Similarly, iron trafficking to different proteins and organelles by intracellular iron chaperones will also modulate iron usage by cellular processes. It is well established that mitochondria are treated preferentially in terms of iron supply within the cell [<xref rid="bb0500" ref-type="bibr">100</xref>,<xref rid="bb0505" ref-type="bibr">101</xref>], suggesting that mitochondrial processes, such as haem and Fe-S cluster synthesis and energy generation, are favoured over other cellular processes. Moreover, certain iron-dependent proteins have redundancies with iron-independent alternatives. For instance, iron-dependent helicases represent only a fraction of the 31 DNA helicases encoded by the human genome [<xref rid="bb1105" ref-type="bibr">221</xref>], suggesting that, during iron limitation, other iron-independent helicases may intervene, reducing or completely preventing dysfunction (although note that different helicases preferentially bind certain nucleic acid structures, meaning that true redundancy between all 31 helicases is unlikely). By contrast, other proteins, such as the haem-dependent CYP proteins involved in steroidogenesis, have no known iron-independent substitutes. Understanding the different sensitivities of tissues, cell types, and proteins to iron scarcity will provide insights into how iron modulation may be used to target specific biological processes.</p><p id="p0355">Iron deficiency is highly prevalent and may make underappreciated contributions to several health issues. For instance, iron deficiency is common in some forms of cancer [<xref rid="bb0355" ref-type="bibr">71</xref>] and heart failure [<xref rid="bb0605" ref-type="bibr">121</xref>], but whether and how iron deficiency contributes to poor health outcomes is not well characterised. Large-scale population studies of biobank data may provide indications of associations between iron deficiency and common health problems, which could then be interrogated mechanistically using cell and animal experimental models. Understanding the biochemical implications of iron restriction on cellular processes should inform how pharmacological and nutritional interventions could be utilised to overcome iron-related impairments in a clinical setting. Speculatively, modalities developed to induce functional iron restriction via ferroportin inhibition (e.g., the hepcidin mimetic rusfertide, which can control iron flow to the erythron in polycythaemia vera [<xref rid="bb1110" ref-type="bibr">222</xref>]) may provide benefit for other disorders, perhaps in immunopathologies. Lastly, iron regulation may be more effective when in combination with other interventions. For instance, combining iron supplementation (intravenous or oral iron) with specific nutritional (e.g., vitamin A) or pharmacological (e.g., dopamine agonists) interventions identified via mechanistic investigation of iron deficiency in specific cell types could provide synergistic and efficacious benefits. Thus, the breadth of iron usage in cells offers not only challenges for understanding the effects of iron deficiency, but also opportunities to improve health.<boxed-text id="b0010" position="float" orientation="portrait"><label>Outstanding questions</label><p id="p0360">What tissues and cell types are most sensitive to iron deficiency in humans?</p><p id="p0365">What is the hierarchy of sensitivity of cellular processes to iron deficiency and what factors (e.g., iron affinity, protein turnover, redundancy, iron trafficking, and localisation) drive this?</p><p id="p0370">Given the role of iron in epigenetic processes, how does iron deficiency impact cell fate and function?</p><p id="p0375">How does iron deficiency impact processes that are mediated by iron-dependent enzymes, including genome fidelity, bile acid synthesis, vitamin A and D metabolism, and steroidogenesis?</p><p id="p0380">What molecular mechanisms underlie the many common clinical features associated with iron deficiency, and can they be targeted therapeutically?</p><p id="p0385">As a comorbidity, how does iron deficiency exacerbate other diseases?</p><p id="p0390">Can a mechanistic understanding of the role of iron in biology inform treatment of iron deficiency-associated disease?</p><notes notes-type="alt-text" specific-use="for-accessibility" id="al0030"><p>Alt-text: Outstanding questions</p></notes></boxed-text></p></sec></body><back><ref-list id="bi0005"><title>References</title><ref id="bb0005"><label>1.</label><element-citation publication-type="journal" id="rf0005"><person-group person-group-type="author"><name name-style="western"><surname>Zoroddu</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>The essential metals for humans: a brief overview</article-title><source>J. Inorg. Biochem.</source><volume>195</volume><year>2019</year><fpage>120</fpage><lpage>129</lpage><pub-id pub-id-type="pmid">30939379</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jinorgbio.2019.03.013</pub-id></element-citation></ref><ref id="bb0010"><label>2.</label><element-citation publication-type="book" id="rf0010"><person-group person-group-type="author"><name name-style="western"><surname>Alberts</surname><given-names>B.</given-names></name><etal/></person-group><part-title>Molecular Biology of the Cell</part-title><edition>4th edn</edition><year>2002</year><publisher-name>Garland Science</publisher-name></element-citation></ref><ref id="bb0015"><label>3.</label><element-citation publication-type="journal" id="rf0015"><person-group person-group-type="author"><name name-style="western"><surname>Archibald</surname><given-names>F.</given-names></name></person-group><article-title><italic toggle="yes">Lactobacillus plantarum</italic>, an organism not requiring iron</article-title><source>FEMS Microb. Lett.</source><volume>19</volume><year>1983</year><fpage>29</fpage><lpage>32</lpage></element-citation></ref><ref id="bb0020"><label>4.</label><element-citation publication-type="journal" id="rf0020"><person-group person-group-type="author"><name name-style="western"><surname>Posey</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Gherardini</surname><given-names>F.C.</given-names></name></person-group><article-title>Lack of a role for iron in the Lyme disease pathogen</article-title><source>Science</source><volume>288</volume><year>2000</year><fpage>1651</fpage><lpage>1653</lpage><pub-id pub-id-type="pmid">10834845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.288.5471.1651</pub-id></element-citation></ref><ref id="bb0025"><label>5.</label><element-citation publication-type="journal" id="rf0025"><person-group person-group-type="author"><name name-style="western"><surname>Sabine</surname><given-names>D.B.</given-names></name><name name-style="western"><surname>Vaselekos</surname><given-names>J.</given-names></name></person-group><article-title>Trace element requirements of <italic toggle="yes">Lactobacillus acidophilus</italic></article-title><source>Nature</source><volume>214</volume><year>1967</year><fpage>520</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/214520a0</pub-id><pub-id pub-id-type="pmid">4962070</pub-id></element-citation></ref><ref id="bb0030"><label>6.</label><element-citation publication-type="journal" id="rf0030"><person-group person-group-type="author"><name name-style="western"><surname>Andreini</surname><given-names>C.</given-names></name><etal/></person-group><article-title>The human iron-proteome</article-title><source>Metallomics</source><volume>10</volume><year>2018</year><fpage>1223</fpage><lpage>1231</lpage><pub-id pub-id-type="pmid">30095136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c8mt00146d</pub-id></element-citation></ref><ref id="bb0035"><label>7.</label><element-citation publication-type="journal" id="rf0035"><person-group person-group-type="author"><name name-style="western"><surname>Ganz</surname><given-names>T.</given-names></name></person-group><article-title>Systemic iron homeostasis</article-title><source>Physiol. Rev.</source><volume>93</volume><year>2013</year><fpage>1721</fpage><lpage>1741</lpage><pub-id pub-id-type="pmid">24137020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/physrev.00008.2013</pub-id></element-citation></ref><ref id="bb0040"><label>8.</label><element-citation publication-type="journal" id="rf0040"><person-group person-group-type="author"><name name-style="western"><surname>Wilson</surname><given-names>M.T.</given-names></name><name name-style="western"><surname>Reeder</surname><given-names>B.J.</given-names></name></person-group><article-title>Oxygen-binding haem proteins</article-title><source>Exp. Physiol.</source><volume>93</volume><year>2008</year><fpage>128</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">17981931</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1113/expphysiol.2007.039735</pub-id></element-citation></ref><ref id="bb0045"><label>9.</label><element-citation publication-type="journal" id="rf0045"><person-group person-group-type="author"><name name-style="western"><surname>GBD</surname></name></person-group><article-title>Anaemia Collaborators (2023) Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021</article-title><source>Lancet Haematol.</source><volume>10</volume><year>2021</year><fpage>e713</fpage><lpage>e734</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3026(23)00160-6</pub-id><pub-id pub-id-type="pmcid">PMC10465717</pub-id><pub-id pub-id-type="pmid">37536353</pub-id></element-citation></ref><ref id="bb0050"><label>10.</label><element-citation publication-type="journal" id="rf0050"><person-group person-group-type="author"><name name-style="western"><surname>Pasricha</surname><given-names>S.R.</given-names></name><etal/></person-group><article-title>Iron deficiency</article-title><source>Lancet</source><volume>397</volume><year>2021</year><fpage>233</fpage><lpage>248</lpage><pub-id pub-id-type="pmid">33285139</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)32594-0</pub-id></element-citation></ref><ref id="bb0055"><label>11.</label><element-citation publication-type="journal" id="rf0055"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>A.J.</given-names></name><etal/></person-group><article-title>Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells</article-title><source>Nat. Metab.</source><volume>3</volume><year>2021</year><fpage>969</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">34155415</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42255-021-00406-7</pub-id><pub-id pub-id-type="pmcid">PMC8316354</pub-id></element-citation></ref><ref id="bb0060"><label>12.</label><element-citation publication-type="journal" id="rf0060"><person-group person-group-type="author"><name name-style="western"><surname>Stoffel</surname><given-names>N.U.</given-names></name><etal/></person-group><article-title>Iron deficiency anemia at time of vaccination predicts decreased vaccine response and iron supplementation at time of vaccination increases humoral vaccine response: a birth cohort study and a randomized trial follow-up study in Kenyan infants</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>1313</fpage><pub-id pub-id-type="pmid">32754150</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.01313</pub-id><pub-id pub-id-type="pmcid">PMC7369313</pub-id></element-citation></ref><ref id="bb0065"><label>13.</label><element-citation publication-type="journal" id="rf0065"><person-group person-group-type="author"><name name-style="western"><surname>Winterbourn</surname><given-names>C.C.</given-names></name></person-group><article-title>Toxicity of iron and hydrogen peroxide: the Fenton reaction</article-title><source>Toxicol. Lett.</source><volume>82-83</volume><year>1995</year><fpage>969</fpage><lpage>974</lpage><pub-id pub-id-type="pmid">8597169</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0378-4274(95)03532-x</pub-id></element-citation></ref><ref id="bb0070"><label>14.</label><element-citation publication-type="journal" id="rf0070"><person-group person-group-type="author"><name name-style="western"><surname>Drakesmith</surname><given-names>H.</given-names></name><name name-style="western"><surname>Prentice</surname><given-names>A.M.</given-names></name></person-group><article-title>Hepcidin and the iron-infection axis</article-title><source>Science</source><volume>338</volume><year>2012</year><fpage>768</fpage><lpage>772</lpage><pub-id pub-id-type="pmid">23139325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1224577</pub-id></element-citation></ref><ref id="bb0075"><label>15.</label><element-citation publication-type="journal" id="rf0075"><person-group person-group-type="author"><name name-style="western"><surname>Galy</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Mechanisms controlling cellular and systemic iron homeostasis</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2023</year><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41580-023-00648-1</pub-id><pub-id pub-id-type="pmid">37783783</pub-id></element-citation></ref><ref id="bb0080"><label>16.</label><element-citation publication-type="journal" id="rf0080"><person-group person-group-type="author"><name name-style="western"><surname>Muckenthaler</surname><given-names>M.U.</given-names></name><etal/></person-group><article-title>A red carpet for iron metabolism</article-title><source>Cell</source><volume>168</volume><year>2017</year><fpage>344</fpage><lpage>361</lpage><pub-id pub-id-type="pmid">28129536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2016.12.034</pub-id><pub-id pub-id-type="pmcid">PMC5706455</pub-id></element-citation></ref><ref id="bb0085"><label>17.</label><element-citation publication-type="journal" id="rf0085"><person-group person-group-type="author"><name name-style="western"><surname>Dautry-Varsat</surname><given-names>A.</given-names></name></person-group><article-title>Receptor-mediated endocytosis: the intracellular journey of transferrin and its receptor</article-title><source>Biochimie</source><volume>68</volume><year>1986</year><fpage>375</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">2874839</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0300-9084(86)80004-9</pub-id></element-citation></ref><ref id="bb0090"><label>18.</label><element-citation publication-type="journal" id="rf0090"><person-group person-group-type="author"><name name-style="western"><surname>Fleming</surname><given-names>M.D.</given-names></name><etal/></person-group><article-title>Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>95</volume><year>1998</year><fpage>1148</fpage><lpage>1153</lpage><pub-id pub-id-type="pmid">9448300</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.95.3.1148</pub-id><pub-id pub-id-type="pmcid">PMC18702</pub-id></element-citation></ref><ref id="bb0095"><label>19.</label><element-citation publication-type="journal" id="rf0095"><person-group person-group-type="author"><name name-style="western"><surname>Canonne-Hergaux</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Cellular and subcellular localization of the Nramp2 iron transporter in the intestinal brush border and regulation by dietary iron</article-title><source>Blood</source><volume>93</volume><year>1999</year><fpage>4406</fpage><lpage>4417</lpage><pub-id pub-id-type="pmid">10361139</pub-id></element-citation></ref><ref id="bb0100"><label>20.</label><element-citation publication-type="journal" id="rf0100"><person-group person-group-type="author"><name name-style="western"><surname>Liuzzi</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Zip14 (Slc39a14) mediates non-transferrin-bound iron uptake into cells</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>103</volume><year>2006</year><fpage>13612</fpage><lpage>13617</lpage><pub-id pub-id-type="pmid">16950869</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0606424103</pub-id><pub-id pub-id-type="pmcid">PMC1564235</pub-id></element-citation></ref><ref id="bb0105"><label>21.</label><element-citation publication-type="journal" id="rf0105"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>C.Y.</given-names></name><etal/></person-group><article-title>ZIP8 is an iron and zinc transporter whose cell-surface expression is up-regulated by cellular iron loading</article-title><source>J. Biol. Chem.</source><volume>287</volume><year>2012</year><fpage>34032</fpage><lpage>34043</lpage><pub-id pub-id-type="pmid">22898811</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M112.367284</pub-id><pub-id pub-id-type="pmcid">PMC3464513</pub-id></element-citation></ref><ref id="bb0110"><label>22.</label><element-citation publication-type="journal" id="rf0110"><person-group person-group-type="author"><name name-style="western"><surname>M&#252;ller</surname><given-names>S.</given-names></name><etal/></person-group><article-title>CD44 regulates epigenetic plasticity by mediating iron endocytosis</article-title><source>Nat. Chem.</source><volume>12</volume><year>2020</year><fpage>929</fpage><lpage>938</lpage><pub-id pub-id-type="pmid">32747755</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41557-020-0513-5</pub-id><pub-id pub-id-type="pmcid">PMC7612580</pub-id></element-citation></ref><ref id="bb0115"><label>23.</label><element-citation publication-type="journal" id="rf0115"><person-group person-group-type="author"><name name-style="western"><surname>Wilkinson</surname><given-names>N.</given-names></name><name name-style="western"><surname>Pantopoulos</surname><given-names>K.</given-names></name></person-group><article-title>The IRP/IRE system in vivo: insights from mouse models</article-title><source>Front. Pharmacol.</source><volume>5</volume><year>2014</year><fpage>176</fpage><pub-id pub-id-type="pmid">25120486</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2014.00176</pub-id><pub-id pub-id-type="pmcid">PMC4112806</pub-id></element-citation></ref><ref id="bb0120"><label>24.</label><element-citation publication-type="journal" id="rf0120"><person-group person-group-type="author"><name name-style="western"><surname>Fischbach</surname><given-names>F.A.</given-names></name><name name-style="western"><surname>Anderegg</surname><given-names>J.W.</given-names></name></person-group><article-title>An x-ray scattering study of ferritin and apoferritin</article-title><source>J. Mol. Biol.</source><volume>14</volume><year>1965</year><fpage>458</fpage><lpage>473</lpage><pub-id pub-id-type="pmid">5880863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-2836(65)80196-6</pub-id></element-citation></ref><ref id="bb0125"><label>25.</label><element-citation publication-type="journal" id="rf0125"><person-group person-group-type="author"><name name-style="western"><surname>Mancias</surname><given-names>J.D.</given-names></name><etal/></person-group><article-title>Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy</article-title><source>Nature</source><volume>509</volume><year>2014</year><fpage>105</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">24695223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature13148</pub-id><pub-id pub-id-type="pmcid">PMC4180099</pub-id></element-citation></ref><ref id="bb0130"><label>26.</label><element-citation publication-type="journal" id="rf0130"><person-group person-group-type="author"><name name-style="western"><surname>Philpott</surname><given-names>C.C.</given-names></name><etal/></person-group><article-title>Cytosolic iron chaperones: proteins delivering iron cofactors in the cytosol of mammalian cells</article-title><source>J. Biol. Chem.</source><volume>292</volume><year>2017</year><fpage>12764</fpage><lpage>12771</lpage><pub-id pub-id-type="pmid">28615454</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.R117.791962</pub-id><pub-id pub-id-type="pmcid">PMC5546017</pub-id></element-citation></ref><ref id="bb0135"><label>27.</label><element-citation publication-type="journal" id="rf0135"><person-group person-group-type="author"><name name-style="western"><surname>Galmozzi</surname><given-names>A.</given-names></name><etal/></person-group><article-title>PGRMC2 is an intracellular haem chaperone critical for adipocyte function</article-title><source>Nature</source><volume>576</volume><year>2019</year><fpage>138</fpage><lpage>142</lpage><pub-id pub-id-type="pmid">31748741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-019-1774-2</pub-id><pub-id pub-id-type="pmcid">PMC6895438</pub-id></element-citation></ref><ref id="bb0140"><label>28.</label><element-citation publication-type="journal" id="rf0140"><person-group person-group-type="author"><name name-style="western"><surname>Donovan</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter</article-title><source>Nature</source><volume>403</volume><year>2000</year><fpage>776</fpage><lpage>781</lpage><pub-id pub-id-type="pmid">10693807</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/35001596</pub-id></element-citation></ref><ref id="bb0145"><label>29.</label><element-citation publication-type="journal" id="rf0145"><person-group person-group-type="author"><name name-style="western"><surname>McKie</surname><given-names>A.T.</given-names></name><etal/></person-group><article-title>A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation</article-title><source>Mol. Cell</source><volume>5</volume><year>2000</year><fpage>299</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">10882071</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1097-2765(00)80425-6</pub-id></element-citation></ref><ref id="bb0150"><label>30.</label><element-citation publication-type="journal" id="rf0150"><person-group person-group-type="author"><name name-style="western"><surname>Abboud</surname><given-names>S.</given-names></name><name name-style="western"><surname>Haile</surname><given-names>D.J.</given-names></name></person-group><article-title>A novel mammalian iron-regulated protein involved in intracellular iron metabolism</article-title><source>J. Biol. Chem.</source><volume>275</volume><year>2000</year><fpage>19906</fpage><lpage>19912</lpage><pub-id pub-id-type="pmid">10747949</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M000713200</pub-id></element-citation></ref><ref id="bb0155"><label>31.</label><element-citation publication-type="journal" id="rf0155"><person-group person-group-type="author"><name name-style="western"><surname>Knutson</surname><given-names>M.D.</given-names></name><etal/></person-group><article-title>Iron release from macrophages after erythrophagocytosis is up-regulated by ferroportin 1 overexpression and down-regulated by hepcidin</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>102</volume><year>2005</year><fpage>1324</fpage><lpage>1328</lpage><pub-id pub-id-type="pmid">15665091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.0409409102</pub-id><pub-id pub-id-type="pmcid">PMC547844</pub-id></element-citation></ref><ref id="bb0160"><label>32.</label><element-citation publication-type="journal" id="rf0160"><person-group person-group-type="author"><name name-style="western"><surname>Sinclair</surname><given-names>J.</given-names></name><name name-style="western"><surname>Hamza</surname><given-names>I.</given-names></name></person-group><article-title>Lessons from bloodless worms: heme homeostasis in <italic toggle="yes">C. elegans</italic></article-title><source>Biometals</source><volume>28</volume><year>2015</year><fpage>481</fpage><lpage>489</lpage><pub-id pub-id-type="pmid">25724951</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10534-015-9841-0</pub-id><pub-id pub-id-type="pmcid">PMC5967260</pub-id></element-citation></ref><ref id="bb0165"><label>33.</label><element-citation publication-type="journal" id="rf0165"><person-group person-group-type="author"><name name-style="western"><surname>Korolnek</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Control of metazoan heme homeostasis by a conserved multidrug resistance protein</article-title><source>Cell Metab.</source><volume>19</volume><year>2014</year><fpage>1008</fpage><lpage>1019</lpage><pub-id pub-id-type="pmid">24836561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2014.03.030</pub-id><pub-id pub-id-type="pmcid">PMC4052561</pub-id></element-citation></ref><ref id="bb0170"><label>34.</label><element-citation publication-type="journal" id="rf0170"><person-group person-group-type="author"><name name-style="western"><surname>Jonker</surname><given-names>J.W.</given-names></name><etal/></person-group><article-title>The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>99</volume><year>2002</year><fpage>15649</fpage><lpage>15654</lpage><pub-id pub-id-type="pmid">12429862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.202607599</pub-id><pub-id pub-id-type="pmcid">PMC137771</pub-id></element-citation></ref><ref id="bb0175"><label>35.</label><element-citation publication-type="journal" id="rf0175"><person-group person-group-type="author"><name name-style="western"><surname>Salahudeen</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis</article-title><source>Science</source><volume>326</volume><year>2009</year><fpage>722</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">19762597</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1176326</pub-id><pub-id pub-id-type="pmcid">PMC3582197</pub-id></element-citation></ref><ref id="bb0180"><label>36.</label><element-citation publication-type="journal" id="rf0180"><person-group person-group-type="author"><name name-style="western"><surname>Vashisht</surname><given-names>A.A.</given-names></name><etal/></person-group><article-title>Control of iron homeostasis by an iron-regulated ubiquitin ligase</article-title><source>Science</source><volume>326</volume><year>2009</year><fpage>718</fpage><lpage>721</lpage><pub-id pub-id-type="pmid">19762596</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1176333</pub-id><pub-id pub-id-type="pmcid">PMC2929180</pub-id></element-citation></ref><ref id="bb0185"><label>37.</label><element-citation publication-type="journal" id="rf0185"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>J.</given-names></name><name name-style="western"><surname>Pantopoulos</surname><given-names>K.</given-names></name></person-group><article-title>Regulation of cellular iron metabolism</article-title><source>Biochem. J.</source><volume>434</volume><year>2011</year><fpage>365</fpage><lpage>381</lpage><pub-id pub-id-type="pmid">21348856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1042/BJ20101825</pub-id><pub-id pub-id-type="pmcid">PMC3048577</pub-id></element-citation></ref><ref id="bb0190"><label>38.</label><element-citation publication-type="journal" id="rf0190"><person-group person-group-type="author"><name name-style="western"><surname>Dandekar</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Identification of a novel iron-responsive element in murine and human erythroid delta-aminolevulinic acid synthase mRNA</article-title><source>EMBO J.</source><volume>10</volume><year>1991</year><fpage>1903</fpage><lpage>1909</lpage><pub-id pub-id-type="pmid">2050126</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/j.1460-2075.1991.tb07716.x</pub-id><pub-id pub-id-type="pmcid">PMC452865</pub-id></element-citation></ref><ref id="bb0195"><label>39.</label><element-citation publication-type="journal" id="rf0195"><person-group person-group-type="author"><name name-style="western"><surname>Gray</surname><given-names>N.K.</given-names></name><etal/></person-group><article-title>Translational regulation of mammalian and <italic toggle="yes">Drosophila</italic> citric acid cycle enzymes via iron-responsive elements</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>93</volume><year>1996</year><fpage>4925</fpage><lpage>4930</lpage><pub-id pub-id-type="pmid">8643505</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.93.10.4925</pub-id><pub-id pub-id-type="pmcid">PMC39381</pub-id></element-citation></ref><ref id="bb0200"><label>40.</label><element-citation publication-type="journal" id="rf0200"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>Y.M.</given-names></name><name name-style="western"><surname>Xie</surname><given-names>L.</given-names></name></person-group><article-title>Hypoxia-inducible factors link iron homeostasis and erythropoiesis</article-title><source>Gastroenterology</source><volume>146</volume><year>2014</year><fpage>630</fpage><lpage>642</lpage><pub-id pub-id-type="pmid">24389303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/j.gastro.2013.12.031</pub-id><pub-id pub-id-type="pmcid">PMC3943938</pub-id></element-citation></ref><ref id="bb0205"><label>41.</label><element-citation publication-type="journal" id="rf0205"><person-group person-group-type="author"><name name-style="western"><surname>Taylor</surname><given-names>C.T.</given-names></name><name name-style="western"><surname>Scholz</surname><given-names>C.C.</given-names></name></person-group><article-title>The effect of HIF on metabolism and immunity</article-title><source>Nat. Rev. Nephrol.</source><volume>18</volume><year>2022</year><fpage>573</fpage><lpage>587</lpage><pub-id pub-id-type="pmid">35726016</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41581-022-00587-8</pub-id><pub-id pub-id-type="pmcid">PMC9208707</pub-id></element-citation></ref><ref id="bb0210"><label>42.</label><element-citation publication-type="journal" id="rf0210"><person-group person-group-type="author"><name name-style="western"><surname>Cho</surname><given-names>E.A.</given-names></name><etal/></person-group><article-title>Differential in vitro and cellular effects of iron chelators for hypoxia inducible factor hydroxylases</article-title><source>J. Cell. Biochem.</source><volume>114</volume><year>2013</year><fpage>864</fpage><lpage>873</lpage><pub-id pub-id-type="pmid">23097160</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcb.24423</pub-id></element-citation></ref><ref id="bb0215"><label>43.</label><element-citation publication-type="journal" id="rf0215"><person-group person-group-type="author"><name name-style="western"><surname>Mu&#241;oz-S&#225;nchez</surname><given-names>J.</given-names></name><name name-style="western"><surname>Ch&#225;nez-C&#225;rdenas</surname><given-names>M.E.</given-names></name></person-group><article-title>The use of cobalt chloride as a chemical hypoxia model</article-title><source>J. Appl. Toxicol.</source><volume>39</volume><year>2019</year><fpage>556</fpage><lpage>570</lpage><pub-id pub-id-type="pmid">30484873</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jat.3749</pub-id></element-citation></ref><ref id="bb0220"><label>44.</label><element-citation publication-type="journal" id="rf0220"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>J.J.</given-names></name></person-group><article-title>Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias</article-title><source>Blood</source><volume>109</volume><year>2007</year><fpage>2693</fpage><lpage>2699</lpage><pub-id pub-id-type="pmid">17110456</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2006-08-041830</pub-id><pub-id pub-id-type="pmcid">PMC1852217</pub-id></element-citation></ref><ref id="bb0225"><label>45.</label><element-citation publication-type="journal" id="rf0225"><person-group person-group-type="author"><name name-style="western"><surname>Fessler</surname><given-names>E.</given-names></name><etal/></person-group><article-title>A pathway coordinated by DELE1 relays mitochondrial stress to the cytosol</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>433</fpage><lpage>437</lpage><pub-id pub-id-type="pmid">32132706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2076-4</pub-id><pub-id pub-id-type="pmcid">PMC7116715</pub-id></element-citation></ref><ref id="bb0230"><label>46.</label><element-citation publication-type="journal" id="rf0230"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Mitochondrial stress is relayed to the cytosol by an OMA1-DELE1-HRI pathway</article-title><source>Nature</source><volume>579</volume><year>2020</year><fpage>427</fpage><lpage>432</lpage><pub-id pub-id-type="pmid">32132707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-020-2078-2</pub-id><pub-id pub-id-type="pmcid">PMC7147832</pub-id></element-citation></ref><ref id="bb0235"><label>47.</label><element-citation publication-type="journal" id="rf0235"><person-group person-group-type="author"><name name-style="western"><surname>Abdel-Nour</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The heme-regulated inhibitor is a cytosolic sensor of protein misfolding that controls innate immune signaling</article-title><source>Science</source><volume>365</volume><year>2019</year><object-id pub-id-type="publisher-id">eaaw4144</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.aaw4144</pub-id><pub-id pub-id-type="pmcid">PMC10433729</pub-id><pub-id pub-id-type="pmid">31273097</pub-id></element-citation></ref><ref id="bb0240"><label>48.</label><element-citation publication-type="journal" id="rf0240"><person-group person-group-type="author"><name name-style="western"><surname>Puig</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Coordinated remodeling of cellular metabolism during iron deficiency through targeted mRNA degradation</article-title><source>Cell</source><volume>120</volume><year>2005</year><fpage>99</fpage><lpage>110</lpage><pub-id pub-id-type="pmid">15652485</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cell.2004.11.032</pub-id></element-citation></ref><ref id="bb0245"><label>49.</label><element-citation publication-type="journal" id="rf0245"><person-group person-group-type="author"><name name-style="western"><surname>Bayeva</surname><given-names>M.</given-names></name><etal/></person-group><article-title>mTOR regulates cellular iron homeostasis through tristetraprolin</article-title><source>Cell Metab.</source><volume>16</volume><year>2012</year><fpage>645</fpage><lpage>657</lpage><pub-id pub-id-type="pmid">23102618</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cmet.2012.10.001</pub-id><pub-id pub-id-type="pmcid">PMC3594686</pub-id></element-citation></ref><ref id="bb0250"><label>50.</label><element-citation publication-type="journal" id="rf0250"><person-group person-group-type="author"><name name-style="western"><surname>Sato</surname><given-names>T.</given-names></name><etal/></person-group><article-title>mRNA-binding protein tristetraprolin is essential for cardiac response to iron deficiency by regulating mitochondrial function</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>115</volume><year>2018</year><fpage>E6291</fpage><lpage>E6300</lpage><pub-id pub-id-type="pmid">29915044</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1804701115</pub-id><pub-id pub-id-type="pmcid">PMC6142244</pub-id></element-citation></ref><ref id="bb0255"><label>51.</label><element-citation publication-type="journal" id="rf0255"><person-group person-group-type="author"><name name-style="western"><surname>Shapiro</surname><given-names>J.S.</given-names></name><etal/></person-group><article-title>Iron drives anabolic metabolism through active histone demethylation and mTORC1</article-title><source>Nat. Cell Biol.</source><volume>25</volume><year>2023</year><fpage>1478</fpage><lpage>1494</lpage><pub-id pub-id-type="pmid">37749225</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-023-01225-6</pub-id><pub-id pub-id-type="pmcid">PMC11407783</pub-id></element-citation></ref><ref id="bb0260"><label>52.</label><element-citation publication-type="journal" id="rf0260"><person-group person-group-type="author"><name name-style="western"><surname>Mariotti</surname><given-names>L.</given-names></name><etal/></person-group><article-title>The iron-sulphur cluster in human DNA2 is required for all biochemical activities of DNA2</article-title><source>Commun. Biol.</source><volume>3</volume><year>2020</year><fpage>322</fpage><pub-id pub-id-type="pmid">32576938</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s42003-020-1048-4</pub-id><pub-id pub-id-type="pmcid">PMC7311471</pub-id></element-citation></ref><ref id="bb0265"><label>53.</label><element-citation publication-type="journal" id="rf0265"><person-group person-group-type="author"><name name-style="western"><surname>Weiner</surname><given-names>B.E.</given-names></name><etal/></person-group><article-title>An iron-sulfur cluster in the C-terminal domain of the p58 subunit of human DNA primase</article-title><source>J. Biol. Chem.</source><volume>282</volume><year>2007</year><fpage>33444</fpage><lpage>33451</lpage><pub-id pub-id-type="pmid">17893144</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M705826200</pub-id></element-citation></ref><ref id="bb0270"><label>54.</label><element-citation publication-type="journal" id="rf0270"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Biogenesis of iron-sulfur clusters and their role in DNA metabolism</article-title><source>Front. Cell Dev. Biol.</source><volume>9</volume><year>2021</year><object-id pub-id-type="publisher-id">735678</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcell.2021.735678</pub-id><pub-id pub-id-type="pmcid">PMC8514734</pub-id><pub-id pub-id-type="pmid">34660592</pub-id></element-citation></ref><ref id="bb0275"><label>55.</label><element-citation publication-type="journal" id="rf0275"><person-group person-group-type="author"><name name-style="western"><surname>Itakura</surname><given-names>M.</given-names></name><name name-style="western"><surname>Holmes</surname><given-names>E.W.</given-names></name></person-group><article-title>Human amidophosphoribosyltransferase. An oxygen-sensitive iron-sulfur protein</article-title><source>J. Biol. Chem.</source><volume>254</volume><year>1979</year><fpage>333</fpage><lpage>338</lpage><pub-id pub-id-type="pmid">762062</pub-id></element-citation></ref><ref id="bb0280"><label>56.</label><element-citation publication-type="journal" id="rf0280"><person-group person-group-type="author"><name name-style="western"><surname>Stubbe</surname><given-names>J.</given-names></name></person-group><article-title>Di-iron-tyrosyl radical ribonucleotide reductases</article-title><source>Curr. Opin. Chem. Biol.</source><volume>7</volume><year>2003</year><fpage>183</fpage><lpage>188</lpage><pub-id pub-id-type="pmid">12714050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s1367-5931(03)00025-5</pub-id></element-citation></ref><ref id="bb0285"><label>57.</label><element-citation publication-type="journal" id="rf0285"><person-group person-group-type="author"><name name-style="western"><surname>Kolberg</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Structure, function, and mechanism of ribonucleotide reductases</article-title><source>Biochim. Biophys. Acta</source><volume>1699</volume><year>2004</year><fpage>1</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">15158709</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbapap.2004.02.007</pub-id></element-citation></ref><ref id="bb0290"><label>58.</label><element-citation publication-type="journal" id="rf0290"><person-group person-group-type="author"><name name-style="western"><surname>Ibrahim</surname><given-names>O.</given-names></name><name name-style="western"><surname>O'Sullivan</surname><given-names>J.</given-names></name></person-group><article-title>Iron chelators in cancer therapy</article-title><source>Biometals</source><volume>33</volume><year>2020</year><fpage>201</fpage><lpage>215</lpage><pub-id pub-id-type="pmid">32757166</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10534-020-00243-3</pub-id></element-citation></ref><ref id="bb0295"><label>59.</label><element-citation publication-type="journal" id="rf0295"><person-group person-group-type="author"><name name-style="western"><surname>Frost</surname><given-names>J.N.</given-names></name><etal/></person-group><article-title>Hepcidin-mediated hypoferremia disrupts immune responses to vaccination and infection</article-title><source>Med</source><volume>2</volume><year>2021</year><fpage>164</fpage><lpage>179</lpage><pub-id pub-id-type="pmid">33665641</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.medj.2020.10.004</pub-id><pub-id pub-id-type="pmcid">PMC7895906</pub-id></element-citation></ref><ref id="bb0300"><label>60.</label><element-citation publication-type="journal" id="rf0300"><person-group person-group-type="author"><name name-style="western"><surname>Liuzzi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>A potent peptidomimetic inhibitor of HSV ribonucleotide reductase with antiviral activity in vivo</article-title><source>Nature</source><volume>372</volume><year>1994</year><fpage>695</fpage><lpage>698</lpage><pub-id pub-id-type="pmid">7990963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/372695a0</pub-id></element-citation></ref><ref id="bb0305"><label>61.</label><element-citation publication-type="journal" id="rf0305"><person-group person-group-type="author"><name name-style="western"><surname>Maio</surname><given-names>N.</given-names></name><etal/></person-group><article-title>Fe-S cofactors in the SARS-CoV-2 RNA-dependent RNA polymerase are potential antiviral targets</article-title><source>Science</source><volume>373</volume><year>2021</year><fpage>236</fpage><lpage>241</lpage><pub-id pub-id-type="pmid">34083449</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.abi5224</pub-id><pub-id pub-id-type="pmcid">PMC8892629</pub-id></element-citation></ref><ref id="bb0310"><label>62.</label><element-citation publication-type="journal" id="rf0310"><person-group person-group-type="author"><name name-style="western"><surname>Maio</surname><given-names>N.</given-names></name><etal/></person-group><article-title>An iron-sulfur cluster in the zinc-binding domain of the SARS-CoV-2 helicase modulates its RNA-binding and -unwinding activities</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>120</volume><year>2023</year><object-id pub-id-type="publisher-id">e2303860120</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2303860120</pub-id><pub-id pub-id-type="pmcid">PMC10438387</pub-id><pub-id pub-id-type="pmid">37552760</pub-id></element-citation></ref><ref id="bb0315"><label>63.</label><element-citation publication-type="journal" id="rf0315"><person-group person-group-type="author"><name name-style="western"><surname>Drakesmith</surname><given-names>H.</given-names></name><name name-style="western"><surname>Prentice</surname><given-names>A.</given-names></name></person-group><article-title>Viral infection and iron metabolism</article-title><source>Nat. Rev. Microbiol.</source><volume>6</volume><year>2008</year><fpage>541</fpage><lpage>552</lpage><pub-id pub-id-type="pmid">18552864</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrmicro1930</pub-id></element-citation></ref><ref id="bb0320"><label>64.</label><element-citation publication-type="journal" id="rf0320"><person-group person-group-type="author"><name name-style="western"><surname>Odermatt</surname><given-names>D.C.</given-names></name><etal/></person-group><article-title>Cancer-associated mutations in the iron-sulfur domain of FANCJ affect G-quadruplex metabolism</article-title><source>PLoS Genet.</source><volume>16</volume><year>2020</year><object-id pub-id-type="publisher-id">e1008740</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pgen.1008740</pub-id><pub-id pub-id-type="pmcid">PMC7316351</pub-id><pub-id pub-id-type="pmid">32542039</pub-id></element-citation></ref><ref id="bb0325"><label>65.</label><element-citation publication-type="journal" id="rf0325"><person-group person-group-type="author"><name name-style="western"><surname>Simon</surname><given-names>A.K.</given-names></name><etal/></person-group><article-title>The iron-sulfur helicase DDX11 promotes the generation of single-stranded DNA for CHK1 activation</article-title><source>Life Sci. Alliance</source><volume>3</volume><year>2020</year><object-id pub-id-type="publisher-id">e201900547</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.26508/lsa.201900547</pub-id><pub-id pub-id-type="pmcid">PMC7032568</pub-id><pub-id pub-id-type="pmid">32071282</pub-id></element-citation></ref><ref id="bb0330"><label>66.</label><element-citation publication-type="journal" id="rf0330"><person-group person-group-type="author"><name name-style="western"><surname>Rudolf</surname><given-names>J.</given-names></name><etal/></person-group><article-title>The DNA repair helicases XPD and FancJ have essential iron-sulfur domains</article-title><source>Mol. Cell</source><volume>23</volume><year>2006</year><fpage>801</fpage><lpage>808</lpage><pub-id pub-id-type="pmid">16973432</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2006.07.019</pub-id></element-citation></ref><ref id="bb0335"><label>67.</label><element-citation publication-type="journal" id="rf0335"><person-group person-group-type="author"><name name-style="western"><surname>Hourvitz</surname><given-names>N.</given-names></name><etal/></person-group><article-title>The many faces of the helicase RTEL1 at telomeres and beyond</article-title><source>Trends Cell Biol.</source><volume>34</volume><year>2023</year><fpage>109</fpage><lpage>121</lpage><pub-id pub-id-type="pmid">37532653</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tcb.2023.07.002</pub-id></element-citation></ref><ref id="bb0340"><label>68.</label><element-citation publication-type="journal" id="rf0340"><person-group person-group-type="author"><name name-style="western"><surname>McGoldrick</surname><given-names>J.P.</given-names></name><etal/></person-group><article-title>Characterization of a mammalian homolog of the <italic toggle="yes">Escherichia coli</italic> MutY mismatch repair protein</article-title><source>Mol. Cell. Biol.</source><volume>15</volume><year>1995</year><fpage>989</fpage><lpage>996</lpage><pub-id pub-id-type="pmid">7823963</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/mcb.15.2.989</pub-id><pub-id pub-id-type="pmcid">PMC231992</pub-id></element-citation></ref><ref id="bb0345"><label>69.</label><element-citation publication-type="journal" id="rf0345"><person-group person-group-type="author"><name name-style="western"><surname>Martin</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Wood</surname><given-names>R.D.</given-names></name></person-group><article-title>DNA polymerase &#950; in DNA replication and repair</article-title><source>Nucleic Acids Res.</source><volume>47</volume><year>2019</year><fpage>8348</fpage><lpage>8361</lpage><pub-id pub-id-type="pmid">31410467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkz705</pub-id><pub-id pub-id-type="pmcid">PMC6895278</pub-id></element-citation></ref><ref id="bb0350"><label>70.</label><element-citation publication-type="journal" id="rf0350"><person-group person-group-type="author"><name name-style="western"><surname>Fedeles</surname><given-names>B.I.</given-names></name><etal/></person-group><article-title>The AlkB family of Fe(II)/&#945;-ketoglutarate-dependent dioxygenases: repairing nucleic acid alkylation damage and beyond</article-title><source>J. Biol. Chem.</source><volume>290</volume><year>2015</year><fpage>20734</fpage><lpage>20742</lpage><pub-id pub-id-type="pmid">26152727</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.R115.656462</pub-id><pub-id pub-id-type="pmcid">PMC4543635</pub-id></element-citation></ref><ref id="bb0355"><label>71.</label><element-citation publication-type="journal" id="rf0355"><person-group person-group-type="author"><name name-style="western"><surname>Busti</surname><given-names>F.</given-names></name><etal/></person-group><article-title>Anemia and iron deficiency in cancer patients: role of iron replacement therapy</article-title><source>Pharmaceuticals (Basel)</source><volume>11</volume><year>2018</year><fpage>94</fpage><pub-id pub-id-type="pmid">30274354</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ph11040094</pub-id><pub-id pub-id-type="pmcid">PMC6315653</pub-id></element-citation></ref><ref id="bb0360"><label>72.</label><element-citation publication-type="journal" id="rf0360"><person-group person-group-type="author"><name name-style="western"><surname>Hyun</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Writing, erasing and reading histone lysine methylations</article-title><source>Exp. Mol. Med.</source><volume>49</volume><year>2017</year><object-id pub-id-type="publisher-id">e324</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/emm.2017.11</pub-id><pub-id pub-id-type="pmcid">PMC6130214</pub-id><pub-id pub-id-type="pmid">28450737</pub-id></element-citation></ref><ref id="bb0365"><label>73.</label><element-citation publication-type="journal" id="rf0365"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>M.S.</given-names></name><etal/></person-group><article-title>2-Oxoglutarate-dependent oxygenases</article-title><source>Annu. Rev. Biochem.</source><volume>87</volume><year>2018</year><fpage>585</fpage><lpage>620</lpage><pub-id pub-id-type="pmid">29494239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1146/annurev-biochem-061516-044724</pub-id></element-citation></ref><ref id="bb0370"><label>74.</label><element-citation publication-type="journal" id="rf0370"><person-group person-group-type="author"><name name-style="western"><surname>Moore</surname><given-names>L.D.</given-names></name><etal/></person-group><article-title>DNA methylation and its basic function</article-title><source>Neuropsychopharmacology</source><volume>38</volume><year>2013</year><fpage>23</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">22781841</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/npp.2012.112</pub-id><pub-id pub-id-type="pmcid">PMC3521964</pub-id></element-citation></ref><ref id="bb0375"><label>75.</label><element-citation publication-type="journal" id="rf0375"><person-group person-group-type="author"><name name-style="western"><surname>Suzuki</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Crucial role of iron in epigenetic rewriting during adipocyte differentiation mediated by JMJD1A and TET2 activity</article-title><source>Nucleic Acids Res.</source><volume>51</volume><year>2023</year><fpage>6120</fpage><lpage>6142</lpage><pub-id pub-id-type="pmid">37158274</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad342</pub-id><pub-id pub-id-type="pmcid">PMC10325906</pub-id></element-citation></ref><ref id="bb0380"><label>76.</label><element-citation publication-type="journal" id="rf0380"><person-group person-group-type="author"><name name-style="western"><surname>Roatsch</surname><given-names>M.</given-names></name><etal/></person-group><article-title>The clinically used iron chelator deferasirox is an inhibitor of epigenetic JumonjiC domain-containing histone demethylases</article-title><source>ACS Chem. Biol.</source><volume>14</volume><year>2019</year><fpage>1737</fpage><lpage>1750</lpage><pub-id pub-id-type="pmid">31287655</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschembio.9b00289</pub-id></element-citation></ref><ref id="bb0385"><label>77.</label><element-citation publication-type="journal" id="rf0385"><person-group person-group-type="author"><name name-style="western"><surname>Jiang</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Iron-dependent histone 3 lysine 9 demethylation controls B cell proliferation and humoral immune responses</article-title><source>Nat. Commun.</source><volume>10</volume><year>2019</year><fpage>2935</fpage><pub-id pub-id-type="pmid">31270335</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-019-11002-5</pub-id><pub-id pub-id-type="pmcid">PMC6610088</pub-id></element-citation></ref><ref id="bb0390"><label>78.</label><element-citation publication-type="journal" id="rf0390"><person-group person-group-type="author"><name name-style="western"><surname>Teh</surname><given-names>M.R.</given-names></name><etal/></person-group><article-title>Analysis of iron and iron-interacting protein dynamics during T-cell activation</article-title><source>Front. Immunol.</source><volume>12</volume><year>2021</year><object-id pub-id-type="publisher-id">714613</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2021.714613</pub-id><pub-id pub-id-type="pmcid">PMC8647206</pub-id><pub-id pub-id-type="pmid">34880854</pub-id></element-citation></ref><ref id="bb0395"><label>79.</label><element-citation publication-type="journal" id="rf0395"><person-group person-group-type="author"><name name-style="western"><surname>Ogawa</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1</article-title><source>EMBO J.</source><volume>20</volume><year>2001</year><fpage>2835</fpage><lpage>2843</lpage><pub-id pub-id-type="pmid">11387216</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/emboj/20.11.2835</pub-id><pub-id pub-id-type="pmcid">PMC125477</pub-id></element-citation></ref><ref id="bb0400"><label>80.</label><element-citation publication-type="journal" id="rf0400"><person-group person-group-type="author"><name name-style="western"><surname>Freeman</surname><given-names>S.L.</given-names></name><etal/></person-group><article-title>Heme binding to human CLOCK affects interactions with the E-box</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>116</volume><year>2019</year><fpage>19911</fpage><lpage>19916</lpage><pub-id pub-id-type="pmid">31527239</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1905216116</pub-id><pub-id pub-id-type="pmcid">PMC6778266</pub-id></element-citation></ref><ref id="bb0405"><label>81.</label><element-citation publication-type="journal" id="rf0405"><person-group person-group-type="author"><name name-style="western"><surname>Matta-Camacho</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Structure of REV-ERB&#946; ligand-binding domain bound to a porphyrin antagonist</article-title><source>J. Biol. Chem.</source><volume>289</volume><year>2014</year><fpage>20054</fpage><lpage>20066</lpage><pub-id pub-id-type="pmid">24872411</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M113.545111</pub-id><pub-id pub-id-type="pmcid">PMC4106322</pub-id></element-citation></ref><ref id="bb0410"><label>82.</label><element-citation publication-type="journal" id="rf0410"><person-group person-group-type="author"><name name-style="western"><surname>Dioum</surname><given-names>E.M.</given-names></name><etal/></person-group><article-title>NPAS2: a gas-responsive transcription factor</article-title><source>Science</source><volume>298</volume><year>2002</year><fpage>2385</fpage><lpage>2387</lpage><pub-id pub-id-type="pmid">12446832</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1078456</pub-id></element-citation></ref><ref id="bb0415"><label>83.</label><element-citation publication-type="journal" id="rf0415"><person-group person-group-type="author"><name name-style="western"><surname>Kuhn</surname><given-names>E.</given-names></name><name name-style="western"><surname>Brodan</surname><given-names>V.</given-names></name></person-group><article-title>Changes in the circadian rhythm of serum iron induced by a 5-day sleep deprivation</article-title><source>Eur. J. Appl. Physiol. Occup. Physiol.</source><volume>49</volume><year>1982</year><fpage>215</fpage><lpage>222</lpage><pub-id pub-id-type="pmid">6889498</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02334070</pub-id></element-citation></ref><ref id="bb0420"><label>84.</label><element-citation publication-type="journal" id="rf0420"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Q.</given-names></name><etal/></person-group><article-title>Cellular iron depletion enhances behavioral rhythm by limiting brain Per1 expression in mice</article-title><source>CNS Neurosci. Ther.</source><volume>30</volume><year>2024</year><object-id pub-id-type="publisher-id">e14592</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/cns.14592</pub-id><pub-id pub-id-type="pmcid">PMC10883092</pub-id><pub-id pub-id-type="pmid">38385622</pub-id></element-citation></ref><ref id="bb0425"><label>85.</label><element-citation publication-type="journal" id="rf0425"><person-group person-group-type="author"><name name-style="western"><surname>Earley</surname><given-names>C.J.</given-names></name><etal/></person-group><article-title>Brain-iron deficiency models of restless legs syndrome</article-title><source>Exp. Neurol.</source><volume>356</volume><year>2022</year><object-id pub-id-type="publisher-id">114158</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.expneurol.2022.114158</pub-id><pub-id pub-id-type="pmcid">PMC9357217</pub-id><pub-id pub-id-type="pmid">35779614</pub-id></element-citation></ref><ref id="bb0430"><label>86.</label><element-citation publication-type="journal" id="rf0430"><person-group person-group-type="author"><name name-style="western"><surname>Zhu</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Ribosome recycling by ABCE1 links lysosomal function and iron homeostasis to 3' UTR-directed regulation and nonsense-mediated decay</article-title><source>Cell Rep.</source><volume>32</volume><year>2020</year><object-id pub-id-type="publisher-id">107895</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2020.107895</pub-id><pub-id pub-id-type="pmcid">PMC7433747</pub-id><pub-id pub-id-type="pmid">32668236</pub-id></element-citation></ref><ref id="bb0435"><label>87.</label><element-citation publication-type="journal" id="rf0435"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>B.S.</given-names></name><etal/></person-group><article-title>Post-transcriptional gene regulation by mRNA modifications</article-title><source>Nat. Rev. Mol. Cell Biol.</source><volume>18</volume><year>2017</year><fpage>31</fpage><lpage>42</lpage><pub-id pub-id-type="pmid">27808276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrm.2016.132</pub-id><pub-id pub-id-type="pmcid">PMC5167638</pub-id></element-citation></ref><ref id="bb0440"><label>88.</label><element-citation publication-type="journal" id="rf0440"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L.S.</given-names></name><etal/></person-group><article-title>ALKBH7-mediated demethylation regulates mitochondrial polycistronic RNA processing</article-title><source>Nat. Cell Biol.</source><volume>23</volume><year>2021</year><fpage>684</fpage><lpage>691</lpage><pub-id pub-id-type="pmid">34253897</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41556-021-00709-7</pub-id><pub-id pub-id-type="pmcid">PMC8716185</pub-id></element-citation></ref><ref id="bb0445"><label>89.</label><element-citation publication-type="journal" id="rf0445"><person-group person-group-type="author"><name name-style="western"><surname>Singleton</surname><given-names>R.S.</given-names></name><etal/></person-group><article-title>OGFOD1 catalyzes prolyl hydroxylation of RPS23 and is involved in translation control and stress granule formation</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>111</volume><year>2014</year><fpage>4031</fpage><lpage>4036</lpage><pub-id pub-id-type="pmid">24550447</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1314482111</pub-id><pub-id pub-id-type="pmcid">PMC3964040</pub-id></element-citation></ref><ref id="bb0450"><label>90.</label><element-citation publication-type="journal" id="rf0450"><person-group person-group-type="author"><name name-style="western"><surname>W&#261;tor</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Cryo-EM structure of human eIF5A-DHS complex reveals the molecular basis of hypusination-associated neurodegenerative disorders</article-title><source>Nat. Commun.</source><volume>14</volume><year>2023</year><fpage>1698</fpage><pub-id pub-id-type="pmid">36973244</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-023-37305-2</pub-id><pub-id pub-id-type="pmcid">PMC10042821</pub-id></element-citation></ref><ref id="bb0455"><label>91.</label><element-citation publication-type="journal" id="rf0455"><person-group person-group-type="author"><name name-style="western"><surname>Frey</surname><given-names>A.G.</given-names></name><etal/></person-group><article-title>Iron chaperones PCBP1 and PCBP2 mediate the metallation of the dinuclear iron enzyme deoxyhypusine hydroxylase</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>111</volume><year>2014</year><fpage>8031</fpage><lpage>8036</lpage><pub-id pub-id-type="pmid">24843120</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1402732111</pub-id><pub-id pub-id-type="pmcid">PMC4050543</pub-id></element-citation></ref><ref id="bb0460"><label>92.</label><element-citation publication-type="journal" id="rf0460"><person-group person-group-type="author"><name name-style="western"><surname>Lane</surname><given-names>D.J.</given-names></name><etal/></person-group><article-title>Cellular iron uptake, trafficking and metabolism: key molecules and mechanisms and their roles in disease</article-title><source>Biochim. Biophys. Acta</source><volume>1853</volume><year>2015</year><fpage>1130</fpage><lpage>1144</lpage><pub-id pub-id-type="pmid">25661197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbamcr.2015.01.021</pub-id></element-citation></ref><ref id="bb0465"><label>93.</label><element-citation publication-type="journal" id="rf0465"><person-group person-group-type="author"><name name-style="western"><surname>Sheftel</surname><given-names>A.D.</given-names></name><etal/></person-group><article-title>Direct interorganellar transfer of iron from endosome to mitochondrion</article-title><source>Blood</source><volume>110</volume><year>2007</year><fpage>125</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">17376890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2007-01-068148</pub-id></element-citation></ref><ref id="bb0470"><label>94.</label><element-citation publication-type="journal" id="rf0470"><person-group person-group-type="author"><name name-style="western"><surname>Wolff</surname><given-names>N.A.</given-names></name><etal/></person-group><article-title>Mitochondria represent another locale for the divalent metal transporter 1 (DMT1)</article-title><source>Channels (Austin)</source><volume>8</volume><year>2014</year><fpage>458</fpage><lpage>466</lpage><pub-id pub-id-type="pmid">25483589</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/19336950.2014.956564</pub-id><pub-id pub-id-type="pmcid">PMC4594545</pub-id></element-citation></ref><ref id="bb0475"><label>95.</label><element-citation publication-type="journal" id="rf0475"><person-group person-group-type="author"><name name-style="western"><surname>Wolff</surname><given-names>N.A.</given-names></name><etal/></person-group><article-title>Evidence for mitochondrial localization of divalent metal transporter 1 (DMT1)</article-title><source>FASEB J.</source><volume>28</volume><year>2014</year><fpage>2134</fpage><lpage>2145</lpage><pub-id pub-id-type="pmid">24448823</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1096/fj.13-240564</pub-id></element-citation></ref><ref id="bb0480"><label>96.</label><element-citation publication-type="journal" id="rf0480"><person-group person-group-type="author"><name name-style="western"><surname>Shaw</surname><given-names>G.C.</given-names></name><etal/></person-group><article-title>Mitoferrin is essential for erythroid iron assimilation</article-title><source>Nature</source><volume>440</volume><year>2006</year><fpage>96</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">16511496</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nature04512</pub-id></element-citation></ref><ref id="bb0485"><label>97.</label><element-citation publication-type="journal" id="rf0485"><person-group person-group-type="author"><name name-style="western"><surname>Paradkar</surname><given-names>P.N.</given-names></name><etal/></person-group><article-title>Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2</article-title><source>Mol. Cell. Biol.</source><volume>29</volume><year>2009</year><fpage>1007</fpage><lpage>1016</lpage><pub-id pub-id-type="pmid">19075006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1128/MCB.01685-08</pub-id><pub-id pub-id-type="pmcid">PMC2643804</pub-id></element-citation></ref><ref id="bb0490"><label>98.</label><element-citation publication-type="journal" id="rf0490"><person-group person-group-type="author"><name name-style="western"><surname>Levi</surname><given-names>S.</given-names></name><etal/></person-group><article-title>A human mitochondrial ferritin encoded by an intronless gene</article-title><source>J. Biol. Chem.</source><volume>276</volume><year>2001</year><fpage>24437</fpage><lpage>24440</lpage><pub-id pub-id-type="pmid">11323407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.C100141200</pub-id></element-citation></ref><ref id="bb0495"><label>99.</label><element-citation publication-type="journal" id="rf0495"><person-group person-group-type="author"><name name-style="western"><surname>Arosio</surname><given-names>P.</given-names></name><name name-style="western"><surname>Levi</surname><given-names>S.</given-names></name></person-group><article-title>Cytosolic and mitochondrial ferritins in the regulation of cellular iron homeostasis and oxidative damage</article-title><source>Biochim. Biophys. Acta</source><volume>1800</volume><year>2010</year><fpage>783</fpage><lpage>792</lpage><pub-id pub-id-type="pmid">20176086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbagen.2010.02.005</pub-id></element-citation></ref><ref id="bb0500"><label>100.</label><element-citation publication-type="journal" id="rf0500"><person-group person-group-type="author"><name name-style="western"><surname>Paul</surname><given-names>B.T.</given-names></name><etal/></person-group><article-title>Mitochondria and Iron: current questions</article-title><source>Expert Rev. Hematol.</source><volume>10</volume><year>2017</year><fpage>65</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">27911100</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/17474086.2016.1268047</pub-id><pub-id pub-id-type="pmcid">PMC5538026</pub-id></element-citation></ref><ref id="bb0505"><label>101.</label><element-citation publication-type="journal" id="rf0505"><person-group person-group-type="author"><name name-style="western"><surname>Pantopoulos</surname><given-names>K.</given-names></name></person-group><article-title>Iron, FRDA, and intermediary metabolism</article-title><source>Blood</source><volume>137</volume><year>2021</year><fpage>1994</fpage><lpage>1995</lpage><pub-id pub-id-type="pmid">33856446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood.2021010835</pub-id></element-citation></ref><ref id="bb0510"><label>102.</label><element-citation publication-type="journal" id="rf0510"><person-group person-group-type="author"><name name-style="western"><surname>Dixon</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Stockwell</surname><given-names>B.R.</given-names></name></person-group><article-title>The hallmarks of ferroptosis</article-title><source>Annu. Rev. Cancer Biol.</source><volume>3</volume><year>2019</year><fpage>35</fpage><lpage>54</lpage></element-citation></ref><ref id="bb0515"><label>103.</label><element-citation publication-type="journal" id="rf0515"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>X.</given-names></name><etal/></person-group><article-title>Dual regulation of SLC25A39 by AFG3L2 and iron controls mitochondrial glutathione homeostasis</article-title><source>Mol. Cell</source><volume>84</volume><year>2023</year><fpage>802</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">38157846</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2023.12.008</pub-id><pub-id pub-id-type="pmcid">PMC10922821</pub-id></element-citation></ref><ref id="bb0520"><label>104.</label><element-citation publication-type="journal" id="rf0520"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Autoregulatory control of mitochondrial glutathione homeostasis</article-title><source>Science</source><volume>382</volume><year>2023</year><fpage>820</fpage><lpage>828</lpage><pub-id pub-id-type="pmid">37917749</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.adf4154</pub-id><pub-id pub-id-type="pmcid">PMC11170550</pub-id></element-citation></ref><ref id="bb0525"><label>105.</label><element-citation publication-type="journal" id="rf0525"><person-group person-group-type="author"><name name-style="western"><surname>Riddle</surname><given-names>R.D.</given-names></name><etal/></person-group><article-title>Expression of delta-aminolevulinate synthase in avian cells: separate genes encode erythroid-specific and nonspecific isozymes</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>86</volume><year>1989</year><fpage>792</fpage><lpage>796</lpage><pub-id pub-id-type="pmid">2915978</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.86.3.792</pub-id><pub-id pub-id-type="pmcid">PMC286563</pub-id></element-citation></ref><ref id="bb0530"><label>106.</label><element-citation publication-type="journal" id="rf0530"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>C.K.</given-names></name><etal/></person-group><article-title>The 2.0 A structure of human ferrochelatase, the terminal enzyme of heme biosynthesis</article-title><source>Nat. Struct. Biol.</source><volume>8</volume><year>2001</year><fpage>156</fpage><lpage>160</lpage><pub-id pub-id-type="pmid">11175906</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/84152</pub-id></element-citation></ref><ref id="bb0535"><label>107.</label><element-citation publication-type="journal" id="rf0535"><person-group person-group-type="author"><name name-style="western"><surname>Chiabrando</surname><given-names>D.</given-names></name><etal/></person-group><article-title>The mitochondrial heme exporter FLVCR1b mediates erythroid differentiation</article-title><source>J. Clin. Invest.</source><volume>122</volume><year>2012</year><fpage>4569</fpage><lpage>4579</lpage><pub-id pub-id-type="pmid">23187127</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI62422</pub-id><pub-id pub-id-type="pmcid">PMC3533534</pub-id></element-citation></ref><ref id="bb0540"><label>108.</label><element-citation publication-type="journal" id="rf0540"><person-group person-group-type="author"><name name-style="western"><surname>Lill</surname><given-names>R.</given-names></name></person-group><article-title>From the discovery to molecular understanding of cellular iron-sulfur protein biogenesis</article-title><source>Biol. Chem.</source><volume>401</volume><year>2020</year><fpage>855</fpage><lpage>876</lpage><pub-id pub-id-type="pmid">32229650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1515/hsz-2020-0117</pub-id></element-citation></ref><ref id="bb0545"><label>109.</label><element-citation publication-type="journal" id="rf0545"><person-group person-group-type="author"><name name-style="western"><surname>Rouault</surname><given-names>T.A.</given-names></name><name name-style="western"><surname>Tong</surname><given-names>W.H.</given-names></name></person-group><article-title>Iron-sulfur cluster biogenesis and human disease</article-title><source>Trends Genet.</source><volume>24</volume><year>2008</year><fpage>398</fpage><lpage>407</lpage><pub-id pub-id-type="pmid">18606475</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tig.2008.05.008</pub-id><pub-id pub-id-type="pmcid">PMC2574672</pub-id></element-citation></ref><ref id="bb0550"><label>110.</label><element-citation publication-type="journal" id="rf0550"><person-group person-group-type="author"><name name-style="western"><surname>Ast</surname><given-names>T.</given-names></name><etal/></person-group><article-title>METTL17 is an Fe-S cluster checkpoint for mitochondrial translation</article-title><source>Mol. Cell</source><volume>84</volume><year>2024</year><fpage>359</fpage><lpage>374</lpage><pub-id pub-id-type="pmid">38199006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molcel.2023.12.016</pub-id><pub-id pub-id-type="pmcid">PMC11046306</pub-id></element-citation></ref><ref id="bb0555"><label>111.</label><element-citation publication-type="journal" id="rf0555"><person-group person-group-type="author"><name name-style="western"><surname>Dallman</surname><given-names>P.R.</given-names></name><name name-style="western"><surname>Goodman</surname><given-names>J.R.</given-names></name></person-group><article-title>The effects of iron deficiency on the hepatocyte: a biochemical and ultrastructural study</article-title><source>J. Cell Biol.</source><volume>48</volume><year>1971</year><fpage>79</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">4322719</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1083/jcb.48.1.79</pub-id><pub-id pub-id-type="pmcid">PMC2108232</pub-id></element-citation></ref><ref id="bb0560"><label>112.</label><element-citation publication-type="journal" id="rf0560"><person-group person-group-type="author"><name name-style="western"><surname>Jarvis</surname><given-names>J.H.</given-names></name><name name-style="western"><surname>Jacobs</surname><given-names>A.</given-names></name></person-group><article-title>Morphological abnormalities in lymphocyte mitochondria associated with iron-deficiency anaemia</article-title><source>J. Clin. Pathol.</source><volume>27</volume><year>1974</year><fpage>973</fpage><lpage>979</lpage><pub-id pub-id-type="pmid">4375687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jcp.27.12.973</pub-id><pub-id pub-id-type="pmcid">PMC475566</pub-id></element-citation></ref><ref id="bb0565"><label>113.</label><element-citation publication-type="journal" id="rf0565"><person-group person-group-type="author"><name name-style="western"><surname>Masini</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Dietary iron deficiency in the rat. I. Abnormalities in energy metabolism of the hepatic tissue</article-title><source>Biochim. Biophys. Acta</source><volume>1188</volume><year>1994</year><fpage>46</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">7947904</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0005-2728(94)90020-5</pub-id></element-citation></ref><ref id="bb0570"><label>114.</label><element-citation publication-type="journal" id="rf0570"><person-group person-group-type="author"><name name-style="western"><surname>Walter</surname><given-names>P.B.</given-names></name><etal/></person-group><article-title>Iron deficiency and iron excess damage mitochondria and mitochondrial DNA in rats</article-title><source>Proc. Natl. Acad. Sci. U. S. A.</source><volume>99</volume><year>2002</year><fpage>2264</fpage><lpage>2269</lpage><pub-id pub-id-type="pmid">11854522</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.261708798</pub-id><pub-id pub-id-type="pmcid">PMC122353</pub-id></element-citation></ref><ref id="bb0575"><label>115.</label><element-citation publication-type="journal" id="rf0575"><person-group person-group-type="author"><name name-style="western"><surname>Klempa</surname><given-names>K.L.</given-names></name><etal/></person-group><article-title>(1989) Iron deficiency decreases gluconeogenesis in isolated rat hepatocytes</article-title><source>J. Appl. Physiol.</source><volume>67</volume><year>1985</year><fpage>1868</fpage><lpage>1872</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/jappl.1989.67.5.1868</pub-id><pub-id pub-id-type="pmid">2600020</pub-id></element-citation></ref><ref id="bb0580"><label>116.</label><element-citation publication-type="journal" id="rf0580"><person-group person-group-type="author"><name name-style="western"><surname>Yarosz</surname><given-names>E.L.</given-names></name><etal/></person-group><article-title>Cutting edge: activation-induced iron flux controls CD4 T cell proliferation by promoting proper IL-2R signaling and mitochondrial function</article-title><source>J. Immunol.</source><volume>204</volume><year>2020</year><fpage>1708</fpage><lpage>1713</lpage><pub-id pub-id-type="pmid">32122995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1901399</pub-id><pub-id pub-id-type="pmcid">PMC7329364</pub-id></element-citation></ref><ref id="bb0585"><label>117.</label><element-citation publication-type="journal" id="rf0585"><person-group person-group-type="author"><name name-style="western"><surname>Voss</surname><given-names>K.</given-names></name><etal/></person-group><article-title>Elevated transferrin receptor impairs T cell metabolism and function in systemic lupus erythematosus</article-title><source>Sci. Immunol.</source><volume>8</volume><year>2023</year><object-id pub-id-type="publisher-id">eabq0178</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciimmunol.abq0178</pub-id><pub-id pub-id-type="pmcid">PMC9936798</pub-id><pub-id pub-id-type="pmid">36638190</pub-id></element-citation></ref><ref id="bb0590"><label>118.</label><element-citation publication-type="journal" id="rf0590"><person-group person-group-type="author"><name name-style="western"><surname>Crooks</surname><given-names>D.R.</given-names></name><etal/></person-group><article-title>Acute loss of iron-sulfur clusters results in metabolic reprogramming and generation of lipid droplets in mammalian cells</article-title><source>J. Biol. Chem.</source><volume>293</volume><year>2018</year><fpage>8297</fpage><lpage>8311</lpage><pub-id pub-id-type="pmid">29523684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.RA118.001885</pub-id><pub-id pub-id-type="pmcid">PMC5971457</pub-id></element-citation></ref><ref id="bb0595"><label>119.</label><element-citation publication-type="journal" id="rf0595"><person-group person-group-type="author"><name name-style="western"><surname>Cerone</surname><given-names>M.</given-names></name><name name-style="western"><surname>Smith</surname><given-names>T.K.</given-names></name></person-group><article-title>Desaturases: structural and mechanistic insights into the biosynthesis of unsaturated fatty acids</article-title><source>IUBMB Life</source><volume>74</volume><year>2022</year><fpage>1036</fpage><lpage>1051</lpage><pub-id pub-id-type="pmid">36017969</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/iub.2671</pub-id><pub-id pub-id-type="pmcid">PMC9825965</pub-id></element-citation></ref><ref id="bb0600"><label>120.</label><element-citation publication-type="journal" id="rf0600"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Cholesterol metabolism: new functions and therapeutic approaches in cancer</article-title><source>Biochim. Biophys. Acta Rev. Cancer</source><volume>1874</volume><year>2020</year><object-id pub-id-type="publisher-id">188394</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbcan.2020.188394</pub-id><pub-id pub-id-type="pmid">32698040</pub-id></element-citation></ref><ref id="bb0605"><label>121.</label><element-citation publication-type="journal" id="rf0605"><person-group person-group-type="author"><name name-style="western"><surname>Lakhal-Littleton</surname><given-names>S.</given-names></name><name name-style="western"><surname>Cleland</surname><given-names>J.G.F.</given-names></name></person-group><article-title>Iron deficiency and supplementation in heart failure</article-title><source>Nat. Rev. Cardiol.</source><volume>8</volume><year>2024</year><fpage>2368</fpage><lpage>2379</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41569-024-00988-1</pub-id><pub-id pub-id-type="pmid">38326440</pub-id></element-citation></ref><ref id="bb0610"><label>122.</label><element-citation publication-type="journal" id="rf0610"><person-group person-group-type="author"><name name-style="western"><surname>Machalz</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Structural insights into understudied human cytochrome P450 enzymes</article-title><source>Drug Discov. Today</source><volume>26</volume><year>2021</year><fpage>2456</fpage><lpage>2464</lpage><pub-id pub-id-type="pmid">34161845</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drudis.2021.06.006</pub-id></element-citation></ref><ref id="bb0615"><label>123.</label><element-citation publication-type="journal" id="rf0615"><person-group person-group-type="author"><name name-style="western"><surname>Miller</surname><given-names>W.L.</given-names></name><name name-style="western"><surname>Auchus</surname><given-names>R.J.</given-names></name></person-group><article-title>The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders</article-title><source>Endocr. Rev.</source><volume>32</volume><year>2011</year><fpage>81</fpage><lpage>151</lpage><pub-id pub-id-type="pmid">21051590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1210/er.2010-0013</pub-id><pub-id pub-id-type="pmcid">PMC3365799</pub-id></element-citation></ref><ref id="bb0620"><label>124.</label><element-citation publication-type="journal" id="rf0620"><person-group person-group-type="author"><name name-style="western"><surname>Au</surname><given-names>Y.P.</given-names></name><name name-style="western"><surname>Schilling</surname><given-names>R.F.</given-names></name></person-group><article-title>Relationship between anemia and cholesterol metabolism in 'sex-linked anemic' (gene symbol, sla) mouse</article-title><source>Biochim. Biophys. Acta</source><volume>883</volume><year>1986</year><fpage>242</fpage><lpage>246</lpage><pub-id pub-id-type="pmid">2874831</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0304-4165(86)90314-4</pub-id></element-citation></ref><ref id="bb0625"><label>125.</label><element-citation publication-type="journal" id="rf0625"><person-group person-group-type="author"><name name-style="western"><surname>Lee</surname><given-names>S.Y.</given-names></name><etal/></person-group><article-title>Association between iron and cholesterol in neuroblastomas</article-title><source>Anticancer Res.</source><volume>41</volume><year>2021</year><fpage>2795</fpage><lpage>2804</lpage><pub-id pub-id-type="pmid">34083269</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.21873/anticanres.15060</pub-id></element-citation></ref><ref id="bb0630"><label>126.</label><element-citation publication-type="journal" id="rf0630"><person-group person-group-type="author"><name name-style="western"><surname>Fisher</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>Iron loading induces cholesterol synthesis and sensitizes endothelial cells to TNF&#945;-mediated apoptosis</article-title><source>J. Biol. Chem.</source><volume>297</volume><year>2021</year><object-id pub-id-type="publisher-id">101156</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jbc.2021.101156</pub-id><pub-id pub-id-type="pmcid">PMC8463868</pub-id><pub-id pub-id-type="pmid">34480898</pub-id></element-citation></ref><ref id="bb0635"><label>127.</label><element-citation publication-type="journal" id="rf0635"><person-group person-group-type="author"><name name-style="western"><surname>Demetz</surname><given-names>E.</given-names></name><etal/></person-group><article-title>The haemochromatosis gene Hfe and Kupffer cells control LDL cholesterol homeostasis and impact on atherosclerosis development</article-title><source>Eur. Heart J.</source><volume>41</volume><year>2020</year><fpage>3949</fpage><lpage>3959</lpage><pub-id pub-id-type="pmid">32227235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurheartj/ehaa140</pub-id></element-citation></ref><ref id="bb0640"><label>128.</label><element-citation publication-type="journal" id="rf0640"><person-group person-group-type="author"><name name-style="western"><surname>Chakraborty</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Revisiting steroidogenesis and its role in immune regulation with the advanced tools and technologies</article-title><source>Genes Immun.</source><volume>22</volume><year>2021</year><fpage>125</fpage><lpage>140</lpage><pub-id pub-id-type="pmid">34127827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41435-021-00139-3</pub-id><pub-id pub-id-type="pmcid">PMC8277576</pub-id></element-citation></ref><ref id="bb0645"><label>129.</label><element-citation publication-type="journal" id="rf0645"><person-group person-group-type="author"><name name-style="western"><surname>Saad</surname><given-names>M.J.</given-names></name><etal/></person-group><article-title>Reduced cortisol secretion in patients with iron deficiency</article-title><source>Ann. Nutr. Metab.</source><volume>35</volume><year>1991</year><fpage>111</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">1651678</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000177633</pub-id></element-citation></ref><ref id="bb0650"><label>130.</label><element-citation publication-type="journal" id="rf0650"><person-group person-group-type="author"><name name-style="western"><surname>Holick</surname><given-names>M.F.</given-names></name></person-group><article-title>Resurrection of vitamin D deficiency and rickets</article-title><source>J. Clin. Invest.</source><volume>116</volume><year>2006</year><fpage>2062</fpage><lpage>2072</lpage><pub-id pub-id-type="pmid">16886050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI29449</pub-id><pub-id pub-id-type="pmcid">PMC1523417</pub-id></element-citation></ref><ref id="bb0655"><label>131.</label><element-citation publication-type="journal" id="rf0655"><person-group person-group-type="author"><name name-style="western"><surname>Bikle</surname><given-names>D.</given-names></name><name name-style="western"><surname>Christakos</surname><given-names>S.</given-names></name></person-group><article-title>New aspects of vitamin D metabolism and action - addressing the skin as source and target</article-title><source>Nat. Rev. Endocrinol.</source><volume>16</volume><year>2020</year><fpage>234</fpage><lpage>252</lpage><pub-id pub-id-type="pmid">32029884</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41574-019-0312-5</pub-id></element-citation></ref><ref id="bb0660"><label>132.</label><element-citation publication-type="journal" id="rf0660"><person-group person-group-type="author"><name name-style="western"><surname>Edmonston</surname><given-names>D.</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>M.</given-names></name></person-group><article-title>FGF23 at the crossroads of phosphate, iron economy and erythropoiesis</article-title><source>Nat. Rev. Nephrol.</source><volume>16</volume><year>2020</year><fpage>7</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">31519999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41581-019-0189-5</pub-id></element-citation></ref><ref id="bb0665"><label>133.</label><element-citation publication-type="journal" id="rf0665"><person-group person-group-type="author"><name name-style="western"><surname>Harris</surname><given-names>M.M.</given-names></name><etal/></person-group><article-title>Dietary iron is associated with bone mineral density in healthy postmenopausal women</article-title><source>J. Nutr.</source><volume>133</volume><year>2003</year><fpage>3598</fpage><lpage>3602</lpage><pub-id pub-id-type="pmid">14608080</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/133.11.3598</pub-id></element-citation></ref><ref id="bb0670"><label>134.</label><element-citation publication-type="journal" id="rf0670"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X.</given-names></name><name name-style="western"><surname>An</surname><given-names>J.</given-names></name></person-group><article-title>Dietary iron intake and its impact on osteopenia/osteoporosis</article-title><source>BMC Endocr. Disord.</source><volume>23</volume><year>2023</year><fpage>154</fpage><pub-id pub-id-type="pmid">37464304</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12902-023-01389-0</pub-id><pub-id pub-id-type="pmcid">PMC10353121</pub-id></element-citation></ref><ref id="bb0675"><label>135.</label><element-citation publication-type="journal" id="rf0675"><person-group person-group-type="author"><name name-style="western"><surname>Katsumata</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Severe iron deficiency decreases both bone formation and bone resorption in rats</article-title><source>J. Nutr.</source><volume>139</volume><year>2009</year><fpage>238</fpage><lpage>243</lpage><pub-id pub-id-type="pmid">19106323</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3945/jn.108.093757</pub-id></element-citation></ref><ref id="bb0680"><label>136.</label><element-citation publication-type="journal" id="rf0680"><person-group person-group-type="author"><name name-style="western"><surname>Medeiros</surname><given-names>D.M.</given-names></name><etal/></person-group><article-title>Bone morphology, strength and density are compromised in iron-deficient rats and exacerbated by calcium restriction</article-title><source>J. Nutr.</source><volume>132</volume><year>2002</year><fpage>3135</fpage><lpage>3141</lpage><pub-id pub-id-type="pmid">12368407</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/131.10.3135</pub-id></element-citation></ref><ref id="bb0685"><label>137.</label><element-citation publication-type="journal" id="rf0685"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>T.</given-names></name><name name-style="western"><surname>Chiang</surname><given-names>J.Y.</given-names></name></person-group><article-title>Bile acid signaling in metabolic disease and drug therapy</article-title><source>Pharmacol. Rev.</source><volume>66</volume><year>2014</year><fpage>948</fpage><lpage>983</lpage><pub-id pub-id-type="pmid">25073467</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1124/pr.113.008201</pub-id><pub-id pub-id-type="pmcid">PMC4180336</pub-id></element-citation></ref><ref id="bb0690"><label>138.</label><element-citation publication-type="journal" id="rf0690"><person-group person-group-type="author"><name name-style="western"><surname>Prasnicka</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Iron overload reduces synthesis and elimination of bile acids in rat liver</article-title><source>Sci. Rep.</source><volume>9</volume><year>2019</year><fpage>9780</fpage><pub-id pub-id-type="pmid">31278332</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-46150-7</pub-id><pub-id pub-id-type="pmcid">PMC6611795</pub-id></element-citation></ref><ref id="bb0695"><label>139.</label><element-citation publication-type="journal" id="rf0695"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>S.M.</given-names></name><etal/></person-group><article-title>Iron deficiency enhances cholesterol gallstone formation</article-title><source>Surgery</source><volume>122</volume><year>1997</year><fpage>354</fpage><lpage>361</lpage><comment>discussion 361-352</comment><pub-id pub-id-type="pmid">9288141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0039-6060(97)90027-1</pub-id></element-citation></ref><ref id="bb0700"><label>140.</label><element-citation publication-type="journal" id="rf0700"><person-group person-group-type="author"><name name-style="western"><surname>Han</surname><given-names>T.Q.</given-names></name><etal/></person-group><article-title>Bile acids in serum and bile of patients with cholesterol gallstone</article-title><source>World J. Gastroenterol.</source><volume>4</volume><year>1998</year><fpage>82</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">11819241</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v4.i1.82</pub-id><pub-id pub-id-type="pmcid">PMC4767775</pub-id></element-citation></ref><ref id="bb0705"><label>141.</label><element-citation publication-type="journal" id="rf0705"><person-group person-group-type="author"><name name-style="western"><surname>Pamuk</surname><given-names>G.E.</given-names></name><etal/></person-group><article-title>Patients with iron deficiency anemia have an increased prevalence of gallstones</article-title><source>Ann. Hematol.</source><volume>88</volume><year>2009</year><fpage>17</fpage><lpage>20</lpage><pub-id pub-id-type="pmid">18679684</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00277-008-0557-x</pub-id></element-citation></ref><ref id="bb0710"><label>142.</label><element-citation publication-type="journal" id="rf0710"><person-group person-group-type="author"><name name-style="western"><surname>Bazinet</surname><given-names>R.P.</given-names></name><name name-style="western"><surname>Lay&#233;</surname><given-names>S.</given-names></name></person-group><article-title>Polyunsaturated fatty acids and their metabolites in brain function and disease</article-title><source>Nat. Rev. Neurosci.</source><volume>15</volume><year>2014</year><fpage>771</fpage><lpage>785</lpage><pub-id pub-id-type="pmid">25387473</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrn3820</pub-id></element-citation></ref><ref id="bb0715"><label>143.</label><element-citation publication-type="journal" id="rf0715"><person-group person-group-type="author"><name name-style="western"><surname>Cunnane</surname><given-names>S.C.</given-names></name><name name-style="western"><surname>McAdoo</surname><given-names>K.R.</given-names></name></person-group><article-title>Iron intake influences essential fatty acid and lipid composition of rat plasma and erythrocytes</article-title><source>J. Nutr.</source><volume>117</volume><year>1987</year><fpage>1514</fpage><lpage>1519</lpage><pub-id pub-id-type="pmid">3116180</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/117.9.1514</pub-id></element-citation></ref><ref id="bb0720"><label>144.</label><element-citation publication-type="journal" id="rf0720"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>G.A.</given-names></name><etal/></person-group><article-title>Reduction of hepatic stearoyl-CoA desaturase activity in rats fed iron-deficient diets</article-title><source>Lipids</source><volume>18</volume><year>1983</year><fpage>573</fpage><lpage>575</lpage><pub-id pub-id-type="pmid">6137751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/BF02535401</pub-id></element-citation></ref><ref id="bb0725"><label>145.</label><element-citation publication-type="journal" id="rf0725"><person-group person-group-type="author"><name name-style="western"><surname>Stangl</surname><given-names>G.I.</given-names></name><name name-style="western"><surname>Kirchgessner</surname><given-names>M.</given-names></name></person-group><article-title>Different degrees of moderate iron deficiency modulate lipid metabolism of rats</article-title><source>Lipids</source><volume>33</volume><year>1998</year><fpage>889</fpage><lpage>895</lpage><pub-id pub-id-type="pmid">9778136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11745-998-0285-8</pub-id></element-citation></ref><ref id="bb0730"><label>146.</label><element-citation publication-type="journal" id="rf0730"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>B.</given-names></name><etal/></person-group><article-title>Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets</article-title><source>Signal Transduct. Target. Ther.</source><volume>6</volume><year>2021</year><fpage>94</fpage><pub-id pub-id-type="pmid">33637672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-020-00443-w</pub-id><pub-id pub-id-type="pmcid">PMC7910446</pub-id></element-citation></ref><ref id="bb0735"><label>147.</label><element-citation publication-type="journal" id="rf0735"><person-group person-group-type="author"><name name-style="western"><surname>Chandrasekharan</surname><given-names>N.V.</given-names></name><name name-style="western"><surname>Simmons</surname><given-names>D.L.</given-names></name></person-group><article-title>The cyclooxygenases</article-title><source>Genome Biol.</source><volume>5</volume><year>2004</year><fpage>241</fpage><pub-id pub-id-type="pmid">15345041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/gb-2004-5-9-241</pub-id><pub-id pub-id-type="pmcid">PMC522864</pub-id></element-citation></ref><ref id="bb0740"><label>148.</label><element-citation publication-type="journal" id="rf0740"><person-group person-group-type="author"><name name-style="western"><surname>Mattera</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Increased release of arachidonic acid and eicosanoids in iron-overloaded cardiomyocytes</article-title><source>Circulation</source><volume>103</volume><year>2001</year><fpage>2395</fpage><lpage>2401</lpage><pub-id pub-id-type="pmid">11352890</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/01.cir.103.19.2395</pub-id></element-citation></ref><ref id="bb0745"><label>149.</label><element-citation publication-type="journal" id="rf0745"><person-group person-group-type="author"><name name-style="western"><surname>De Simone</surname><given-names>G.</given-names></name><etal/></person-group><article-title>Human nitrobindin: the first example of an all-&#946;-barrel ferric heme-protein that catalyzes peroxynitrite detoxification</article-title><source>FEBS Open Bio.</source><volume>8</volume><year>2018</year><fpage>2002</fpage><lpage>2010</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/2211-5463.12534</pub-id><pub-id pub-id-type="pmcid">PMC6275384</pub-id><pub-id pub-id-type="pmid">30524950</pub-id></element-citation></ref><ref id="bb0750"><label>150.</label><element-citation publication-type="journal" id="rf0750"><person-group person-group-type="author"><name name-style="western"><surname>Putnam</surname><given-names>C.D.</given-names></name><etal/></person-group><article-title>Active and inhibited human catalase structures: ligand and NADPH binding and catalytic mechanism</article-title><source>J. Mol. Biol.</source><volume>296</volume><year>2000</year><fpage>295</fpage><lpage>309</lpage><pub-id pub-id-type="pmid">10656833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1006/jmbi.1999.3458</pub-id></element-citation></ref><ref id="bb0755"><label>151.</label><element-citation publication-type="journal" id="rf0755"><person-group person-group-type="author"><name name-style="western"><surname>McDonough</surname><given-names>M.A.</given-names></name><etal/></person-group><article-title>Structure of human phytanoyl-CoA 2-hydroxylase identifies molecular mechanisms of Refsum disease</article-title><source>J. Biol. Chem.</source><volume>280</volume><year>2005</year><fpage>41101</fpage><lpage>41110</lpage><pub-id pub-id-type="pmid">16186124</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M507528200</pub-id></element-citation></ref><ref id="bb0760"><label>152.</label><element-citation publication-type="book" id="rf0760"><person-group person-group-type="author"><name name-style="western"><surname>Kohlmeier</surname><given-names>M.</given-names></name></person-group><part-title>Amino acids and nitrogen compounds</part-title><person-group person-group-type="editor"><name name-style="western"><surname>Kohlmeier</surname><given-names>M.</given-names></name></person-group><source>Nutrient Metabolism</source><edition>2nd edn</edition><year>2015</year><publisher-name>Academic Press</publisher-name><fpage>265</fpage><lpage>477</lpage></element-citation></ref><ref id="bb0765"><label>153.</label><element-citation publication-type="journal" id="rf0765"><person-group person-group-type="author"><name name-style="western"><surname>Seo</surname><given-names>S.K.</given-names></name><name name-style="western"><surname>Kwon</surname><given-names>B.</given-names></name></person-group><article-title>Immune regulation through tryptophan metabolism</article-title><source>Exp. Mol. Med.</source><volume>55</volume><year>2023</year><fpage>1371</fpage><lpage>1379</lpage><pub-id pub-id-type="pmid">37394584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s12276-023-01028-7</pub-id><pub-id pub-id-type="pmcid">PMC10394086</pub-id></element-citation></ref><ref id="bb0770"><label>154.</label><element-citation publication-type="journal" id="rf0770"><person-group person-group-type="author"><name name-style="western"><surname>Wenninger</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Associations between tryptophan and iron metabolism observed in individuals with and without iron deficiency</article-title><source>Sci. Rep.</source><volume>9</volume><year>2019</year><fpage>14548</fpage><pub-id pub-id-type="pmid">31601941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41598-019-51215-8</pub-id><pub-id pub-id-type="pmcid">PMC6787180</pub-id></element-citation></ref><ref id="bb0775"><label>155.</label><element-citation publication-type="journal" id="rf0775"><person-group person-group-type="author"><name name-style="western"><surname>Mendel</surname><given-names>R.R.</given-names></name></person-group><article-title>The molybdenum cofactor</article-title><source>J. Biol. Chem.</source><volume>288</volume><year>2013</year><fpage>13165</fpage><lpage>13172</lpage><pub-id pub-id-type="pmid">23539623</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.R113.455311</pub-id><pub-id pub-id-type="pmcid">PMC3650355</pub-id></element-citation></ref><ref id="bb0780"><label>156.</label><element-citation publication-type="journal" id="rf0780"><person-group person-group-type="author"><name name-style="western"><surname>Schwarz</surname><given-names>G.</given-names></name></person-group><article-title>Molybdenum cofactor and human disease</article-title><source>Curr. Opin. Chem. Biol.</source><volume>31</volume><year>2016</year><fpage>179</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">27055119</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbpa.2016.03.016</pub-id></element-citation></ref><ref id="bb0785"><label>157.</label><element-citation publication-type="journal" id="rf0785"><person-group person-group-type="author"><name name-style="western"><surname>Bender</surname><given-names>D.</given-names></name><etal/></person-group><article-title>Oxygen and nitrite reduction by heme-deficient sulphite oxidase in a patient with mild sulphite oxidase deficiency</article-title><source>J. Inherit. Metab. Dis.</source><volume>43</volume><year>2020</year><fpage>748</fpage><lpage>757</lpage><pub-id pub-id-type="pmid">31950508</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jimd.12216</pub-id></element-citation></ref><ref id="bb0790"><label>158.</label><element-citation publication-type="journal" id="rf0790"><person-group person-group-type="author"><name name-style="western"><surname>Kelley</surname><given-names>M.K.</given-names></name><name name-style="western"><surname>Amy</surname><given-names>N.K.</given-names></name></person-group><article-title>Effect of molybdenum-deficient and low iron diets on xanthine oxidase activity and iron status in rats</article-title><source>J. Nutr.</source><volume>114</volume><year>1984</year><fpage>1652</fpage><lpage>1659</lpage><pub-id pub-id-type="pmid">6547977</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/114.9.1652</pub-id></element-citation></ref><ref id="bb0795"><label>159.</label><element-citation publication-type="journal" id="rf0795"><person-group person-group-type="author"><name name-style="western"><surname>Rao</surname><given-names>N.J.</given-names></name><name name-style="western"><surname>Jagadeesan</surname><given-names>V.</given-names></name></person-group><article-title>Effect of long term iron deficiency on the activities of hepatic and extra-hepatic drug metabolising enzymes in Fischer rats</article-title><source>Comp. Biochem. Physiol. B Biochem. Mol. Biol.</source><volume>110</volume><year>1995</year><fpage>167</fpage><lpage>173</lpage><pub-id pub-id-type="pmid">7858940</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0305-0491(94)00109-8</pub-id></element-citation></ref><ref id="bb0800"><label>160.</label><element-citation publication-type="journal" id="rf0800"><person-group person-group-type="author"><name name-style="western"><surname>Jabara</surname><given-names>H.H.</given-names></name><etal/></person-group><article-title>A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency</article-title><source>Nat. Genet.</source><volume>48</volume><year>2016</year><fpage>74</fpage><lpage>78</lpage><pub-id pub-id-type="pmid">26642240</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/ng.3465</pub-id><pub-id pub-id-type="pmcid">PMC4696875</pub-id></element-citation></ref><ref id="bb0805"><label>161.</label><element-citation publication-type="journal" id="rf0805"><person-group person-group-type="author"><name name-style="western"><surname>Aljohani</surname><given-names>A.H.</given-names></name><etal/></person-group><article-title>Clinical and immunological characterization of combined immunodeficiency due to TFRC mutation in eight patients</article-title><source>J. Clin. Immunol.</source><volume>40</volume><year>2020</year><fpage>1103</fpage><lpage>1110</lpage><pub-id pub-id-type="pmid">32851577</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10875-020-00851-1</pub-id><pub-id pub-id-type="pmcid">PMC7449781</pub-id></element-citation></ref><ref id="bb0810"><label>162.</label><element-citation publication-type="journal" id="rf0810"><person-group person-group-type="author"><name name-style="western"><surname>Aba</surname><given-names>&#220;.</given-names></name><etal/></person-group><article-title>A novel homozygous germline mutation in transferrin receptor 1 (TfR1) leads to combined immunodeficiency and provides new insights into iron-immunity axis</article-title><source>J. Clin. Immunol.</source><volume>44</volume><year>2024</year><fpage>55</fpage><pub-id pub-id-type="pmid">38270687</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10875-024-01658-0</pub-id><pub-id pub-id-type="pmcid">PMC10811203</pub-id></element-citation></ref><ref id="bb0815"><label>163.</label><element-citation publication-type="journal" id="rf0815"><person-group person-group-type="author"><name name-style="western"><surname>F&#252;l&#246;p</surname><given-names>T.</given-names><suffix>Jr.</suffix></name><etal/></person-group><article-title>Relationship between the response to influenza vaccination and the nutritional status in institutionalized elderly subjects</article-title><source>J. Gerontol. A Biol. Sci. Med. Sci.</source><volume>54</volume><year>1999</year><fpage>M59</fpage><lpage>M64</lpage><pub-id pub-id-type="pmid">10051856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/gerona/54.2.m59</pub-id></element-citation></ref><ref id="bb0820"><label>164.</label><element-citation publication-type="journal" id="rf0820"><person-group person-group-type="author"><name name-style="western"><surname>Drakesmith</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Vaccine efficacy and iron deficiency: an intertwined pair?</article-title><source>Lancet Haematol.</source><volume>8</volume><year>2021</year><fpage>e666</fpage><lpage>e669</lpage><pub-id pub-id-type="pmid">34450104</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2352-3026(21)00201-5</pub-id><pub-id pub-id-type="pmcid">PMC8384343</pub-id></element-citation></ref><ref id="bb0825"><label>165.</label><element-citation publication-type="journal" id="rf0825"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Iron metabolism and immune regulation</article-title><source>Front. Immunol.</source><volume>13</volume><year>2022</year><object-id pub-id-type="publisher-id">816282</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2022.816282</pub-id><pub-id pub-id-type="pmcid">PMC8983924</pub-id><pub-id pub-id-type="pmid">35401569</pub-id></element-citation></ref><ref id="bb0830"><label>166.</label><element-citation publication-type="journal" id="rf0830"><person-group person-group-type="author"><name name-style="western"><surname>Soares</surname><given-names>M.P.</given-names></name><name name-style="western"><surname>Hamza</surname><given-names>I.</given-names></name></person-group><article-title>Macrophages and iron metabolism</article-title><source>Immunity</source><volume>44</volume><year>2016</year><fpage>492</fpage><lpage>504</lpage><pub-id pub-id-type="pmid">26982356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2016.02.016</pub-id><pub-id pub-id-type="pmcid">PMC4794998</pub-id></element-citation></ref><ref id="bb0835"><label>167.</label><element-citation publication-type="journal" id="rf0835"><person-group person-group-type="author"><name name-style="western"><surname>Cronin</surname><given-names>S.J.F.</given-names></name><etal/></person-group><article-title>The role of iron regulation in immunometabolism and immune-related disease</article-title><source>Front. Mol. Biosci.</source><volume>6</volume><year>2019</year><fpage>116</fpage><pub-id pub-id-type="pmid">31824960</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmolb.2019.00116</pub-id><pub-id pub-id-type="pmcid">PMC6883604</pub-id></element-citation></ref><ref id="bb0840"><label>168.</label><element-citation publication-type="journal" id="rf0840"><person-group person-group-type="author"><name name-style="western"><surname>Arnhold</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Redox properties of myeloperoxidase</article-title><source>Redox Rep.</source><volume>8</volume><year>2003</year><fpage>179</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">14599340</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/135100003225002664</pub-id></element-citation></ref><ref id="bb0845"><label>169.</label><element-citation publication-type="journal" id="rf0845"><person-group person-group-type="author"><name name-style="western"><surname>Vazquez-Torres</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Antimicrobial actions of the NADPH phagocyte oxidase and inducible nitric oxide synthase in experimental salmonellosis. I. Effects on microbial killing by activated peritoneal macrophages in vitro</article-title><source>J. Exp. Med.</source><volume>192</volume><year>2000</year><fpage>227</fpage><lpage>236</lpage><pub-id pub-id-type="pmid">10899909</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.192.2.227</pub-id><pub-id pub-id-type="pmcid">PMC2193262</pub-id></element-citation></ref><ref id="bb0850"><label>170.</label><element-citation publication-type="journal" id="rf0850"><person-group person-group-type="author"><name name-style="western"><surname>Frost</surname><given-names>J.N.</given-names></name><etal/></person-group><article-title>Plasma iron controls neutrophil production and function</article-title><source>Sci. Adv.</source><volume>8</volume><year>2022</year><object-id pub-id-type="publisher-id">eabq5384</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.abq5384</pub-id><pub-id pub-id-type="pmcid">PMC9534512</pub-id><pub-id pub-id-type="pmid">36197985</pub-id></element-citation></ref><ref id="bb0855"><label>171.</label><element-citation publication-type="journal" id="rf0855"><person-group person-group-type="author"><name name-style="western"><surname>Bonadonna</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Iron regulatory protein (IRP)-mediated iron homeostasis is critical for neutrophil development and differentiation in the bone marrow</article-title><source>Sci. Adv.</source><volume>8</volume><year>2022</year><object-id pub-id-type="publisher-id">eabq4469</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/sciadv.abq4469</pub-id><pub-id pub-id-type="pmcid">PMC9534496</pub-id><pub-id pub-id-type="pmid">36197975</pub-id></element-citation></ref><ref id="bb0860"><label>172.</label><element-citation publication-type="journal" id="rf0860"><person-group person-group-type="author"><name name-style="western"><surname>Recalcati</surname><given-names>S.</given-names></name><etal/></person-group><article-title>Differential regulation of iron homeostasis during human macrophage polarized activation</article-title><source>Eur. J. Immunol.</source><volume>40</volume><year>2010</year><fpage>824</fpage><lpage>835</lpage><pub-id pub-id-type="pmid">20039303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/eji.200939889</pub-id></element-citation></ref><ref id="bb0865"><label>173.</label><element-citation publication-type="journal" id="rf0865"><person-group person-group-type="author"><name name-style="western"><surname>Sindrilaru</surname><given-names>A.</given-names></name><etal/></person-group><article-title>An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice</article-title><source>J. Clin. Invest.</source><volume>121</volume><year>2011</year><fpage>985</fpage><lpage>997</lpage><pub-id pub-id-type="pmid">21317534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI44490</pub-id><pub-id pub-id-type="pmcid">PMC3049372</pub-id></element-citation></ref><ref id="bb0870"><label>174.</label><element-citation publication-type="journal" id="rf0870"><person-group person-group-type="author"><name name-style="western"><surname>Pereira</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Acute iron deprivation reprograms human macrophage metabolism and reduces inflammation in vivo</article-title><source>Cell Rep.</source><volume>28</volume><year>2019</year><fpage>498</fpage><lpage>511</lpage><pub-id pub-id-type="pmid">31291584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2019.06.039</pub-id><pub-id pub-id-type="pmcid">PMC6635384</pub-id></element-citation></ref><ref id="bb0875"><label>175.</label><element-citation publication-type="journal" id="rf0875"><person-group person-group-type="author"><name name-style="western"><surname>Glas</surname><given-names>R.</given-names></name><etal/></person-group><article-title>Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype. An adaptive component of NK cell-mediated responses</article-title><source>J. Exp. Med.</source><volume>191</volume><year>2000</year><fpage>129</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">10620611</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1084/jem.191.1.129</pub-id><pub-id pub-id-type="pmcid">PMC2195802</pub-id></element-citation></ref><ref id="bb0880"><label>176.</label><element-citation publication-type="journal" id="rf0880"><person-group person-group-type="author"><name name-style="western"><surname>Littwitz-Salomon</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Metabolic requirements of NK cells during the acute response against retroviral infection</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>5376</fpage><pub-id pub-id-type="pmid">34508086</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-25715-z</pub-id><pub-id pub-id-type="pmcid">PMC8433386</pub-id></element-citation></ref><ref id="bb0885"><label>177.</label><element-citation publication-type="journal" id="rf0885"><person-group person-group-type="author"><name name-style="western"><surname>Chaplin</surname><given-names>D.D.</given-names></name></person-group><article-title>Overview of the immune response</article-title><source>J. Allergy Clin. Immunol.</source><volume>125</volume><year>2010</year><fpage>S3</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">20176265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2009.12.980</pub-id><pub-id pub-id-type="pmcid">PMC2923430</pub-id></element-citation></ref><ref id="bb0890"><label>178.</label><element-citation publication-type="journal" id="rf0890"><person-group person-group-type="author"><name name-style="western"><surname>Park</surname><given-names>Y.J.</given-names></name><etal/></person-group><article-title>The role of calcium-calcineurin-NFAT signaling pathway in health and autoimmune diseases</article-title><source>Front. Immunol.</source><volume>11</volume><year>2020</year><fpage>195</fpage><pub-id pub-id-type="pmid">32210952</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fimmu.2020.00195</pub-id><pub-id pub-id-type="pmcid">PMC7075805</pub-id></element-citation></ref><ref id="bb0895"><label>179.</label><element-citation publication-type="journal" id="rf0895"><person-group person-group-type="author"><name name-style="western"><surname>Mertz</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Kinetic and spectroscopic analyses of mutants of a conserved histidine in the metallophosphatases calcineurin and lambda protein phosphatase</article-title><source>J. Biol. Chem.</source><volume>272</volume><year>1997</year><fpage>21296</fpage><lpage>21302</lpage><pub-id pub-id-type="pmid">9261141</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.272.34.21296</pub-id></element-citation></ref><ref id="bb0900"><label>180.</label><element-citation publication-type="journal" id="rf0900"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Iron deprivation restrains the differentiation and pathogenicity of T helper 17 cell</article-title><source>J. Leukoc. Biol.</source><volume>110</volume><year>2021</year><fpage>1057</fpage><lpage>1067</lpage><pub-id pub-id-type="pmid">34612525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/JLB.3MA0821-015R</pub-id></element-citation></ref><ref id="bb0905"><label>181.</label><element-citation publication-type="journal" id="rf0905"><person-group person-group-type="author"><name name-style="western"><surname>Lai</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Iron controls T helper cell pathogenicity by promoting glucose metabolism in autoimmune myopathy</article-title><source>Clin. Transl. Med.</source><volume>12</volume><year>2022</year><object-id pub-id-type="publisher-id">e999</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ctm2.999</pub-id><pub-id pub-id-type="pmcid">PMC9345506</pub-id><pub-id pub-id-type="pmid">35917405</pub-id></element-citation></ref><ref id="bb0910"><label>182.</label><element-citation publication-type="journal" id="rf0910"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Z.</given-names></name><etal/></person-group><article-title>Iron drives T helper cell pathogenicity by promoting RNA-binding protein PCBP1-mediated proinflammatory cytokine production</article-title><source>Immunity</source><volume>49</volume><year>2018</year><fpage>80</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">29958803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2018.05.008</pub-id></element-citation></ref><ref id="bb0915"><label>183.</label><element-citation publication-type="journal" id="rf0915"><person-group person-group-type="author"><name name-style="western"><surname>Georgieff</surname><given-names>M.K.</given-names></name><etal/></person-group><article-title>Nutritional influences on brain development</article-title><source>Acta Paediatr.</source><volume>107</volume><year>2018</year><fpage>1310</fpage><lpage>1321</lpage><pub-id pub-id-type="pmid">29468731</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/apa.14287</pub-id><pub-id pub-id-type="pmcid">PMC6045434</pub-id></element-citation></ref><ref id="bb0920"><label>184.</label><element-citation publication-type="journal" id="rf0920"><person-group person-group-type="author"><name name-style="western"><surname>Berthou</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Iron, neuro-bioavailability and depression</article-title><source>EJHaem</source><volume>3</volume><year>2022</year><fpage>263</fpage><lpage>275</lpage><pub-id pub-id-type="pmid">35846210</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jha2.321</pub-id><pub-id pub-id-type="pmcid">PMC9175715</pub-id></element-citation></ref><ref id="bb0925"><label>185.</label><element-citation publication-type="journal" id="rf0925"><person-group person-group-type="author"><name name-style="western"><surname>Manconi</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Restless legs syndrome</article-title><source>Nat. Rev. Dis. Primers</source><volume>7</volume><year>2021</year><fpage>80</fpage><pub-id pub-id-type="pmid">34732752</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-021-00311-z</pub-id></element-citation></ref><ref id="bb0930"><label>186.</label><element-citation publication-type="journal" id="rf0930"><person-group person-group-type="author"><name name-style="western"><surname>Tran</surname><given-names>P.V.</given-names></name><etal/></person-group><article-title>Fetal iron deficiency induces chromatin remodeling at the Bdnf locus in adult rat hippocampus</article-title><source>Am. J. Physiol. Regul. Integr. Comp. Physiol.</source><volume>308</volume><year>2015</year><fpage>R276</fpage><lpage>R282</lpage><pub-id pub-id-type="pmid">25519736</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.00429.2014</pub-id><pub-id pub-id-type="pmcid">PMC4329464</pub-id></element-citation></ref><ref id="bb0935"><label>187.</label><element-citation publication-type="journal" id="rf0935"><person-group person-group-type="author"><name name-style="western"><surname>Connor</surname><given-names>J.R.</given-names></name><name name-style="western"><surname>Menzies</surname><given-names>S.L.</given-names></name></person-group><article-title>Relationship of iron to oligodendrocytes and myelination</article-title><source>Glia</source><volume>17</volume><year>1996</year><fpage>83</fpage><lpage>93</lpage><pub-id pub-id-type="pmid">8776576</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/(SICI)1098-1136(199606)17:2&lt;83::AID-GLIA1&gt;3.0.CO;2-7</pub-id></element-citation></ref><ref id="bb0940"><label>188.</label><element-citation publication-type="journal" id="rf0940"><person-group person-group-type="author"><name name-style="western"><surname>Georgieff</surname><given-names>M.K.</given-names></name></person-group><article-title>The importance of iron deficiency in pregnancy on fetal, neonatal, and infant neurodevelopmental outcomes</article-title><source>Int. J. Gynaecol. Obstet.</source><volume>162</volume><year>2023</year><fpage>83</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">37538010</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ijgo.14951</pub-id><pub-id pub-id-type="pmcid">PMC10421617</pub-id></element-citation></ref><ref id="bb0945"><label>189.</label><element-citation publication-type="journal" id="rf0945"><person-group person-group-type="author"><name name-style="western"><surname>Hu</surname><given-names>S.</given-names></name><name name-style="western"><surname>Rayman</surname><given-names>M.P.</given-names></name></person-group><article-title>Multiple nutritional factors and the risk of Hashimoto's thyroiditis</article-title><source>Thyroid</source><volume>27</volume><year>2017</year><fpage>597</fpage><lpage>610</lpage><pub-id pub-id-type="pmid">28290237</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1089/thy.2016.0635</pub-id></element-citation></ref><ref id="bb0950"><label>190.</label><element-citation publication-type="journal" id="rf0950"><person-group person-group-type="author"><name name-style="western"><surname>L&#243;pez</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Energy balance regulation by thyroid hormones at central level</article-title><source>Trends Mol. Med.</source><volume>19</volume><year>2013</year><fpage>418</fpage><lpage>427</lpage><pub-id pub-id-type="pmid">23707189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.molmed.2013.04.004</pub-id></element-citation></ref><ref id="bb0955"><label>191.</label><element-citation publication-type="journal" id="rf0955"><person-group person-group-type="author"><name name-style="western"><surname>Hess</surname><given-names>S.Y.</given-names></name><etal/></person-group><article-title>Iron deficiency anemia reduces thyroid peroxidase activity in rats</article-title><source>J. Nutr.</source><volume>132</volume><year>2002</year><fpage>1951</fpage><lpage>1955</lpage><pub-id pub-id-type="pmid">12097675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/132.7.1951</pub-id></element-citation></ref><ref id="bb0960"><label>192.</label><element-citation publication-type="journal" id="rf0960"><person-group person-group-type="author"><name name-style="western"><surname>Beard</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Interactions of iron deficiency, anemia, and thyroid hormone levels in response of rats to cold exposure</article-title><source>Life Sci.</source><volume>30</volume><year>1982</year><fpage>691</fpage><lpage>697</lpage><pub-id pub-id-type="pmid">7070226</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0024-3205(82)90285-5</pub-id></element-citation></ref><ref id="bb0965"><label>193.</label><element-citation publication-type="journal" id="rf0965"><person-group person-group-type="author"><name name-style="western"><surname>Beard</surname><given-names>J.L.</given-names></name><etal/></person-group><article-title>Impaired thermoregulation and thyroid function in iron-deficiency anemia</article-title><source>Am. J. Clin. Nutr.</source><volume>52</volume><year>1990</year><fpage>813</fpage><lpage>819</lpage><pub-id pub-id-type="pmid">2239756</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcn/52.5.813</pub-id></element-citation></ref><ref id="bb0970"><label>194.</label><element-citation publication-type="journal" id="rf0970"><person-group person-group-type="author"><name name-style="western"><surname>Martinez-Torres</surname><given-names>C.</given-names></name><etal/></person-group><article-title>Effect of exposure to low temperature on normal and iron-deficient subjects</article-title><source>Am. J. Phys.</source><volume>246</volume><year>1984</year><fpage>R380</fpage><lpage>R383</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpregu.1984.246.3.R380</pub-id><pub-id pub-id-type="pmid">6703092</pub-id></element-citation></ref><ref id="bb0975"><label>195.</label><element-citation publication-type="journal" id="rf0975"><person-group person-group-type="author"><name name-style="western"><surname>Ricard-Blum</surname><given-names>S.</given-names></name></person-group><article-title>The collagen family</article-title><source>Cold Spring Harb. Perspect. Biol.</source><volume>3</volume><year>2011</year><object-id pub-id-type="publisher-id">a004978</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1101/cshperspect.a004978</pub-id><pub-id pub-id-type="pmcid">PMC3003457</pub-id><pub-id pub-id-type="pmid">21421911</pub-id></element-citation></ref><ref id="bb0980"><label>196.</label><element-citation publication-type="journal" id="rf0980"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Iron deficiency and iron deficiency anemia: potential risk factors in bone loss</article-title><source>Int. J. Mol. Sci.</source><volume>24</volume><year>2023</year><fpage>6891</fpage><pub-id pub-id-type="pmid">37108056</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms24086891</pub-id><pub-id pub-id-type="pmcid">PMC10138976</pub-id></element-citation></ref><ref id="bb0985"><label>197.</label><element-citation publication-type="journal" id="rf0985"><person-group person-group-type="author"><name name-style="western"><surname>von Lintig</surname><given-names>J.</given-names></name><etal/></person-group><article-title>Carotenoid metabolism at the intestinal barrier</article-title><source>Biochim. Biophys. Acta Mol. Cell Biol. Lipids</source><volume>1865</volume><year>2020</year><object-id pub-id-type="publisher-id">158580</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbalip.2019.158580</pub-id><pub-id pub-id-type="pmcid">PMC7987234</pub-id><pub-id pub-id-type="pmid">31794861</pub-id></element-citation></ref><ref id="bb0990"><label>198.</label><element-citation publication-type="journal" id="rf0990"><person-group person-group-type="author"><name name-style="western"><surname>Isoherranen</surname><given-names>N.</given-names></name><name name-style="western"><surname>Zhong</surname><given-names>G.</given-names></name></person-group><article-title>Biochemical and physiological importance of the CYP26 retinoic acid hydroxylases</article-title><source>Pharmacol. Ther.</source><volume>204</volume><year>2019</year><object-id pub-id-type="publisher-id">107400</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.pharmthera.2019.107400</pub-id><pub-id pub-id-type="pmcid">PMC6881548</pub-id><pub-id pub-id-type="pmid">31419517</pub-id></element-citation></ref><ref id="bb0995"><label>199.</label><element-citation publication-type="journal" id="rf0995"><person-group person-group-type="author"><name name-style="western"><surname>Jang</surname><given-names>J.T.</given-names></name><etal/></person-group><article-title>Kinetic analysis shows that iron deficiency decreases liver vitamin A mobilization in rats</article-title><source>J. Nutr.</source><volume>130</volume><year>2000</year><fpage>1291</fpage><lpage>1296</lpage><pub-id pub-id-type="pmid">10801932</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/130.5.1291</pub-id></element-citation></ref><ref id="bb1000"><label>200.</label><element-citation publication-type="journal" id="rf1000"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>Dietary iron repletion stimulates hepatic mobilization of vitamin A in previously iron-deficient rats as determined by model-based compartmental analysis</article-title><source>J. Nutr.</source><volume>150</volume><year>2020</year><fpage>1982</fpage><lpage>1988</lpage><pub-id pub-id-type="pmid">32297934</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/jn/nxaa098</pub-id><pub-id pub-id-type="pmcid">PMC7443722</pub-id></element-citation></ref><ref id="bb1005"><label>201.</label><element-citation publication-type="journal" id="rf1005"><person-group person-group-type="author"><name name-style="western"><surname>Greer</surname><given-names>R.M.</given-names></name><etal/></person-group><article-title>Vitamin A levels in patients with CF are influenced by the inflammatory response</article-title><source>J. Cyst. Fibros.</source><volume>3</volume><year>2004</year><fpage>143</fpage><lpage>149</lpage><pub-id pub-id-type="pmid">15463900</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jcf.2004.04.003</pub-id></element-citation></ref><ref id="bb1010"><label>202.</label><element-citation publication-type="journal" id="rf1010"><person-group person-group-type="author"><name name-style="western"><surname>Moiseyev</surname><given-names>G.</given-names></name><etal/></person-group><article-title>RPE65 is an iron(II)-dependent isomerohydrolase in the retinoid visual cycle</article-title><source>J. Biol. Chem.</source><volume>281</volume><year>2006</year><fpage>2835</fpage><lpage>2840</lpage><pub-id pub-id-type="pmid">16319067</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M508903200</pub-id></element-citation></ref><ref id="bb1015"><label>203.</label><element-citation publication-type="journal" id="rf1015"><person-group person-group-type="author"><name name-style="western"><surname>Poliakov</surname><given-names>E.</given-names></name><etal/></person-group><article-title>Key role of conserved histidines in recombinant mouse beta-carotene 15,15'-monooxygenase-1 activity</article-title><source>J. Biol. Chem.</source><volume>280</volume><year>2005</year><fpage>29217</fpage><lpage>29223</lpage><pub-id pub-id-type="pmid">15951442</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1074/jbc.M500409200</pub-id></element-citation></ref><ref id="bb1020"><label>204.</label><element-citation publication-type="journal" id="rf1020"><person-group person-group-type="author"><name name-style="western"><surname>Kong</surname><given-names>Y.</given-names></name><etal/></person-group><article-title>HIF2&#945; activation and mitochondrial deficit due to iron chelation cause retinal atrophy</article-title><source>EMBO Mol. Med.</source><volume>15</volume><year>2023</year><object-id pub-id-type="publisher-id">e16525</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.15252/emmm.202216525</pub-id><pub-id pub-id-type="pmcid">PMC9906391</pub-id><pub-id pub-id-type="pmid">36645044</pub-id></element-citation></ref><ref id="bb1025"><label>205.</label><element-citation publication-type="journal" id="rf1025"><person-group person-group-type="author"><name name-style="western"><surname>Lakhal-Littleton</surname><given-names>S.</given-names></name><etal/></person-group><article-title>An essential cell-autonomous role for hepcidin in cardiac iron homeostasis</article-title><source>Elife</source><volume>5</volume><year>2016</year><object-id pub-id-type="publisher-id">e19804</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7554/eLife.19804</pub-id><pub-id pub-id-type="pmcid">PMC5176354</pub-id><pub-id pub-id-type="pmid">27897970</pub-id></element-citation></ref><ref id="bb1030"><label>206.</label><element-citation publication-type="journal" id="rf1030"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Lethal cardiomyopathy in mice lacking transferrin receptor in the heart</article-title><source>Cell Rep.</source><volume>13</volume><year>2015</year><fpage>533</fpage><lpage>545</lpage><pub-id pub-id-type="pmid">26456827</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.celrep.2015.09.023</pub-id><pub-id pub-id-type="pmcid">PMC4618069</pub-id></element-citation></ref><ref id="bb1035"><label>207.</label><element-citation publication-type="journal" id="rf1035"><person-group person-group-type="author"><name name-style="western"><surname>Kalisch-Smith</surname><given-names>J.I.</given-names></name><etal/></person-group><article-title>Maternal iron deficiency perturbs embryonic cardiovascular development in mice</article-title><source>Nat. Commun.</source><volume>12</volume><year>2021</year><fpage>3447</fpage><pub-id pub-id-type="pmid">34103494</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-021-23660-5</pub-id><pub-id pub-id-type="pmcid">PMC8187484</pub-id></element-citation></ref><ref id="bb1040"><label>208.</label><element-citation publication-type="journal" id="rf1040"><person-group person-group-type="author"><name name-style="western"><surname>Hagler</surname><given-names>L.</given-names></name><etal/></person-group><article-title>Influence of dietary iron deficiency on hemoglobin, myoglobin, their respective reductases, and skeletal muscle mitochondrial respiration</article-title><source>Am. J. Clin. Nutr.</source><volume>34</volume><year>1981</year><fpage>2169</fpage><lpage>2177</lpage><pub-id pub-id-type="pmid">6271003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcn/34.10.2169</pub-id></element-citation></ref><ref id="bb1045"><label>209.</label><element-citation publication-type="journal" id="rf1045"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Myocardial iron deficiency and mitochondrial dysfunction in advanced heart failure in humans</article-title><source>J. Am. Heart Assoc.</source><volume>11</volume><year>2022</year><object-id pub-id-type="publisher-id">e022853</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/JAHA.121.022853</pub-id><pub-id pub-id-type="pmcid">PMC9238720</pub-id><pub-id pub-id-type="pmid">35656974</pub-id></element-citation></ref><ref id="bb1050"><label>210.</label><element-citation publication-type="journal" id="rf1050"><person-group person-group-type="author"><name name-style="western"><surname>Chung</surname><given-names>Y.J.</given-names></name><etal/></person-group><article-title>Iron-deficiency anemia results in transcriptional and metabolic remodeling in the heart toward a glycolytic phenotype</article-title><source>Front. Cardiovasc. Med.</source><volume>7</volume><year>2020</year><object-id pub-id-type="publisher-id">616920</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fcvm.2020.616920</pub-id><pub-id pub-id-type="pmcid">PMC7859254</pub-id><pub-id pub-id-type="pmid">33553263</pub-id></element-citation></ref><ref id="bb1055"><label>211.</label><element-citation publication-type="journal" id="rf1055"><person-group person-group-type="author"><name name-style="western"><surname>Cartier</surname><given-names>L.J.</given-names></name><etal/></person-group><article-title>Perturbation of mitochondrial composition in muscle by iron deficiency. Implications regarding regulation of mitochondrial assembly</article-title><source>J. Biol. Chem.</source><volume>261</volume><year>1986</year><fpage>13827</fpage><lpage>13832</lpage><pub-id pub-id-type="pmid">3020053</pub-id></element-citation></ref><ref id="bb1060"><label>212.</label><element-citation publication-type="journal" id="rf1060"><person-group person-group-type="author"><name name-style="western"><surname>Nemeth</surname><given-names>E.</given-names></name><etal/></person-group><article-title>IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin</article-title><source>J. Clin. Invest.</source><volume>113</volume><year>2004</year><fpage>1271</fpage><lpage>1276</lpage><pub-id pub-id-type="pmid">15124018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI20945</pub-id><pub-id pub-id-type="pmcid">PMC398432</pub-id></element-citation></ref><ref id="bb1065"><label>213.</label><element-citation publication-type="journal" id="rf1065"><person-group person-group-type="author"><name name-style="western"><surname>Qualls</surname><given-names>J.E.</given-names></name><name name-style="western"><surname>Murray</surname><given-names>P.J.</given-names></name></person-group><article-title>Immunometabolism within the tuberculosis granuloma: amino acids, hypoxia, and cellular respiration</article-title><source>Semin. Immunopathol.</source><volume>38</volume><year>2016</year><fpage>139</fpage><lpage>152</lpage><pub-id pub-id-type="pmid">26490974</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00281-015-0534-0</pub-id><pub-id pub-id-type="pmcid">PMC4779414</pub-id></element-citation></ref><ref id="bb1070"><label>214.</label><element-citation publication-type="journal" id="rf1070"><person-group person-group-type="author"><name name-style="western"><surname>Bullock</surname><given-names>G.C.</given-names></name><etal/></person-group><article-title>Iron control of erythroid development by a novel aconitase-associated regulatory pathway</article-title><source>Blood</source><volume>116</volume><year>2010</year><fpage>97</fpage><lpage>108</lpage><pub-id pub-id-type="pmid">20407036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2009-10-251496</pub-id><pub-id pub-id-type="pmcid">PMC2904585</pub-id></element-citation></ref><ref id="bb1075"><label>215.</label><element-citation publication-type="journal" id="rf1075"><person-group person-group-type="author"><name name-style="western"><surname>Shah</surname><given-names>A.</given-names></name><etal/></person-group><article-title>Systemic hypoferremia and severity of hypoxemic respiratory failure in COVID-19</article-title><source>Crit. Care</source><volume>24</volume><year>2020</year><fpage>320</fpage><pub-id pub-id-type="pmid">32517773</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13054-020-03051-w</pub-id><pub-id pub-id-type="pmcid">PMC7280775</pub-id></element-citation></ref><ref id="bb1080"><label>216.</label><element-citation publication-type="journal" id="rf1080"><person-group person-group-type="author"><name name-style="western"><surname>Hippchen</surname><given-names>T.</given-names></name><etal/></person-group><article-title>Hypoferremia is associated with increased hospitalization and oxygen demand in COVID-19 patients</article-title><source>Hemasphere</source><volume>4</volume><year>2020</year><object-id pub-id-type="publisher-id">e492</object-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/HS9.0000000000000492</pub-id><pub-id pub-id-type="pmcid">PMC7665253</pub-id><pub-id pub-id-type="pmid">33205000</pub-id></element-citation></ref><ref id="bb1085"><label>217.</label><element-citation publication-type="journal" id="rf1085"><person-group person-group-type="author"><name name-style="western"><surname>Sonnweber</surname><given-names>T.</given-names></name><etal/></person-group><article-title>The impact of iron dyshomeostasis and anaemia on long-term pulmonary recovery and persisting symptom burden after COVID-19: a prospective observational cohort study</article-title><source>Metabolites</source><volume>12</volume><year>2022</year><fpage>546</fpage><pub-id pub-id-type="pmid">35736479</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/metabo12060546</pub-id><pub-id pub-id-type="pmcid">PMC9228477</pub-id></element-citation></ref><ref id="bb1090"><label>218.</label><element-citation publication-type="journal" id="rf1090"><person-group person-group-type="author"><name name-style="western"><surname>Hanson</surname><given-names>A.L.</given-names></name><etal/></person-group><article-title>Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19</article-title><source>Nat. Immunol.</source><volume>25</volume><year>2024</year><fpage>471</fpage><lpage>482</lpage><pub-id pub-id-type="pmid">38429458</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-024-01754-8</pub-id><pub-id pub-id-type="pmcid">PMC10907301</pub-id></element-citation></ref><ref id="bb1095"><label>219.</label><element-citation publication-type="journal" id="rf1095"><person-group person-group-type="author"><name name-style="western"><surname>Marques</surname><given-names>O.</given-names></name><name name-style="western"><surname>Muckenthaler</surname><given-names>M.U.</given-names></name></person-group><article-title>Alterations of iron homeostasis as a potential druggable driver of long COVID</article-title><source>Nat. Immunol.</source><volume>25</volume><year>2024</year><fpage>387</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">38429459</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41590-024-01759-3</pub-id></element-citation></ref><ref id="bb1100"><label>220.</label><element-citation publication-type="journal" id="rf1100"><person-group person-group-type="author"><name name-style="western"><surname>McNeill</surname><given-names>L.A.</given-names></name><etal/></person-group><article-title>Hypoxia-inducible factor prolyl hydroxylase 2 has a high affinity for ferrous iron and 2-oxoglutarate</article-title><source>Mol. BioSyst.</source><volume>1</volume><year>2005</year><fpage>321</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">16880998</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/b511249b</pub-id></element-citation></ref><ref id="bb1105"><label>221.</label><element-citation publication-type="journal" id="rf1105"><person-group person-group-type="author"><name name-style="western"><surname>Umate</surname><given-names>P.</given-names></name><etal/></person-group><article-title>Genome-wide comprehensive analysis of human helicases</article-title><source>Commun. Integr. Biol.</source><volume>4</volume><year>2011</year><fpage>118</fpage><lpage>137</lpage><pub-id pub-id-type="pmid">21509200</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/cib.4.1.13844</pub-id><pub-id pub-id-type="pmcid">PMC3073292</pub-id></element-citation></ref><ref id="bb1110"><label>222.</label><element-citation publication-type="journal" id="rf1110"><person-group person-group-type="author"><name name-style="western"><surname>Kremyanskaya</surname><given-names>M.</given-names></name><etal/></person-group><article-title>Rusfertide, a hepcidin mimetic, for control of erythrocytosis in polycythemia vera</article-title><source>N. Engl. J. Med.</source><volume>390</volume><year>2024</year><fpage>723</fpage><lpage>735</lpage><pub-id pub-id-type="pmid">38381675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa2308809</pub-id></element-citation></ref><ref id="bb1115"><label>223.</label><element-citation publication-type="journal" id="rf1115"><person-group person-group-type="author"><name name-style="western"><surname>Adams</surname><given-names>P.C.</given-names></name><etal/></person-group><article-title>Haemochromatosis</article-title><source>Lancet</source><volume>401</volume><year>2023</year><fpage>1811</fpage><lpage>1821</lpage><pub-id pub-id-type="pmid">37121243</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(23)00287-8</pub-id></element-citation></ref><ref id="bb1120"><label>224.</label><element-citation publication-type="journal" id="rf1120"><person-group person-group-type="author"><name name-style="western"><surname>Dixon</surname><given-names>S.J.</given-names></name><etal/></person-group><article-title>Human haploid cell genetics reveals roles for lipid metabolism genes in nonapoptotic cell death</article-title><source>ACS Chem. Biol.</source><volume>10</volume><year>2015</year><fpage>1604</fpage><lpage>1609</lpage><pub-id pub-id-type="pmid">25965523</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acschembio.5b00245</pub-id><pub-id pub-id-type="pmcid">PMC4509420</pub-id></element-citation></ref><ref id="bb1125"><label>225.</label><element-citation publication-type="journal" id="rf1125"><person-group person-group-type="author"><name name-style="western"><surname>Doll</surname><given-names>S.</given-names></name><etal/></person-group><article-title>ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition</article-title><source>Nat. Chem. Biol.</source><volume>13</volume><year>2017</year><fpage>91</fpage><lpage>98</lpage><pub-id pub-id-type="pmid">27842070</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nchembio.2239</pub-id><pub-id pub-id-type="pmcid">PMC5610546</pub-id></element-citation></ref><ref id="bb1130"><label>226.</label><element-citation publication-type="journal" id="rf1130"><person-group person-group-type="author"><name name-style="western"><surname>Kagan</surname><given-names>V.E.</given-names></name><etal/></person-group><article-title>Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis</article-title><source>Nat. Chem. Biol.</source><volume>13</volume><year>2017</year><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">27842066</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nchembio.2238</pub-id><pub-id pub-id-type="pmcid">PMC5506843</pub-id></element-citation></ref><ref id="bb1135"><label>227.</label><element-citation publication-type="journal" id="rf1135"><person-group person-group-type="author"><name name-style="western"><surname>Yuan</surname><given-names>H.</given-names></name><etal/></person-group><article-title>Identification of ACSL4 as a biomarker and contributor of ferroptosis</article-title><source>Biochem. Biophys. Res. Commun.</source><volume>478</volume><year>2016</year><fpage>1338</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">27565726</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbrc.2016.08.124</pub-id></element-citation></ref><ref id="bb1140"><label>228.</label><element-citation publication-type="journal" id="rf1140"><person-group person-group-type="author"><name name-style="western"><surname>Dixon</surname><given-names>S.J.</given-names></name><name name-style="western"><surname>Olzmann</surname><given-names>J.A.</given-names></name></person-group><article-title>The cell biology of ferroptosis</article-title><source>Nat. Rev. Mol. Cell Biol.</source><year>2024</year><comment>Published online February 16, 2024. </comment><pub-id pub-id-type="doi">10.1038/s41580-024-00703-5</pub-id><pub-id pub-id-type="pmid">38366038</pub-id></element-citation></ref></ref-list><glossary id="gl0005"><title>Glossary</title><def-list id="gs0005"><def-item id="ge0005"><term><bold>2-Oxoglutarate dependent dioxygenases (2-OGDDs)</bold></term><def><p>oxygen-, iron- and 2-oxoglutarate-requiring enzymes that mediate hydroxylation reactions.</p></def></def-item><def-item id="ge0010"><term><bold>3-Hydroxyanthranilate 3,4-dioxygenase (HAAO)</bold></term><def><p>involved in kynurenine production.</p></def></def-item><def-item id="ge0015"><term><bold>4-Hydroxyphenylpyruvate dioxygenase (HPD)</bold></term><def><p>involved in breakdown of tyrosine.</p></def></def-item><def-item id="ge0020"><term><bold>5-aminolevulinic acid synthase (ALAS)-1/2</bold></term><def><p>enzymes involved in production of 5-aminolevulinic acid, the first step of haem synthesis.</p></def></def-item><def-item id="ge0025"><term><bold>Alkylation B homolog (ALKBH) enzymes</bold></term><def><p>2-OGDD enzymes involved in hydroxylation and demethylation of substrates, including DNA, mRNAs and tRNAs.</p></def></def-item><def-item id="ge0030"><term><bold>Brain-derived neurotrophic factor (BDNF)</bold></term><def><p>growth factor that promotes neuronal survival and growth.</p></def></def-item><def-item id="ge0035"><term><bold>Cytochrome P450 (CYP) enzymes</bold></term><def><p>haem-dependent enzymes, frequently mono-oxygenases, involved in cellular metabolism and xenobiotic detoxification.</p></def></def-item><def-item id="ge0040"><term><bold>Deoxyhypusine monooxygenase (DOHH)</bold></term><def><p>conjugates a hypusine moiety to eIF5A.</p></def></def-item><def-item id="ge0045"><term><bold>Electron transfer flavoprotein dehydrogenase (ETFDH)</bold></term><def><p>enzyme involved in linking &#946;-oxidation to the ETC.</p></def></def-item><def-item id="ge0050"><term><bold>Fatty acid desaturase (FADS)</bold></term><def><p>enzymes involved in formation of double bonds within fatty acid chains.</p></def></def-item><def-item id="ge0055"><term><bold>Fe-S cluster assembly 1 and 2 (ISCA1/2)</bold></term><def><p>involved in production of [4Fe-4S] clusters.</p></def></def-item><def-item id="ge0060"><term><bold>Glutaredoxins (GLRXs)</bold></term><def><p>proteins that utilise a glutathione cofactor to mediate redox reactions, including in Fe-S cluster synthesis.</p></def></def-item><def-item id="ge0065"><term><bold>Histone lysine demethylases (KDMs)</bold></term><def><p>2-OGDD enzymes involved in demethylation of lysine residues located in histone tails.</p></def></def-item><def-item id="ge0070"><term><bold>Homogentisate 1,2-dioxygenase (HGD)</bold></term><def><p>involved in breakdown of tyrosine.</p></def></def-item><def-item id="ge0075"><term><bold>Indoleamine 2,3-dioxygenase 1/2 (IDO1/2)</bold></term><def><p>involved in kynurenine production.</p></def></def-item><def-item id="ge0080"><term><bold>Lipoic acid synthase (LIAS)</bold></term><def><p>protein-modifying enzyme that conjugates lipoic acid to proteins.</p></def></def-item><def-item id="ge0085"><term><bold>Myeloperoxidase (MPO)</bold></term><def><p>haem-containing enzyme that uses H<sub>2</sub>O<sub>2</sub> to oxidise its targets.</p></def></def-item><def-item id="ge0090"><term><bold>NADH:ubiquinone oxidoreductase core subunit S1 (NDUFS1)</bold></term><def><p>core Fe-S cluster binding subunit of complex I.</p></def></def-item><def-item id="ge0095"><term><bold>Phenylalanine hydroxylase (PAH)</bold></term><def><p>converts phenylalanine to tyrosine.</p></def></def-item><def-item id="ge0100"><term><bold>Phosphoenolpyruvate carboxykinase (PCK)</bold></term><def><p>gluconeogenic enzyme that converts oxaloacetate to phosphoenolpyruvate.</p></def></def-item><def-item id="ge0105"><term><bold>Phosphoribosyl pyrophosphate aminotransferase (PPAT)</bold></term><def><p>catalyses first step in <italic toggle="yes">de novo purine synthesis.</italic></p></def></def-item><def-item id="ge0110"><term><bold>Phytanoyl-CoA dioxygenase (PHYH)</bold></term><def><p>peroxisomal enzyme involved in phytanic acid breakdown.</p></def></def-item><def-item id="ge0115"><term><bold>Polyunsaturated fatty acids (PUFAs)</bold></term><def><p>fatty acids containing multiple double bonds.</p></def></def-item><def-item id="ge0120"><term><bold>Procollagen lysine 2-oxoglutarate 5-dioxygenase (PLOD) enzymes</bold></term><def><p>2-OGDD enzymes that hydroxylate lysine residues during collagen synthesis.</p></def></def-item><def-item id="ge0125"><term><bold>Solute carrier (SLC) proteins</bold></term><def><p>superfamily of membrane transport proteins mediating substrate transfer, including iron, glucose, and sodium.</p></def></def-item><def-item id="ge0130"><term><bold>Stearoyl-CoA desaturase (SCD)</bold></term><def><p>converts unsaturated fatty acids to monosaturated fatty acids.</p></def></def-item><def-item id="ge0135"><term><bold>Ten-eleven translocases (TETs)</bold></term><def><p>2-OGDD enzymes involved in demethylation of DNA methyl groups.</p></def></def-item><def-item id="ge0140"><term><bold>Thyroid peroxidase (TPO)</bold></term><def><p>involved in production of the thyroid hormones triiodothyronine (T3) and thyroxine (T4).</p></def></def-item><def-item id="ge0145"><term><bold>Tryptophan 1,2-dioxygenase (TDO)</bold></term><def><p>involved in kynurenine production.</p></def></def-item><def-item id="ge0150"><term><bold>Tryptophan hydroxylase 1/2 (TPH1/2)</bold></term><def><p>converts tryptophan to serotonin.</p></def></def-item><def-item id="ge0155"><term><bold>Tyrosine hydroxylase (TH)</bold></term><def><p>involved in conversion of tyrosine to dopamine and noradrenaline.</p></def></def-item><def-item id="ge0160"><term><bold>Ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1 (UQCRFS1)</bold></term><def><p>Fe-S cluster binding subunit of complex III.</p></def></def-item><def-item id="ge0165"><term><bold>Xanthine dehydrogenase (XDH)</bold></term><def><p>a molybdenum and iron cofactor-containing enzyme that degrades xanthine in the purine degradation pathway.</p></def></def-item></def-list></glossary><ack id="ac0005"><sec id="s0160"><title>Acknowledgements</title><p id="p0395">This work was supported by a UK <funding-source id="gts0005"><institution-wrap><institution-id institution-id-type="doi">10.13039/501100000265</institution-id><institution>Medical Research Council</institution></institution-wrap></funding-source>, MRC Human Immunology Unit grant awarded to H.D. (<award-id award-type="grant" rid="gts0005">MCU_12010/10</award-id>). We acknowledge that, due to space limitations, we were unable to cite all relevant publications.</p></sec><sec sec-type="COI-statement" id="s0165"><title>Declaration of Interests</title><p id="p0400">H.D. is a consultant for Pharmacosmos. M.R.T and A.E.A. declare no competing interests.</p></sec></ack></back></article></pmc-articleset>